Aƙalla tsawon lokacin da waɗannan alamun suka kasance?
Kuma duk ciwon kirji ya kamata a bi da shi kamar haka musamman a shekarunka.
Kuma ka yi ta ƙonawa da ita.
Kuma za ku gwada yawan cholesterol da kuma karfin jini.
Kuma kana da zazzabi yanzu?
Kuma yanzu kana jin zafi a kirjinka?
Kuma kuna da wahalar numfashi?
Kuma za ka gaya mini abin da sauran alamun da ke tattare da hakan suke?
Kuma zafin jikinka ya tashi sosai.
Kuma ina da tari.
Kuma ina da wani sanyi cough.
Kuma a yau na ji zafi sosai a kirjina.
Kuma a lokacin ne zafin ya tashi.
Kuma hakan zai iya sa a ji ciwon kirji.
Kuma ina ganin ina da zazzabi.
Kuma ina so ka bayyana min inda zuciyarka take ciwo
Kuma suna da zazzabi.
Kuma da tarihin ciwon sukari
Kuma ka sani, kamar na ji kamar na yi rauni.
Kuma ka san mutane suna ciwon ni a koyaushe.
Kuma zuciyarka tana ciwo.
Kuma ka ce kana jin wani matsin lamba a kirjinka
Wani a cikin iyalin yana da matsalar zuciya, cututtukan zuciya, ciwon zuciya, yawan cholesterol, da kuma hawan jini.
Shin, akwai wasu alamun da za su iya sa ka ji kamar kana ciwon tsoka?
Shin akwai wasu marasa lafiya a cikin gida da suke da irin wannan alamun?
Shin kana da wasu alamun cutar?
Kana da matsalar numfashi?
Kana da ciwon kirji?
Domin wannan lokacin na mura ne.
Amma, ba za mu manta da ciwon zuciya ba.
Amma abin da ya fi muhimmanci yanzu shi ne ciwon kirji.
Amma ina da wahalar numfashi.
Amma na san mutane da yawa sun yi aski a gabana.
Amma dole ne mu kula da kowace ciwon kirji da muhimmanci.
Amma a yanzu ba ka da wata matsala wajen numfashi, ko?
Na manta da wannan ciwon kirji.
Kamar dai wani yana matsa maka a kirji.
Har yanzu kana shan numfashi?
Shin sun yi zargin cewa suna da irin wannan alamun?
Shin kana da wata cuta mai tsanani kamar hawan jini ko kuma wani abu makamancin haka?
Shin kana da wata cuta ko kuma wata cuta mai tsanani kamar ciwon sukari?
Shin kana da wata matsala ta numfashi da wannan ciwon a kirjinka?
Kana da hawan jini?
Shin kana shan numfashi?
Ka san alamun da ke nuna hakan?
Za ka ga wannan hoton?
Ka sha ruwa sosai a yau
Na yi gwajin ciwon sukari.
Amma, yana da alamun da na samu.
Yaya zafin jikinka ya tashi?
Yaya hawan jini yake?
Idan zazzabi ya yi tsanani ko kuma ya yi tsanani,
Idan kana da zazzabi mai zafi ko fiye da haka
Idan kana ganin kana bukatar ka yi bincike sosai game da alamun da kake fama da su
Na yi zazzabi a jiya.
Ni ma na ji zafi sosai.
Na yi zazzabi a jiya.
Ina da ciwo mai tsanani a cikin kirji a nan.
Ina samun matsala wajen numfashi.
Zan aiko maka da hoto.
Na ji zafi a kirji a yau.
A yau na ji ciwon kai da zazzabi.
Ina ganin wannan mura ce.
Ina ganin wannan mura ce mai sauƙi.
Kamar dai wani mutum mai nauyi yana zaune a kirjinka?
Hakan ya fara ne daga ciwon kai, kuma a lokaci guda, zazzabi ya fara.
Yana daukan ni a tsakiyar ƙirjina.
Wannan ya zama kamar ciwon kirji.
Yana cikin ƙirjina.
Yana cikin zuciyata.
Yana cikin tsakiyar kirji.
Ina jin zafi a ƙirjina.
Na damu sosai game da wannan ciwon kirji.
Ka gaya mini game da wannan ciwon kirjin ka.
Alal misali, za mu iya samun ciwon sukari ko kuma hawan jini.
Kamar dai a tsakiyar ƙirjin.
Yanzu za ku iya ɗaukar takalma na takalma don zazzabi.
To, Maryamu, ka daɗe kana da irin waɗannan alamun?
Ka ce kana da ciwon kirji a kirji.
Wani lokaci na ji zafi a ƙirjina.
Shin akwai wasu alamun cutar da za ka iya gani banda ciwon da ke tattare da cutar?
Ko kuma wani yana zaune a kan ƙirjinka?
A cikin irin wannan yanayin, zazzabi da tari, ciwon kai da ciwon tsoka suna da yawa.
A tsakiyar zuciyata.
Ka nuna min a wannan hoton inda kake jin zafi.
Domin kana da zazzabi.
Shin kana ganin wasu daga cikin waɗannan alamun suna da alaƙa da yin ciki?
Shin yaranku suna da irin waɗannan alamun?
Ka gaya mini game da ciwon kirjinka.
Zafin yana ƙaruwa da dare.
Na yi zazzabi na kwanaki biyu da suka gabata.
A daren jiya, zazzabin ya fara ƙaruwa.
Ni ne Dr. Porter na gaggawa a Cibiyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar
Za ka iya gaya mini game da ciwon kirjinka?
Na ji zafi a cikin kirji a gaban jiki.
Ga shi, ina da ciwo mai tsanani a ƙirjina.
Amma, idan na ji ciwon kirji,
Yaya za ka ji a zuciyarka?
A wane lokaci ne wannan ciwon ya soma?
Ina ciwon kirjinka?
A ina kake jin wannan ciwon a kirjinka?
Kana ganin kana da wani matsin lamba a kirjinka.
Ka san cewa ina da ciwon sukari.
Ka ce kana da ciwon kirji a cikin kirji.
Kasancewar cutar COVID-19 a cikin EU / Yankin Tattalin Arzikin Turai da Burtaniya daga 1 ga Janairu zuwa 15 ga Maris 2020
Cutar coronavirus (COVID-19) ta nuna irin wannan yanayin tsakanin kasashen EU / Yankin Tattalin Arzikin Turai da Burtaniya wanda ke tabbatar da cewa, duk da cewa a matakai daban-daban dangane da ƙasa, cutar COVID-19 tana ci gaba da sauri a duk ƙasashe.
Bisa ga ilimin da aka samu daga Italiya, dole ne kasar, asibitoci da kuma raka'a masu tsanani su kara shirye-shirye don samun saurin karuwa na marasa lafiya da ke bukatar kulawar lafiya da kuma kulawa mai tsanani.
A ranar 31 ga watan Disamba na shekarar 2019, an samu rahoton wani mummunan cutar pneumonia a birnin Wuhan, lardin Hubei, kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar kasar Sin ta bayyana cewa an sake kiran sabon coronavirus a matsayin mai tasiri a matsayin cutar ta SARS-CoV-2 (Cov-2).
Saboda haka, an sanya sunan cutar ta hanyar kamuwa da cutar SARS-CoV-2 zuwa cutar Coronavirus (COVID-19).
Har zuwa yau, tabbataccen bayani shine cewa kashi 80% na mutanen da suka kamu da COVID-19 suna da wata cuta mai laushi, wato, kamuwa da cutar huhu tare da ko ba tare da cutar huhu ba, kuma yawancin su sun warke.
Daga cikin kashi 14 cikin dari na wadanda suka kamu da cutar, COVID-19 ya zama mafi tsanani wanda ya haifar da bukatar shiga asibiti, yayin da kashi 6 cikin dari na wadanda suka kamu da cutar suka kamu da mummunan rashin lafiya wanda ke buƙatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da aka kwantar da su daga asibiti saboda COVID-19 ya kai kusan kashi 4 cikin 100.
A cikin wannan binciken, muna nazarin yanayin karuwar COVID-19 a kowace ƙasa ta EU / European Economic Area (EU/EEA) da kuma a cikin United Kingdom (UK) da kuma kwatanta su da lardin Hubei na China.
Mun kuma kwatanta yawan mutanen da suka kamu da COVID-19 a cikin EU/EEA da kuma Birtaniya da adadin mutanen da suka kamu da COVID-19 a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Kasashen EU / EEA da UK sun sami COVID-19
Kasar Sin ta koma baya yayin da COVID-19 ke yaduwa a fannin duniya, kuma halin da COVID-19 ke fama da shi a sauran sassan duniya a halin yanzu yana bin kasar.
Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya bayyana COVID-19 a matsayin annoba a ranar 11 ga Maris, 2020.
A cikin EuroServAlance na 5 ga Maris, 2020, Spiteri da abokan aikinsa sun ba da rahoton farkon Turai da aka tabbatar da COVID-19 a matsayin sanarwa ta WHO.
A cikin EU/EEA, Faransa ta sanar da cewa a ranar 24 ga Janairu, 2020, akwai mutane uku na farko da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, duk ƙasashen EU/EEA 30 da Burtaniya (UK) sun kamu da COVID-19, inda aka ba da rahoton 39,768 da mutuwar 1,727 daga 31 ga Disamba, 2019 zuwa kwanan wata da aka ambata, tare da 17,750 da mutuwar 1,441 a Italiya kadai.
Samun karuwar adadin masu kamuwa da COVID-19 da kuma karuwar yaduwar cutar
Cibiyar Tarayyar Turai don Rigakafin Cututtuka da Kulawa (ECDC) ta ba da rahoton adadin COVID-19 a kowace ƙasa ta duniya, wanda aka samu daga ma'aikatun lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da ƙasa da na yanki da kuma tushen gwamnati kamar WHO, wanda aka sabunta a kowace safiya da karfe 8:00.
An yi amfani da wannan bayanan ne don tantance yanayin COVID-19 a cikin EU / EEA da Burtaniya da kuma kwatanta abin da ya faru a Italiya.
A matsayin wakili na barkewar cutar COVID-19 mai aiki, mun lissafa kwanaki 14 na gajeren karuwar COVID-19, don haka muna la'akari da yanayin yanayin COVID-19 na halitta a kowace ƙasa ta EU/EEA da Burtaniya a tsakanin 1 ga Janairu - 15 ga Maris 2020.
Mun kuma gabatar da jerin adadin shari'o'in da aka rubuta a kowace ƙasa har zuwa 8:00 na safe na 15 ga Maris 2020 idan aka kwatanta da waɗanda aka rubuta a Italiya a lokacin 31 ga Janairu zuwa 15 ga Maris 2020.
Hanyoyin COVID-19 a cikin EU / EEA da Burtaniya
Yanayin karuwar COVID-19 a cikin EU/EEA da Burtaniya a cikin kwanaki 14 ya biyo bayan yanayin lardin Hubei (China) gaba ɗaya (Figure 1).
Ga EU/EEA da kuma Burtaniya gabaɗaya, karuwar COVID-19 ta fara ƙaruwa a kusa da 21 ga Fabrairu sannan ta karu da ƙarfi a kusa da 28 ga Fabrairu 2020 (ƙarin abu).
Wannan yafi haifar da saurin karuwa a cikin adadin shari'o'in da aka ruwaito a Italiya, amma duk sauran kasashen EU/EEA da Burtaniya sun nuna irin wannan karuwar karuwar abubuwan da suka faru na COVID-19 (abincin).
Hoton 2 ya kwatanta lambobin Italiya da yawan adadin COVID-19 a cikin EU/EEA da Burtaniya don lokacin 31 Janairu-15 Maris 2020.
Ya kamata a lura cewa, a karfe 8:00 na safe na 15 ga Maris, sauran kasashe 15 na EU/EEA da kuma Birtaniya sun riga sun ba da rahoton adadin adadin da aka kwatanta da na Italiya a makonni 3 ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin sanannun shari'o'in COVID-19 suna ƙaruwa cikin sauri a cikin EU / EEA da Burtaniya.
Hanyoyin da aka lura a cikin karuwar COVID-19 sun nuna cewa annobar tana ci gaba da sauri a duk ƙasashe.
Wannan duk da cewa ƙasashe suna da matakan daban-daban, duk da bambancin martani ga lafiyar jama'a a cikin ƙasa, da kuma bambancin ƙayyadaddun masu kamuwa da cutar da kuma ladabi daban-daban don zaɓar marasa lafiya a cikin ƙasashe waɗanda dole ne a gwada su don tabbatar da COVID-19, gami da gwajin kama-da-wane.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da ke fama da cutar ta COVID-19 a Italiya sun bayyana halin da ake ciki inda kashi 10% na marasa lafiya da ke fama da COVID-19 ke bukatar kulawa mai tsanani, kuma kafofin yada labarai sun bayyana cewa asibitoci da wuraren kula da gaggawa a yankunan sun riga sun kai ga iyakar ƙarfin su.
Bayanai game da shigar da COVID-19 a asibiti da / ko a cikin ICU a halin yanzu suna samuwa ne a cikin kashi 6% da 1% na masu cutar a matakin EU / EEA, bi da bi (ba a nuna bayanai ba).
Duk da haka, ya kamata a tattara su ta hanyar tsari don cika bayanan kulawa na yanzu wanda ke mai da hankali kan yawan shari'o'in da aka ruwaito da yawan mutuwar.
Wani bincike a 2010-11 a kan yanayin gadaje 4.2 a kan yawan yara 100,000 a Jamus daga 29.2 a Portugal ya nuna babban bambanci tsakanin samun gadon kulawa mai tsanani da gadon kulawa na matsakaici a Turai.
Wannan yana nufin cewa ƙasashe na iya samun ƙasa da ƙasa da albarkatu fiye da Italiya (a cikin 201011 ana samun 12.5 a kowace 100,000 mutane da gadaje na kulawa ta tsakiya).
Idan aka duba yawan adadin COVID-19 da aka yi asibiti a kowace ƙasa ta EU/EEA da Burtaniya, yanayin samfurin haɗakar da iyawar kula da lafiya ya nuna cewa akwai > 90% na haɗarin lalacewar kwanciyar hankali a cikin gadon kulawa mai tsanani, wanda aka bayar a cikin sabuntawar shida na ECDC na COVID-19 Rapid Risk Assessment.
Tun da har yanzu ana samun cututtuka a cikin ƙasashen EU/EEA da wasu yankuna na Burtaniya, kuma asibitoci da raka'a masu kulawa da gaggawa galibi suna ba da sabis na yanki ga jama'a, yana da kyau a sami bayanai game da marasa lafiya da wuraren kula da gaggawa ta hanyar tsarin suna na yanki don matakan Statistics 2 (NUTS-2).
Kwarewar Italiya da kuma abubuwan da ke faruwa a yanzu a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ci gaba da sauri a cikin EU/EEA da Burtaniya.
Saboda haka, dole ne kasashe, asibitoci da kuma raka'a masu kulawa da gaggawa su shirya kansu don yanayin kamuwa da cutar SARS-CoV-2 da ke gudana a cikin al'umma da kuma bukatar kula da lafiya da kuma kulawa mai tsanani, musamman ma, kamar yadda ya faru a yankunan da suka shafi Italiya, don karuwar yawan masu cutar COVID-19.
Kamar yadda ECDC ta kwanan nan ta nuna a cikin saurin kimanta haɗari, saurin, ingantaccen, da kuma daidaitaccen tsarin da ake buƙata don jinkirta yaduwar SARS-COV-2, tare da canji daga matsi zuwa ragewa, saboda idan ba a aiwatar da shi a kan lokaci ba, saurin saurin da ake tsammani na adadin shari'o'in zai ba masu yanke shawara da asibitoci lokaci mai yawa don fahimta, karɓa da kuma samar da martani daidai.
Saurin tantance hadarin ya ba da jerin matakan kiwon lafiya na jama'a don rage tasirin cutar.
Akwai gajeren lokaci na dama a lokacin da ƙasashe za su iya ƙara ƙoƙari don rage saurin yaduwar SARS-CoV-2 da kuma rage matsin lamba akan kiwon lafiya.
Idan hakan bai yi nasara ba, akwai yiwuwar cewa tsarin kula da lafiya a sauran kasashen EU/EEA zai fuskanci karuwar yawan marasa lafiya da ke bukatar kulawa mai tsanani a cikin 'yan kwanaki ko makonni masu zuwa.
Cutar coronavirus ta 2019 (COVID-19) da ta haifar da cutar ta SARS-CoV-2 ta haifar da mutuwar mutane 3,000 a China da sauran duniya, kuma fiye da mutane 80,000 sun kamu da cutar, wanda ya haifar da bala'i ga bil'adama.
SARS-CoV yana kama da irin wannan kwayar cutar da ta haifar da SARS a dubban mutane a 2003, SARS-CoV-2 na iya kamuwa da cutar daga kumfa kuma ta hanyar wannan hanyar yana haifar da alamun bayyanar cututtuka.
Koyaya, COVID-19 yana da ƙarancin tsanani da mutuwa fiye da SARS amma yana da yawa fiye da kamuwa da cutar kuma yana cutar da maza fiye da tsofaffi da mata fiye da matasa.
A cikin martani ga yawancin wallafe-wallafen da suka yi gaggawa game da cututtukan da ke tasowa, wannan labarin ya yi ƙoƙarin samar da wani bita mai dacewa da cikakkiyar bayani game da batun bincike mai sauri.
Za mu hada da abubuwan farko game da cututtukan cututtuka, ilimin halittu, ilimin cututtuka, bincike, magani, alamun cututtuka da rigakafi.
Duk da cewa har yanzu akwai tambayoyi da yawa da ake bukata, muna fatan wannan bita zai taimaka wajen fahimtar cutar da ke damunmu.
Bikin bazara na 25 ga Janairu 2020 ya zama abin tunawa ga dukkan Sinawa, waɗanda aka gaya musu su kasance a gida har tsawon lokacin hutu kuma har tsawon makonni bayan haka saboda barkewar sabuwar cuta.
Wannan cutar tana da alaƙa da cutar coronavirus (CoV) wacce ta haifar da barkewar cutar ta SARS mai tsanani a cikin 2003; saboda haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta sake suna da SARS-CoV-2 kuma ta sake suna da cutar da ta danganta da ita ta CoV cutar-19 (COVID-19).
Cutar ta fara ne a Wuhan, China, kuma da sauri ta bazu a duk faɗin ƙasar da kuma fiye da ƙasashe 50 a duniya.
A ranar 2 ga Maris, 2020, an sami karin shari'o'i 80,000 na COVID-19 saboda cutar, wanda ya hada da fiye da 40,000 marasa lafiya da suka warke kuma fiye da 3,000 marasa lafiya sun mutu.
"WHO ta yi gargadin cewa COVID-19 "maƙiyi na 1 ga jama'a" ne kuma wataƙila ya fi ta'addanci ƙarfi".
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin kasa da watanni biyu tun bayan da aka fara bayar da rahoton a ranar 7 ga Janairu 2020, an wallafa labarai sama da 200 game da COVID-19, gami da kwayar cutar, cututtukan cututtuka, ilimin lissafi, bincike da magani, wanda ya tsara tsarin kwayar cutar daga marasa lafiya da yawa.
Wannan bita na samar da wani bayani game da ci gaban bincike a kan wani sabon abu da ke bunkasa cikin sauri.
A duk lokacin da zai yiwu, za mu gwada COVID-19 da SARS da kuma wani cuta na CoV, cuta ta numfashi ta Gabas ta Tsakiya (MERS, annoba a 2012).
Mun tattauna abubuwan da muka sani game da rigakafi da kuma tsinkaya, da kuma wasu tambayoyi masu muhimmanci da suka rage.
CoVs an dauke su a matsayin masu cutar da ba su da cutar a cikin mutane, wanda ke haifar da kusan 15% na yawan cututtukan sanyi.
A cikin wannan karni, duk da haka, mun fuskanci cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Saboda haka, COVID-19 na yanzu shine fashewar COVID-19 ta uku a tarihin ɗan adam.
Kamar yadda aka nuna a Figure 1.1 , an fara bayar da rahoton cutar pneumonia ga Hukumar Lafiya ta Kasa ta kasar Sin daga Wuhan a ranar 31 ga Disamba, 2019.
Bayan kwana bakwai, an fitar da jerin abubuwan da suka faru na COVID.
An bayar da rahoton mutuwar farko a Wuhan a ranar 15 ga Janairu, 2020.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwan da ke kewaye da ita, larduna da ƙasashe.
A ranar 20 ga watan Janairu, an sanar da masu ba da sabis na kiwon lafiya game da kamuwa da cuta, wanda ya nuna cewa ana iya kamuwa da cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an kulle birnin Wuhan kuma an dakatar da duk hanyoyin sufuri.
A cikin binciken farko na cutar a ranar 24 ga Janairu, an gano cewa daga cikin masu kamuwa da cutar 41 da aka tabbatar, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar Wuhan Seafood (abincin teku) wanda ake ganin shine farkon farkon kamuwa da cutar daga asalin dabbobi da ba a sani ba.
A ranar 30 ga watan Janairu, WHO ta ayyana barkewar cutar a matsayin dokar ta baci ta duniya.
A lokacin da aka ba da rahoton, cutar ta riga ta bazu a kasar Sin da kuma wasu ƙasashe 50 a duniya (Figure 2).
Yayin da yanayin ke kara tsanantawa, har yanzu ana bukatar a tantance matakin da kuma yadda za a yi annobar.
A ranar 11 ga Fabrairu, 2020, wani bincike mai zurfi a kan marasa lafiya 8,866 ciki har da mutane 4,021 da suka tabbatar da COVID-19 ya gabatar da bayanan da suka biyo baya game da annobar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya shafi mutane na kowane zamani, amma an gano shi ne a cikin shekaru 30-65.
Kimanin rabin masu kamuwa da cutar (47.7%) sun fi shekaru 50 da haihuwa, kaɗan ne daga cikinsu sun fi shekaru 20 da haihuwa, kuma mutane 14 ne kawai suka kamu da cutar a ƙarƙashin shekaru 10.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya yi tasiri sosai a cikin Huawei da kewaye da shi.
Ana ɗaukar kimanin kwanaki 5 (2-9) daga lokacin bayyanar COVID-19 zuwa lokacin ganewar asali.
Matsakaicin lokacin incubacin kwayoyin ya kasance kwanaki 4.8 (3.0-7.2).
A matsakaici, tsawon lokacin da aka yi daga kamuwa da cutar zuwa mutuwa ya kai kwanaki 9.5 (4.8-13).
Yawan haihuwa na farko (R0) ya kasance 3.77 (95% CI: 3.51-4.05), kuma R0 mai daidaitawa ya kasance 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu da sauri kafin 23 ga Janairu 2020, daidai da lokacin jigilar kayayyaki da yawa kafin bikin bazara na kasar Sin.
Yawan mutuwar da aka tabbatar a cikin shari'o'in ya kasance 1.44% (95% CI: 1.10-1.86%) da kuma hadadden mutuwar da aka samu a cikin dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Babban abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (≥60) da mummunar cutar huhu.
CoVs sune ƙananan ƙananan ƙwayoyin cuta masu girma da ke ɗauke da tsari guda ɗaya na RNA.
Ana iya rarraba su cikin nau'i hudu ko nau'i-nau'i, wato alpha, beta, gamma, da delta, wanda aka sani da alpha-da-beta-COV-suna kamuwa da mutane.
S glycoprotein mai ɗaurewa don SARS-CoV da MERS-CoV, bi da bi, yana ɗaure da enzymes 2 (ACE2) da dipeptidial peptidase 4 (DPP4) masu amfani da shi na ƙwayoyin cuta, sannan kuma an haɗa shi da membrane.
Ana sakin RNA na kwayar cuta a cikin cytoplasm; bayan an yi kwafin kwayar cuta, an ɓoye shi zuwa ƙwayoyin cuta na RNA na kwayar cuta, ko ƙwayoyin cuta, tare da glycoproteins da nucleocapside proteins, wanda ke haɗuwa da ƙwayar cuta na plasma don sakin kwayar cuta.
An bayyana labarin farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 sabon nau'in beta-CoV ne wanda ya sami fiye da kashi 99.98% na samfurori 10 na jere da aka tattara daga kasuwar abincin teku ta Hunan, Wuhan, inda cutar ta barke.
SARS-CoV-2 yana da kamanceceniya da SARS-CoV fiye da MES-CoV.
Ta hanyar yin amfani da microscopy na lantarki, an gano SARS-CoV-2 kwayoyin a cikin ƙananan sassan epithelium na numfashi na mutum.
An gano cewa mutum yana da ACE2 mai karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar
Koyaya, sunadarai na S na SARS-CoV-2 sun fi rauni sosai a cikin mutum fiye da SARS-CoV2, wanda ya dace da gaskiyar cewa SARS-CoV-2 ba ya haifar da cututtuka masu tsanani a cikin marasa lafiya fiye da SARS-CoV-2.
SARS-CoV-2 yana samar da ƙaramin furotin da aka yi wa lambar orf3b kuma yana iya samar da furotin da aka yi wa lambar orf8.
Orf3b na SARS-CoV-2 na iya taka rawa wajen haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan
A ranar 18 ga Fabrairu, 2020, Zhou da sauransu sun ba da rahoton tsarin Cryo-EM na cikakken tsawon mutum ACE2 a cikin ƙuduri na 2.9 Å a cikin mahaɗan da ke da mahaɗan amino acid transporter B0AT1.
Sun gano cewa an haɗa mahaɗan da aka buɗe da kuma rufe a matsayin dimer, kuma mahaɗan ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda ke ba da tabbacin ganowa da kamuwa da CoV.
Don rage kamuwa da cutar SARS-CoV-2, B0AT1 na iya zama manufa ta magani don gwajin magani.
Babban da kuma matsakaici tufafi
An gano cewa SARS-CoV da MERS-CoV sun fito ne daga kwari kuma sun yada su zuwa jikin mutum ta hanyar cats da camels, bi da bi.
Ta hanyar kwatanta SARS-CoV-2 da sauran CoVs, an yi la'akari da kunar bakin wake a matsayin mai ɗaukar SARS-CoV-2 na halitta saboda sabon kwayar cutar ya dace da kashi 96% na CoVs kamar SARS-like da aka samo daga kunar bakin wake, bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, ba a san abin da ke taimakawa matsakaiciyar gurɓataccen ƙwayar cutar ta wuce ƙuntataccen nau'in don kamuwa da mutane ba, kuma har yanzu ana buƙatar cikakken bayani game da hanyar kamuwa da cutar.
Ji da sauransu sun bayyana maciji a matsayin mai ɗaukar kwayar cutar daga gizo-gizo zuwa mutum wanda ke da alaƙa da sake haɗuwa da homologous zuwa S-protein.
A cewar wani binciken, masu bincike a Guangzhou, China sun nuna cewa daga cikin CoV  da aka gano a cikin SARS-CoV-2 da kuma pangolin, mai yiwuwa a cikin 99% na SARS-CoV-2 mai yiwuwa ne mai tsaka-tsaki na SARS-CoV-2 bisa ga homology na kwayoyin halitta, wanda ake amfani dashi a cikin magungunan gargajiya na kasar Sin.
Duk da haka, bambancin kashi 1% a tsakanin jinsunan biyu ya kasance babban bambanci; saboda haka har yanzu ana jiran sakamakon ƙarshe don tabbatar da tabbataccen hujja (Fig. (Fig.
Har yanzu ba a san yawancin halayen halayen halayen SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa har zuwa kwanaki 5 a yanayin bushewa a waje da jiki a yanayin zafi na tsawon awanni 48 da kuma a yanayin zafi na ƙasa da 20 °C da zafi na 40%-50%.
SARS-CoV-2 na iya samun irin wannan fasalin.
An ruwaito cewa SARS-CoV-2 yana da matukar damuwa da hasken ultraviolet da zafi na tsawon minti 30 zuwa 56 °C; wasu fatty solvents banda ether, 75% ethanol, chlorine-containing disinfectants, paracetic acid, chloroform, da chlorhexidine na iya kashe cutar yadda ya kamata.
Dukan 'yan Adam suna da rashin ƙarfi na rigakafin SARS-CoV-2 a cikin al'ada, kuma saboda haka suna cikin haɗarin kamuwa da sabon kwayar cutar.
Babu cikakken binciken da aka bayar a halin yanzu game da maganin rigakafi na SARS-CoV-2.
Saboda haka, za mu iya ganin binciken da aka yi a baya game da sauran CoVs, musamman SARS-CoV da MERS-CoV (Fig. 4).
A cikin al'ada, bayan shigar da kwayar cutar a cikin tufafi, ana fara gano ta ta ta hanyar masu karɓar ƙwayoyin cuta na al'ada na tufafi ta hanyar masu karɓar ƙwayoyin cuta. Waɗannan masu karɓar sun haɗa da masu karɓar kamar C-type lactine, masu karɓar kamar Toll (TLR), masu karɓar kamar NOD, da masu karɓar kamar RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar cututtuka masu kumburi, haɓakar ƙwayoyin dendritic, da haɗuwa da nau'in I-interferens (IFNs) waɗanda ke iyakance watsa kwayar cutar da hanzarta macrophage phagocytosis na maganin rigakafi na kwayar cuta.
Duk da haka, furotin N na SARS-CoV na iya taimakawa cutar ta tsayayya da amsawar garkuwar jiki.
Ba da daɗewa ba, maganin rigakafi da aka yi amfani da shi ya shiga cikin yaƙi da cutar.
T lymphocytes, ciki har da CD4+ da CD8+ T cells, suna taka muhimmiyar rawa wajen karewa.
CD4+ T cells suna motsa B cells su samar da ƙwayoyin cuta na musamman, kuma CD8+ T cells suna kashe ƙwayoyin cuta kai tsaye.
Kwayoyin T-helper suna samar da cytokines na proinflammatory don taimakawa kwayoyin rigakafi.
Koyaya, CoV na iya hana T cell aiki ta hanyar haifar da mutuwar T cell.
Hakanan ana buƙatar rigakafin jikin mutum tare da ƙarin kamar C3a da C5a da antibodies don yaƙar kamuwa da cutar.
Alal misali, antibodies da aka ware daga marasa lafiya da suka warke suna hana MERS-CoV.
A gefe guda kuma, rashin jin daɗi na tsarin garkuwar jiki yana haifar da yawan radicals kyauta a cikin gida wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, kuma a mafi munin yanayin, rashin lafiyar gabobin jiki na iya haifar da mutuwa.
Ana iya cutar da tsofaffi da mata masu ciki da ke da cututtukan da suka gabata ta hanyar kamuwa da cutar SARS-CoV-2, wanda ke nuna alamun farawar cutar.
A bayyane yake cewa mutanen da suka kamu da cutar ko kuma waɗanda ke da rauni suna da mafi yawan haɗarin kamuwa da cutar fiye da sauran.
A cikin binciken da aka yi na farko na mutane 425 da suka kamu da cutar a Wuhan, an kiyasta matsakaicin lokacin kamuwa da cutar SARS-CoV-2 na kwanaki 1-14 a cikin mafi yawan lokuta, kwanaki 3-7.
Koyaya, binciken da aka yi a kan mutane 1,099 ya nuna cewa matsakaicin lokacin incubacin kwayar cutar ya kasance kwanaki 3 kuma tsawonsa ya kasance daga kwana 0 zuwa 24.
A cikin wani binciken da aka yi kwanan nan, an nuna cewa a cikin mutane 8,866 da aka kamu da cutar, an yi kwanaki 4.8 (3.0-7.2) kafin cutar ta kamu.
Yana da mahimmanci ga hukumomin lafiya su daidaita lokacin killacewa mai inganci bisa ga lokacin gano mafi kyawun ƙwayoyin cuta don hana kamuwa da cutar daga mutane masu kamuwa da cutar amma ba su da alamun cutar.
A matsayinka na al'ada, ana buƙatar waɗanda suka kamu da cutar ko suka haɗu da ita su kasance cikin keɓewa na kwanaki 14.
Shin akwai bukatar kara tsawon lokacin killacewa zuwa kwanaki 24?
A yawancin lokuta, zazzabi shine babban kuma farkon alamar COVID-19, wanda ba zai iya zama ba ko kuma wasu alamun kamar tari, numfashi mai tsauri, ciwon tsoka, rashin barci, ciwon kai, ciwon wuya, rhinorrhea, ciwon kirji, diarrhea, kumburi da kumburi.
Wasu marasa lafiya sun ji dyspnia (rashin numfashi) da / ko hypoxia mako guda bayan bayyanar cutar.
A cikin matsanancin yanayi, marasa lafiya suna ci gaba da ciwon huhu mai tsanani, tsokoki na tsakiya, ƙwayar cuta da kuma coagulopathy.
Ana buƙatar gwajin cutar a farkon ganewar asali ga marasa lafiya da ke fama da zazzabi da / ko rashin numfashi da alamun zazzabi mai tsanani, koda kuwa ba su da ƙarancin ƙwayar huhu.
Wani binciken da aka yi a watan Disamba na 2019 ya nuna cewa kashi 98% na marasa lafiya sun kamu da zazzabi, kashi 76% na marasa lafiya sun kamu da tari, kashi 55% na masu fama da dyspnea, kuma kashi 3% na masu fama da cutar sun kamu da cutar; kashi 8% na marasa lafiya suna bukatar taimakon iska.
Wani bincike na kwanan nan ya nuna cewa akwai irin wannan binciken a cikin wani rukuni na rukuni (family cluster) da kuma rukuni na rukuni (cluster) wanda ya haifar da kamuwa da cutar daga mutum mara alamun.
A wani kwatanci, wani binciken da aka yi a shekara ta 2012 ya nuna cewa manyan alamun cutar a cikin mutanen da ke da cutar MERS-CoV sune zazzabi (98%), tari mai bushe (47%) da dyspnia (55%).
Duk da haka, sun bukaci goyon bayan iska na kashi 80 cikin dari, wanda ya fi na marasa lafiya da ke fama da COVID-19 yawa kuma ya ci gaba da kasancewa da mafi girman iyawar cutar MERS fiye da COVID-19.
An kuma lura da ciwon ciki (26%) da kuma ciwon wuya (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS an tabbatar da cewa zazzabi (99% -100%), tari mai bushe (29% -75%), dyspnia (40% -42%), fitsari (20-25%), da ciwon wuya (13) -25%) sune manyan alamun bayyanar cututtuka, kuma kusan 14% -20% na marasa lafiya suna buƙatar taimakon iska.
A ranar 14 ga Fabrairu, adadin mutuwar COVID-19 a duniya ya kai kashi 2 cikin 100 yayin da adadin wadanda suka kamu da cutar ya kai 66,576.
A kwatancen, SARS ya kai kashi 10 cikin 100 na adadin mutuwar da aka tabbatar da 8,096 a watan Nuwamba na 2002.
A cikin wani binciken da aka gudanar a watan Yuni na shekarar 2012, an samu kashi 37 cikin 100 na mutane 2,494 da suka kamu da cutar MERS.
Wani binciken da aka yi a baya ya nuna cewa R0 na SARS-CoV-2 ya fi 6.47 da 95% Confidence Interval (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya kasance daga 2 zuwa 4 kawai.
Ana kwatanta MERS-CoV da SARA-CoV da SARS-CoV-2 dangane da bayyanar cututtuka, yawan mutuwa da R0 a cikin Table 1.1.
Lambobin da ke sama sun nuna cewa cutar SARS-CoV-2 tana da damar yadawa fiye da MERS-CoV da SARS-CoV, amma ba ta da haɗari fiye da sauran biyu.
Saboda haka, yana da matukar wuya a sarrafa cutar ta SARS-CoV-2 fiye da cutar ta MERS-CoV da SARS-CoV.
A cikin rukuni, cututtuka sukan fara ne daga iyali ɗaya ko kuma daga irin wannan taro ko jirgin ruwa na teku.
A yawancin lokuta, marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu wuraren da ke da cutar ko kuma sun sadu da mutane ko marasa lafiya waɗanda suka kamu da cutar a cikin makonni biyu da suka gabata.
Amma an samu rahotanni cewa mutane na iya ɗaukar cutar ba tare da wata alama ba har tsawon makonni biyu, kuma marasa lafiya da suka warke daga asibiti na iya ɗaukar cutar sake, wanda ke aika da gargadi don tsawaita lokacin killacewa.
A farkon lokaci, yawan fararen jini (musamman lymphocytes) a cikin marasa lafiya na yau da kullum ko ƙananan.
Misali, an gano matakan lymphophenia da kuma cutar viremia tare da adadin fararen jini <4 × 109 / L tare da yawan lymphocytes <1 × 109 / L a cikin 1,099 marasa lafiya na COVID-19. Misali, an gano matakan lymphophonia da cutar viremia tare da yawan fararen jini <4 × 109 / L tare da yawan lymphocytes <1 × 109 / L.
Wasu marasa lafiya sun sami karuwa a cikin jini na hanta da na tsoka da kuma matakan myooglobin, kuma yawancin marasa lafiya sun sami karuwa a cikin jini na C-reactive protein da erythrocytes.
A cikin marasa lafiya masu fama da cutar, an ƙara yawan D-dimer, wanda shine samfurin lalata fiber a cikin jini, kuma an rage yawan lymphocytes.
Yawancin marasa lafiya na COVID-19 suna da rashin daidaituwa na radiography na kirji kuma suna da alamun inorganic shading ko rashin tsabta na gilashin gilashi a cikin huhu.
A yawancin lokuta, marasa lafiya suna fama da cutar pneumonia marar bayyanar cututtuka, mummunan rauni na huhu, da kuma cututtukan numfashi mai tsanani (ARDS).
Lokacin da ARDS ta faru, kumburi mara kyau, kumburi na ruwa, da ci gaba da haɓakar fiberosis suna haifar da haɗari mai tsanani ga musayar gas.
Ayyukan da ba a saba gani na type-I da type-II pneumocytes suna rage yawan surfactant da kuma ƙara surface-tone, yana rage ƙarfin numfashi don fadadawa da kuma ƙara haɗarin rauni na huhu.
Saboda haka, mafi munin binciken gwajin rediyo na iya faruwa a mafi munin yanayin cutar.
A ranar 18 ga Fabrairu, 2020, an gano kwayoyin cuta masu yawa a cikin huhu na mutumin da ya mutu daga cutar ta COVID-19, wanda ya dace da cututtukan cututtukan cuta da ARDS, da kuma irin wannan a cikin marasa lafiya na SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar juyawa-transcriptase polymerase chain reaction (RT-PCR) a matsayin babban ma'auni don gano COVID-19.
Amma, saboda yawan kuskuren kuskuren kuskuren, wanda zai iya hanzarta annobar, daga 13 ga Fabrairu, 2020, a China, an fara amfani da asibiti ko bayyanar cututtuka don ganewar asali (wanda ba ya dogara da RT-PCR kawai).
Hakazalika, ana samun irin wannan yanayin a binciken SARS.
Saboda haka, don gano cutar da kyau, haɗuwa da tarihin cutar, nunawa, gwajin gwaji, da binciken radiological suna da mahimmanci kuma dole ne.
A ranar 14 ga Fabrairu, 2020, Feng Zhang Group ta bayyana wata yarjejeniya ta amfani da fasaha ta CRISPR-based SHERLOCK don tantance SARS-CoV-2, wanda ke tantance ɓangarorin RNA na SARS-CoV-2 na roba a cikin 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (ƙawata 10-100 kwafi na microlytes a kowace shigarwa) ta amfani da dipstics a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan haɓaka ba.
Ana sa ran cewa sabon dabarun zai iya kara yawan yadda ake sa ido da kuma yadda ake samun sakamako idan aka duba samfurin.
Saboda rashin kwarewa a cikin CoV na ƙwallon ƙafa, likitoci na iya ba da taimako na musamman ga marasa lafiya na COVID-19 tare da ƙoƙarin da aka yi amfani da su a baya ko kuma da aka ba da shawarar don magance sauran nau'ikan CoV kamar SARS-CoV da MERS-CoV da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
Wannan maganin ya hada da maganin rigakafi, hana rigakafin rigakafi, steroids, plasmas na marasa lafiya da suka warke, magani na kasar Sin da kuma taimakon tunani na yanzu da kuma yiwuwar magani.
An kuma ba da shawarar yin amfani da jini daga marasa lafiya da suka warke don yin magani.
Kamfanonin magunguna sun yi gasa don samar da rigakafi da alluran rigakafi don cutar.
SARS-CoV-2 ya fara kai hari ga huhu, kuma yana iya kai hari ga wasu gabobin da ACE2 ke bayyanawa kamar su tsarin gastrointestinal da koda.
Duk da haka, rashin numfashi da rashin ƙarfi sune manyan abubuwan da ke haifar da barazana da mutuwa ga marasa lafiya.
Saboda haka, taimakon numfashi yana da muhimmanci don rage alamun cutar kuma yana ceton rayuka, kuma ya haɗa da maganin oxygen na yau da kullun, oxygen mai gudana sosai, iska mai ƙarancin ƙarfi da iska mai ƙarancin ƙarfi wanda ke buƙatar yankewa da iska ta inji wanda ke buƙatar yankewa dangane da yanayin cutar.
Dole ne a tallafa wa marasa lafiya da ke da alamun numfashi masu tsanani tare da Oxygenation of Extrasocorporeal Membranes (ECMO), wanda shine ingantaccen fasahar bugun zuciya da ƙwayar cuta, wanda ake amfani dashi don magance cututtukan zuciya ko rashin numfashi.
Hakanan yana da mahimmanci a kula da daidaitattun electrolytes a cikin marasa lafiya na SARS-CoV-2, hanawa da magance cututtukan kai tsaye da kuma mummunan rauni, da kuma kare aikin gabobin jiki masu mahimmanci.
An gano cewa sakamakon cutar cytokine ya fito ne daga yawan maganin rigakafi a cikin marasa lafiya na SARS da MERS.
Cytokine disruption wani nau'i ne na kumburi na jijiyoyin jiki wanda ya faru ta hanyar sakin nau'ikan cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan cytokines suna fitar da ƙwayoyin cuta masu yawa na free radicals ta hanyar ƙwayoyin cuta, wanda shine babban dalilin ARDS da kuma lalata kwayoyin halitta.
A cikin maganin cutar cytokine, hana amsawa yana da mahimmanci musamman ga marasa lafiya masu tsanani.
An yi amfani da corticosteroids da tosilisumab, wanda shine anti-IL6 monoclonal antibody, don magance cutar cytokine.
Sauran maganin hana rigakafin rigakafi don cutar cytokine ya hada da gyara T cell-directed immune response; IFN-γ, IL-1, da TNF blockage; JAK calm; Blinatumobab (blinatumomab); inhibitor na cytokine signing 4; da kuma HDAC inhibitors.
Don rage mummunan lalacewar kumburi, an yi amfani da steroids a matsayin masu hana rigakafi a maganin SARS.
Ko da yake steroids a cikin babban sashi ba su da amfani ga mummunan rauni na huhu a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman a cikin osteonecrosis na avascular, wanda ke shafar yiwuwar yin aure.
Duk da haka, an ba da shawarar yin amfani da gajeren lokaci na cortisone steroid a ƙananan zuwa matsakaiciyar sashi don marasa lafiya masu cutar COVID-19 da ke da ciwon lafiya.
Har zuwa lokacin rubuce-rubuce, babu tabbacin cewa akwai maganin rigakafi mai tasiri.
Duk da haka, amfani da interstitial na Remdesivir, wanda ya hada da analog na nucleotide, ya tabbatar da inganci ga mai haƙuri na Amurka da COVID-19.
Remedecivir wani magani ne na maganin riga-kafi, wanda Gilead ta fara kirkira don magance cututtukan da ke haifar da cutar Ebola da cutar Marlburg.
Daga baya, mun nuna yiwuwar rigakafin RNA na wasu kwayoyin halitta, ciki har da MERS da SARS.
A cewarsa, Gilead ta ba da wannan fili ga kasar Sin don gudanar da gwaji guda biyu a kan mutane da ke dauke da cutar SARS-CoV-2, kuma sakamakon yana da matukar fata.
Ana ba da shawarar baricitinb (baricitinb), interferon-α, lopinavir / ritonavir, da ribavirin a matsayin magani mai yiwuwa ga marasa lafiya da ke da alamun numfashi.
Yin amfani da maganin Lopinovir/Ritonavir na iya haifar da ciwon hanji, kumburi, kumburi, cutar hanta da sauran sakamako masu illa.
Ana bukatar a lura da yadda wannan magani yake shafar sauran magunguna da ake amfani da su a cikin marasa lafiya.
Ana samar da jini da kuma rigakafi daga marasa lafiya da suka warke
Akwai dogon tarihi na tattara jini daga marasa lafiya da suka warke daga cututtukan da ke kamuwa da cutar don magance wasu marasa lafiya da ke fama da wannan cuta ko kuma don hana mutane lafiya kamuwa da cutar.
A gaskiya ma, marasa lafiya da suka warke suna da yawan adadin rigakafi a cikin jinin su dangane da cutar.
Antibodies sune immunoglobulin (Ig) wanda B lymphocytes ke samarwa don yaƙar ƙwayoyin cuta da sauran abubuwa masu banƙyama kuma suna gano kwayoyin da keɓaɓɓun cututtukan kuma suna sauƙaƙe su kai tsaye.
Bisa ga wannan, an tattara plasma daga jinin wani rukuni na marasa lafiya da suka warke daga COVID-19 kuma an yi musu allura a cikin marasa lafiya 10 masu ciwo mai tsanani.
A cikin sa'o'i 24 bayyanar cututtukan sun inganta, kuma hakan ya rage kumburi da kuma cutar ta kwayar cuta da kuma ingantaccen oxygen a cikin jini.
Koyaya, ba a ci gaba da wasu magunguna ba kuma ana buƙatar tabbatarwa da kuma bayyanawa don bayar da shawarar hanyoyin amfani da yawa kafin hakan.
Bugu da ƙari, a cikin yanayin maganin, wasu matsalolin da suka shafi plasma ya kamata a yi la'akari da su sosai.
Alal misali, maganin rigakafi na iya yin amfani da maganin rigakafi don yin amfani da shi sosai kuma ya haifar da cutar cytokine, wanda zai iya zama mai haɗari.
Ana yawan samun ƙananan ƙwayoyin rigakafi a cikin jini, kuma ana bukatar plasma sosai don magance marasa lafiya masu ciwon cuta.
A wasu lokutan, yana da wuya a ci gaba da samar da rigakafi da sauri don magance cutar ta duniya.
Saboda haka, gano kwayoyin halitta na musamman da kuma tasiri don ware B-cell daga marasa lafiya da suka warke da kuma saka idanu kan kwayoyin da ke da tasiri ko kuma yin amfani da su wajen tsara kwayoyin da ke da tasiri a kan furotin da cutar ke bukata.
Ta haka ne, za mu iya ƙara yawan maganin rigakafi.
An yi amfani da TCM a kasar Sin don magance cututtuka na shekaru dubbai.
Duk da haka, tasirinsa ya dogara ne da haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da ganewar asali bisa ga ka'idar TCM.
Yawancin abubuwa masu amfani ba a sani ba ko kuma ba a bayyana su ba, saboda yana da wuya a cire su kuma a tabbatar da irin waɗannan abubuwa ko kuma haɗuwa da su.
A halin yanzu, saboda rashin ingantaccen magani na COVID-19, TCM ya zama babbar hanyar magani ga marasa lafiya masu sauƙi zuwa matsakaici ko waɗanda suka dawo daga mawuyacin yanayi.
Alal misali, an gano cewa Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules suna da tasiri wajen magance COVID-19.
A wasu jihohin kasar Sin, inda aka yi amfani da TCM wajen kula da mutane da suka kamu da cutar COVID-19, inda kashi 87% na marasa lafiya suka sami mafi yawan dawo da, ciki har da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, inda aka yi amfani da TCM wajen kashi 30% na marasa lafiya, ya sami mafi ƙarancin dawo da (13%).
Duk da haka, wannan kwatancen yana da ɗan gajeren lokaci saboda ya kamata a haɗa wasu dalilai masu tasiri kamar yawan marasa lafiya da kuma tsanani a cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aiki sun buga wani binciken da ya kwatanta maganin WM da TCM tare da maganin Magungunan Yammacin Turai (WM).
Sun gano cewa lokacin da ake bukata domin dawo da zafin jiki zuwa al'ada, kawar da cututtuka, da kuma shiga asibiti ya yi ƙasa sosai a cikin WM+TCM fiye da na WM kawai.
Mafi ban sha'awa, ƙimar lalacewa ta alama (mai haske zuwa mai tsanani) ta kasance ƙasa da ƙasa sosai fiye da na WM+TCM kawai (7.4% vs. 46.2%) a cikin ƙungiyar WM+TCM kawai, kuma mutuwar ta kasance ƙasa da na WM+TCM kawai (8.8% vs. 39%).
Duk da haka, TCM yana da tasiri da tsaro wanda ke jiran ƙarin gwaji a cikin manyan cibiyoyi da kuma cibiyoyin da yawa.
Zai zama da ban sha'awa a gano tsarin aiki kuma, idan ya yiwu, a bayyana abubuwan da ke cikin maganin TCM ko kuma haɗuwa da su.
Yawancin marasa lafiya da ake zargi ko tabbatar da COVID-19 suna jin tsoron cututtukan da ke da matukar yaduwa har ma da kisa, kuma waɗanda ke keɓewa suna jin kadaici, kadaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, hypoxia, tari da kuma illa na magani kamar rashin barci da corticosteroids ke haifar, na iya haifar da ƙarin damuwa da damuwa.
A farkon barkewar cutar SARS, an bayar da rahoton bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
A matsayin wani ɓangare na amsawar lafiyar jama'a ga barkewar COVID-19, bin ƙa'idodin tuntuɓar da ke tattare da killacewa na iya haifar da ƙarin damuwa da laifi game da tasirin kamuwa da cuta, killacewa da kuma lalata danginsu da abokai.
Saboda haka, dole ne a ba da kulawar lafiyar hankali ga marasa lafiya da masu zargin COVID-19 da waɗanda suka sadu da su da kuma talakawa da suke bukatar hakan.
Taimako na tunani ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiya na tunani daga fannoni da yawa na ilimin likitanci, sadarwa mai kyau game da barkewar cutar SARS-CoV-2 da kuma tsarin kula da lafiyar jiki, da kuma daidaitaccen sabuntawa game da amfani da na'urorin lantarki da aikace-aikacen masu sana'a don kauce wa kusanci da juna.
Ana buƙatar alluran rigakafi masu tasiri don hana jerin cututtuka daga dabbobi da kuma mutane masu cutar da ke kamuwa da cutar, kuma galibi suna ba da ƙarin maganin rigakafin cutar a cikin maganin annobar da ke haifar da kwayar cutar da ke fitowa.
An yi ƙoƙari don haɓaka alluran rigakafi na S-protein don ƙirƙirar antibodies masu tsayayya da tsayayya da SARS-CoV da kuma / ko haɓaka rigakafin rigakafi.
An gwada rigakafin da aka yi amfani da shi a cikin samfurin SARS na dabba.
Amma kafin a fara binciken asibiti, ba a tabbatar da ingancin rigakafin a cikin tsofaffin mutane da kuma a cikin samfurin ƙalubalen mutuwa ba, da kuma kariya daga kamuwa da cutar daga tushen dabba zuwa mutane.
Wannan na iya kasancewa saboda SARS ta hallaka shekaru 17 da suka gabata kuma ba a sami sabon kamuwa da cutar ba tun daga wannan lokacin.
A akasin haka, ana ci gaba da samun yaduwar cutar MERS a Gabas ta Tsakiya, kuma ana samun yaduwar cutar a wasu yankuna saboda kasancewar tushen zoonotic a yankin da cutar ta shafa.
An shirya hanyoyin yin rigakafi don MERS ta amfani da ƙwayoyin cuta marasa aiki, DNA plasmids, vectors na kwayar cuta, nanoparticles, ƙwayoyin cuta kamar ƙwayar cuta da kuma subunits na ƙwayoyin cuta masu sake haɗawa, kuma an kimanta wasu daga cikin su a cikin samfurin dabba.
Shirya rigakafi mai lafiya da inganci ga mutanen da ba su da rigakafi ga SARS-CoV-2 aiki ne na gaggawa da kuma muhimmiyar aiki don sarrafa annobar.
Duk da haka, yana da wuyar shawo kan wannan matsalar saboda dogon lokaci (ma'ana watanni 18) da ake bukata don samar da rigakafi da kuma canjin motsi na CoV.
A matsayin sabon cuta, cikakken tsarin ganewar asali na COVID-19 ya fara bunkasa ne kawai ga dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya ba tare da wani abu ba na farko na rashin lafiya na iya samun sauki a hankali.
Amma, kamar SARS da MERS, COVID-19 yana da alaƙa da rashin lafiya da yawan mutuwa a cikin marasa lafiya masu tsanani.
Saboda haka, yana da mahimmanci ga hukumomin kiwon lafiya su samar da samfurin tsinkaya na cutar don fifita ayyukan su, musamman a yankunan da ke da iyakantaccen albarkatu.
Bisa ga binciken bincike da aka bayar zuwa yanzu, akwai wasu dalilai masu zuwa da zasu iya shafar ko kuma su danganta ga yanayin yanayin cutar a cikin marasa lafiya na COVID-19 (Table (Table 33):
Shekaru: Shekaru shine mafi mahimmancin abin da ya haifar da cutar SARS, wanda yake gaskiya ne ga COVID-19.
A cikin binciken da aka yi na mutane 8,866 da aka ambata a sama, COVID-19 ya faru ne tsakanin shekaru 30 zuwa 65 da kuma 47.7% na waɗanda suka wuce shekaru 50.
Marasa lafiya da ke bukatar kulawa mai tsanani sun fi fuskantar wasu cututtuka da rikitarwa a lokaci guda kuma sun fi tsufa fiye da sauran (66 da shekaru da suka wuce da kuma 51 da suka wuce) wanda ke nuna shekaru a matsayin mai nuna alamar yanayin cutar ga sakamakon COVID-19.
Jima'i: Maza sun fi kamuwa da SARS-CoV-2 fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka bayyana a sama.
Rashin ciwo da kuma rikitarwa: Marasa lafiya da ke da COVID-19 da ke bukatar kulawa mai tsawo suna da mafi yawan haɗarin ciwon zuciya mai tsanani da kuma arrhythmias.
Hakanan cututtukan zuciya sune manyan abubuwan da ke haifar da mutuwar marasa lafiya na SARS.
An kuma ruwaito cewa SARS-CoV-2 na iya haɗuwa da ACE2-positive colangiocytes, wanda zai haifar da aikin hanta mara kyau a cikin marasa lafiya na COVID-19.
Ya kamata a tuna cewa shekaru da cututtukan da ke ciki suna da alaƙa sosai kuma suna iya tsoma baki da juna.
Bayanai na asibiti: Matsayin C-reactive protein (CRP) a cikin jini yana nuna yadda mummunan rauni yake a cikin kumburi ko kuma a cikin ƙwayoyin halitta, kuma an ba da shawarar cewa yana nuna yanayin rashin lafiya, amsawar magani, da kuma yiwuwar warkarwa.
An kuma ba da shawarar dangantakar da ke tsakanin tsananin COVID-19 da kuma tsinkaya da matakin CRP.
Bugu da ƙari, lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango ko hasashen sakamakon.
Wadannan kwayoyin suna bayyana sosai a cikin gabobin jiki, musamman a zuciya da hanta, kuma suna fitowa ne lokacin lalacewar ƙwayoyin halitta.
Saboda haka, suna da alamun alamun rashin aiki na zuciya ko hanta.
Babban alamun ganewar asali: Domin sanin rikitarwa da kuma sakamakon COVID-19, tare da sauran matsaloli, dole ne a yi la'akari da ci gaban cututtukan ƙirjin da kuma bayyanar cututtukan ganewar asali.
Amfani da Steroids: Kamar yadda aka bayyana a sama, don rage yawan cutar kumburi, steroids sune magungunan rigakafi da aka fi amfani da su a matsayin magani na kari ga cututtukan cututtuka.
Tun da aka yi amfani da manyan kwayoyin corticosteroids a cikin marasa lafiya masu tsanani na SARS, yawancin zuriyar sun sha wahala daga cutar avascular osteonecrosis, tare da rashin ƙarfi na dogon lokaci da rashin ingancin rayuwa.
Saboda haka, idan ya cancanta, a cikin marasa lafiya na COVID-19, ya kamata a yi amfani da steroids a ƙananan allurai da gajeren lokaci.
Matsin lamba: Kamar yadda aka bayyana a sama, a lokacin annobar COVID-19, yawancin marasa lafiya suna fuskantar zaman rigakafi na dogon lokaci da matsanancin rashin tabbas, kuma suna fuskantar matsanancin damuwa yayin da suke ganin mutuwar dangi da abokan hulɗa.
Don taimakawa marasa lafiya su warke daga damuwa da komawa rayuwa ta al'ada, yana da mahimmanci a ba da shawara ta tunani da kuma ba da tallafi na dogon lokaci.
A cewar binciken da aka yi a kan al'umma, cutar COVID-19 ta bambanta da SARS.
Baya ga yin kwayar a cikin ƙananan huhu, SARS-CoV-2 na iya yin kwayar a cikin huhu sosai kuma yana haifar da bayyanar cututtuka masu sauƙi ko babu bayyanar cututtuka a farkon matakin kamuwa da cutar, kamar sauran CoVs da ke haifar da sanyi na yau da kullun.
Saboda haka, masu fama da cutar suna iya samar da kwayar cutar mai yawa a lokacin aikin yau da kullun, wanda ke haifar da wahalar sarrafa cutar a farkon lokacin da cutar ta fara ko kuma a lokacin da cutar ta fara.
Duk da haka, ana ganin cewa SARS-CoV zai iya kamuwa da cutar idan marasa lafiya suka yi rashin lafiya sosai, yayin da yawancin kamuwa da cutar ba su faru a farkon lokaci ba.
Saboda haka, cutar COVID-19 ta yanzu ta fi ta SARS tsanani kuma yana da wuyar sarrafawa.
A halin yanzu, kasar Sin tana da manyan ayyuka, ciki har da kulle-kulle a Wuhan da garuruwan da ke kusa da ita da kuma killace kusan dukkanin al'ummar kasar don hana yaduwar SARS-CoV-2.
Duk da cewa wadannan matakan sun yi mummunan tasiri ga tattalin arziki da sauran bangarorin kasar, adadin sabbin cututtuka na raguwa, wanda ke nuna cewa annobar ta yi jinkiri.
Mafi kyawun tsammanin shine cewa cutar za ta ƙare a watan Maris kuma za a ci gaba da raguwa na watanni 3-4.
Amma, wasu masana ba su da irin wannan begen.
Paul Hunter da sauransu sun yi hasashen cewa COVID-19, wanda ya zama mai cutarwa fiye da SARS, ba zai ƙare ba a shekarar 2020.
Ira Longini da sauransu sun kafa wata hanyar yin hasashen sakamakon annobar, kuma sun nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan duniya.
Wani rukuni na Kanada ya ruwaito cewa an gano SARS-CoV-2 a cikin marasa lafiya da aka dawo da su daga asibiti makonni 2 da suka gabata a cikin lalaras na tsakiyar-tarbinet da kuma daga cikin hanci, wanda ke nuna cewa sabon kwayar cutar da aka gano za ta zama irin wannan zazzabi na kumburi kamar mura.
Duk da haka, a China akwai wasu alamun da ke nuna cewa dabarun da ake amfani da su a yanzu za su iya aiki, bisa ga yawan sabbin cututtuka.
An yi hasashen cewa cutar Ebola za ta haifar da mutum miliyan daya, tare da mutuwar rabin miliyan.
Amma, ta hanyar tsauraran killacewa da keɓewa, cutar ta kasance a ƙarshe a cikin iko.
Hakanan yana yiwuwa, kamar SARS-CoV, SARS-CoV-2 na iya zama mai rauni a cikin kamuwa da cutar kuma a ƙarshe ya lalace ko ya zama ƙananan ƙwayoyin cuta a cikin hulɗa da mutane.
A ƙasa akwai kwatancen SARS da MERS da annobar COVID-19 (Figure 55).
SARS-CoV-2 yana da matukar yaduwa ta hanyar tari ko tari kuma wataƙila ta hanyar tuntuɓar kai tsaye da kayan da cutar ta gurbata.
An gano cutar a cikin maniyyi wanda ya nuna sabon yiwuwar kamuwa da cutar daga maniyyi zuwa maniyyi.
Wani binciken da aka yi kwanan nan a kan mutane 138 ya nuna cewa kashi 41 cikin 100 na kamuwa da cutar sun kasance sakamakon kamuwa da cutar nasocomal (wanda ya taso a asibiti), ciki har da wasu marasa lafiya 17 da suka fi fama da cututtuka na baya da kuma masu ba da kiwon lafiya 40.
Saboda haka, dole ne a yi hankali sosai don kiyaye mutane, musamman ma masu ba da kiwon lafiya, ma'aikatan jama'a, 'yan uwa, abokan aiki, har ma da waɗanda suke kusa da marasa lafiya ko waɗanda ke fama da cutar.
Ana iya amfani da abin rufe fuska a matsayin matakin farko na kariya don rage haɗarin kamuwa da cuta; amfani da abin rufe fuska na tiyata da abin rufe fuska na N95 (series # 1860s) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na fuska na tiyata yana hana ƙananan saukad da ruwa daga mai yiwuwa mai kamuwa da cutar daga iska ko kuma su makale a saman abu, daga inda zasu iya yadawa zuwa wasu.
Duk da haka, N95 (series # 1860s) kawai na iya kare mask daga karɓar ƙananan ƙwayoyin cuta ta hanyar numfashi kamar 10 zuwa 80 nm, kawai 5% na ƙwayoyin cuta suna iya shiga gaba ɗaya; girman SARS-CoV-2 yayi daidai da na SARS-CoV kuma duka suna da kusan 85 nm.
Tun da kwayoyin za su iya shiga cikin fuskokin tiyata na biyar a jere, masu ba da sabis na kiwon lafiya da ke fuskantar marasa lafiya kai tsaye ba za su sa fuskokin tiyata ba, amma N95 (series# 1860s).
Don rage haɗuwa da cutar, masu ba da sabis na kiwon lafiya dole ne su sa masks, ban da haka, su sa rigunan keɓewa masu dacewa.
Hakanan cutar tana iya kamuwa da mutum ta hanyar idanu.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa ya sa abin rufe fuska na N95; cutar ta shiga jikinsa ta hanyar idanunsa masu kumburi.
Saboda haka, masu ba da sabis na kiwon lafiya suna buƙatar masu haƙuri su sa murfin fuska mai tsabta ko kuma tabarau yayin aiki.
A cikin jama'a a yankunan da ke da tasiri ko waɗanda za su iya cutar, an ba da shawarar kowa ya wanke hannayensu da sabulu mai ƙwayoyin cuta fiye da yadda ya saba, ya yi ƙoƙari ya kasance a cikin gida don keɓe kansa, kuma ya rage haɗuwa da mutanen da ke da cutar.
Ana ganin cewa mutum ya yi nesa da mutum da ya kai ƙafa biyu don ya kasance a nesa da mai haƙuri.
Wannan matakin da aka dauka na rage hadarin kamuwa da cutar da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya zo duniya a matsayin sabon cutar, saboda babban kamanceceniya da SARS-CoV, kamar yadda rahoton 7 ga Janairu 2020 ya nuna, ya kamata a ɗauki babban gargadi daga China saboda zurfin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar
Duk da haka, har zuwa 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka a Wuhan ya ƙarfafa 'yan ƙasa da cewa ƙwayoyin cuta ba su da yawa kuma suna da iyakanceccen damar haihuwa daga mutum zuwa mutum, kuma babu matsala a hana da sarrafa cutar.
Wannan sakon ya sauƙaƙa firgita a cikin jama'a, musamman ma yayin da duk ƙasar ke shirin bikin bazara kuma an ɓata lokaci mai yawa don kawar da cutar a Wuhan.
Hukumar kula da cututtuka ta kasar Sin za ta iya koyi da wannan darasi mai zurfi kuma ta samu ci gaba mai kyau a nan gaba.
Alal misali, waɗannan hukumomi suna bukatar su (1) yi hankali sosai a lokacin da suke yin sanarwa a fili domin kowane kalma za ta yi la'akari da 'yan ƙasa kuma hakan zai iya canza halayensu da shawarwarin su; (2) su kasance da ƙwarewa da kuma amsawa ga bayanan da ba a so daga asibitoci ba, ba tare da jiran rahoton likita ko jami'a ba; (3) su kasance da ƙwarewa da kuma iko sosai don hana yiwuwar annobar a farkon matakin maimakon ƙoƙarin ta'azantar da jama'a; da kuma (4) su ba da sanarwa da kuma ingantattun ayyuka don ƙara wayar da kan jama'a game da cututtukan cutar da kuma inganta tsarin amsawar jama'a daga lokaci zuwa lokaci.
An fara barkewar COVID-19 a ƙarshen Disamba 2019 sakamakon cutar SARS-CoV-2.
A cikin kasa da watanni biyu, cutar ta bazu ko'ina cikin kasar Sin, kuma a lokacin da aka rubuta wannan rahoto, ta riga ta shiga kasashe 50 a duniya.
Tun da yake cutar ta yi kama da SARS-CoV kuma tana kama da alamun COVID-19 da SARS, barkewar COVID-19 ta haifar da jin kamar SARS ta dawo.
Duk da haka, akwai wasu bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS waɗanda suke da mahimmanci don hana annoba da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar maza fiye da mata fiye da matasa, kuma yawan tsanani da mutuwar ya fi girma fiye da matasa.
Yawan mutuwar SARS ya fi COVID-19 girma (10.91% da 1.44%)
Masu dauke da COVID-19 suna kamuwa da cutar ba tare da wata alama ba, yayin da masu dauke da SARS ke kamuwa da cutar a lokacin da suke da ciwo mai tsanani, wanda hakan ya sa ya zama da wahala a hana kamuwa da COVID-19 fiye da SARS.
Wannan ya bayyana dalilin da ya sa SARS-CoV-2 ya yi sauri da kuma yaduwa fiye da SARS-CoV.
A wasu marasa lafiya na COVID-19, ana iya yin gwajin RNA na yau da kullun don SARS-CoV-2.
A gefe guda kuma, marasa lafiya da suka warke za su iya samun cutar.
Waɗannan binciken sun ƙara haɗarin yaduwar cutar sosai.
Ganin irin wannan ci gaban da ake samu a binciken COVID-19, akwai wasu muhimman batutuwa da suka rage a warware:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an gano homology na 96% tsakanin SARS-CoV-2 da kuma SARS-CoV na biyu, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 ya fito ne daga kwayar cutar ba.
Waɗanne dabbobi ne suka kasance masu tsakiya don watsa cutar daga gizo-gizo zuwa mutane?
Idan ba mu san amsoshin # 1 da # 2 ba, ba za mu iya rage yaduwar cutar ba kuma cutar za ta iya dawowa a kowane lokaci.
Ko da yake samfurin kwayoyin halitta da kimantaccen halittu sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, ta yaya kwayar cutar ta shiga cikin ƙwayoyin numfashi kuma ta haifar da canje-canje na rigakafi na gaba?
Shin kwayar cutar tana hana kwayar halitta ta ACE2 daga wasu gabobin jiki?
Idan ba mu da amsar da ta dace ga wannan tambayar ba, ba za mu iya samun ganewar asali da magani mai kyau da sauri ba.
Har yaushe za a ci gaba da annobar?
Ta yaya kwayoyin cutar ke bunkasa yayin da ake watsa su zuwa mutane?
Shin zai zama annoba ta duniya, mutuwa kamar SARS, ko kuma wani lokaci, sake fashewa kamar mura?
Yana da muhimmanci, amma yana bukatar lokaci don samun amsoshin tambayoyin da aka ambata a sama da kuma wasu.
Amma duk farashin da ya kai, babu abin da za mu iya yi sai dai dakatar da annobar da wuri-wuri da kuma dawo da rayuwarmu ta al'ada.
Dabbobin dabbobi ne ke haifar da cutar korona a cikin mutane
Canji da kuma daidaitawa sun haifar da co-juyin halittar coronavirus (CoV) da kuma halayensa, gami da ɗan adam, tsawon dubban shekaru.
Kafin 2003, an san cewa CoV (HCoV) guda biyu na mutum suna haifar da rashin lafiya mai sauƙi kamar sanyi.
Fashewar cutar ta SARS da kuma cutar ta MERS ta Gabas ta Tsakiya ta juyo don nuna yadda cutar HCoV za ta iya zama mummunar cuta da kisa.
Yunƙurin SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake kawo CoVs a saman tattaunawa kuma ya ba mu mamaki da nuna mafi girman kamuwa da cutar da ƙananan cututtuka fiye da ɗan'uwanmu SARS-CoV.
HCoV cuta ce ta dabbobi kuma fahimtar asalin HCoV na iya taimaka mana.
Yawancin HCoVs sun samo asali ne daga gizo-gizo inda ba su da cutarwa.
An kuma bayyana wasu masu ba da mafaka na Aadhaar a tsakanin wasu nau'ikan HCoVs.
Gano abubuwan da ke cikin dabba yana da tasiri kai tsaye a rigakafin mutum.
Binciken musayar masu ba da tallafi na CoV tsakanin dabbobi na iya ba da mahimman bayanai game da kamuwa da cutar CoV a cikin mutane.
A cikin wannan bita, muna taƙaita ilimin da ake da shi game da HCoVs bakwai, tare da mayar da hankali kan tarihin gano su da kuma tushen dabbobi da kuma cututtukan da suka shafi su.
Abu mai mahimmanci, muna kwatanta HCoVs daban-daban daga ra'ayi na juyin halitta na kwayar cuta da kuma sake haɗuwa da kwayoyin halitta.
A cikin wannan mahallin, an tattauna game da cutar COVID-19 ta yanzu.
Bugu da ƙari, ana lura da buƙatar sauya mai ba da mafaka mai nasara da tasirin juyin juya halin cutar a cikin matsanancin cutar.
Coronavirus (CoV-Cluster) na cikin gidan coronavirus, wanda ya ƙunshi rukuni na ɓoye, mai kyau-m, single-stranded RNA viruses.
"Kasuwancin da ke da manyan kwayoyin halitta daga 26 zuwa 32kB na RNAs an kira su ""CoV"" saboda tsarin da ke ƙarƙashin microwave na lantarki".
A tsarin tsarin, CoVs suna da nau'in kwayoyin halitta na musamman waɗanda suke cikin ƙungiya ɗaya.
Kimanin kashi biyu bisa uku na genomes suna da manyan manyan manyan bayanan karatu (ORF1a da ORF1b), waɗanda aka canza zuwa pp1a da pp1ab replicase polyproteins (fassara).
Ana sarrafa polyproteins don samar da wasu 16 masu ba da tsari, wanda aka sanya suna nsp1~16.
Sauran kwayoyin halitta suna da ORF don furotin masu gina jiki wanda ya hada da keylocks (S), wrappings (E), membranes (M), da nucleoproteins (N).
Wasu nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'an nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'
Dangane da bambancin jerin sunadarai, an rarraba CoVs zuwa nau'ikan rukuni huɗu (Alpha-CoV, Beta-CoV, Gamma-CoV, da Delta-CoV), wanda yawancin HCoVs a cikin nau'ikan beta-CoV suke da shi kuma an rarraba shi zuwa nau'ikan hudu (A, B, C, da D).
Shaidar jinsi ta nuna cewa farar da beraye suna aiki ne a matsayin tushen asalin asalin asalin alpha-CoV da beta-CoVs, yayin da tsuntsaye sune tushen tushen tushen gamma-CoVs da Delta-CoVs.
A cikin dubban shekaru, CoVs sun ci gaba da ƙetare ƙuntatawa tsakanin jinsuna kuma sun zama manyan cututtukan mutum.
Har zuwa yau, an samu kamuwa da cutar mutum bakwai (HCoVs).
HCoV-229E da HCoV-NL63 sun haɗa da alpha-CoV.
Sauran beta-CoV guda biyar sun hada da HCoV-OC43, HCoV-HKU1, SARS-CoV, MERS-CoV, da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da bayyanar cututtuka masu sauƙi kamar sanyi na yau da kullun da / ko fitsari.
A gefe guda, SARS-CoV, MERS-CoV da sabon gano SARS-CoV-2 suna haifar da cututtukan cututtukan cututtukan huhu masu tsanani (Acute Respiratory Stress Syndrome, ARDS) da kuma cututtukan cututtukan huhu masu tsanani a cikin marasa lafiya da yawa waɗanda ke da babban yiwuwar bayyanawa a waje da huhu.
An tattara nau'in HCoV-229E na farko, B814 daga nasal discharge na marasa lafiya masu sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar nazarin zurfin HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun da ke iyakance kansu.
A gaskiya ma, har zuwa barkewar cutar SARS, an karɓi ra'ayin cewa kamuwa da HCoVs ba su da lafiya.
Cutar SARS ta 2003 ta kasance daya daga cikin mummunan abubuwan da suka faru a tarihin kwanan nan, wanda ya shafi mutane 8,000 kuma yawan mutuwar da aka samu a cikin kwayoyin halitta ya kusan 10%.
Shekaru goma bayan haka, cutar ta ci gaba da yaduwa a yankin Larabawa, kuma ta bazu a sauran duniya, saboda barkewar cutar ta MERS.
2019 Novel HCoV (2019-nCoV), wanda aka sake suna SARS-CoV-2, shine mai aiki na cutar coronavirus ta yanzu ta 2019 (COVID-19), wanda ya haifar da mutuwar mutane sama da 3,120 da kamuwa da cutar sama da 91,000 a ranar 3 ga Maris, 2020.
Ana kiran kararrawar da ake yi a yanzu kuma dole ne duniya ta shirya don annobar SARS-CoV-2.
Kowace ƙungiya ta HCoV guda bakwai tana da asalin dabba daga farar fata, beraye ko dabbobi.
Akwai shaidu da yawa da suka goyi bayan asalin juyin halitta na duk HCoVs daga gizo-gizo, inda ƙwayoyin cuta suka dace sosai kuma ba su da lafiya amma suna nuna bambancin kwayoyin halitta mai kyau.
Cutar COVID-19 ta kawo manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da kuma ɗabi'a ga China da duniya.
Binciken asalin dabbobi na HCoV-group yana ba da tsari don fahimtar abubuwan da ke haifar da tarihin halitta, ƙarfin motsawa, da kuma iyakancewar jinsin zuwa jinsin (jumping).
Yana iya jagorantar ko kuma gudanar da bincike kan tushen, matsakaici da kuma masu karuwa na SARS-CoV-2, tare da abubuwan da ke da mahimmanci a cikin hana zubar da jini na gaba.
A cikin wannan bita, muna gabatar da taƙaitaccen bayani game da asalin dabbobi, kamuwa da cututtuka tsakanin jinsuna da kuma kamuwa da cutar HCoV.
Musamman, muna so mu sa kowa ya san cewa kwayoyin cutar HCoV-Cluster suna da cutarwa a cikin masu ba da mafaka na asali amma suna da cutarwa bayan sun shiga cikin sabon mai ba da mafaka.
Muna kuma nazarin yanayin juyin halitta na HCoV inda yawan cututtuka yakan ragu yayin da ake samun karuwar kamuwa da cutar.
An kuma tattauna sakamakon barkewar cutar SARS-CoV-2 a yanzu.
An san dabbobi da cutar CoV tun daga ƙarshen shekarun 1930.
An tattara tarin nau'ikan CoVs daban-daban a cikin dabbobi masu kamuwa da cutar, gashi, beraye, alade, cats da karnuka, kafin a fara tattara nau'in B814 na HCoV-229E daga hanci na marasa lafiya masu sanyi na yau da kullun.
A cikin shekarun da suka gabata, an gano HCoVs bakwai.
Wannan taƙaitaccen tarihin gano HCoV a cikin jerin lokutan (Table 1) zai zama mai bayani da ilimi.
An ware nau'in HCoV-229E na farko daga hanyoyin numfashi na marasa lafiya da ke fama da cututtukan sama a cikin 1966 kuma an daidaita shi don haɓaka zuwa layin WI-38 na ƙwayoyin huhu.
A cikin marasa lafiya da ke dauke da cutar HCoV-229E, an nuna alamun sanyi na yau da kullun, ciki har da ciwon kai, tari, rashin lafiya da ciwon wuya, kuma a cikin 10 zuwa 20% na waɗanda suka kamu da cutar, an nuna zazzabi da tari.
Daga baya a 1967, an tattara HCoV-OC43 daga ci gaban kwayar cutar a cikin kwayoyin halitta da kuma a hankali a cikin kwakwalwar dabbobin da ke shan madara.
Alamomin asibiti na kamuwa da cutar HCoV-OC43 suna kama da alamun cutar HCoV-229E, wanda ba za a iya rarrabe shi da alamun cututtukan sauran cututtukan numfashi kamar su cutar Influenza A da rhinovirus ba.
HCoV-229E da HCoV-OC43 suna yaduwa a duniya kuma suna kamuwa da cutar a lokacin hunturu a lokacin zafi.
Yawancin lokaci, waɗannan ƙwayoyin cuta biyu suna da ɗan lokaci na rashin lafiya na ƙasa da mako guda, sannan kusan makonni 2.
Wani binciken da aka yi na masu aikin sa kai na mutum ya nuna cewa mutanen da ke da lafiya da ke dauke da cutar HCoV-229E sun kamu da cutar sanyi mai sauki.
A wasu lokutan, an lura da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
"SARS, wanda aka fi sani da ""antipical pneumonia"", shi ne cutar ta farko da aka rubuta a tarihin 'yan Adam da ke tattare da cutar HCoV, kuma wakili na asali shi ne SARS-CoV, HCoV na uku da aka gano".
An fara samun SARS a lardin Guangdong na kasar Sin a karshen shekarar 2002.
A cikin shekaru da dama da suka gabata, an samu rahoton kamuwa da cutar ta SARS a cikin kasashe da nahiyoyi da dama, inda mutum 774 suka mutu.
Baya ga masu yadawa, an kiyasta cewa kowane hali tare da lokacin incuba na kwanaki 4 zuwa 7 da kuma bayyanar cututtuka a rana ta 10 na rashin lafiya zai iya ƙara kusan ƙarin lokuta biyu na ƙarshe na ɗaukar hoto tare da nuna alamun ƙarshe na ɗaukar hoto.
A cikin marasa lafiya da ke dauke da SARS-CoV, an fara nuna alamar ciwon tsoka, ciwon kai, zazzabi, rashin jin daɗi, da kuma numfashi, tari, da kuma jinkirin numfashi bayan sanyi.
Lymphophenia, gwajin aikin hanta da kuma karuwar creatine kinase sune wasu cututtukan laboratory na SARS.
An kuma lura da lalacewar alveolar da aka rarraba, yaduwar kwayoyin halitta da karuwar macrophages a cikin marasa lafiya da ke fama da SARS.
Kimanin kashi 20-30 na marasa lafiya suna buƙatar kulawa mai tsanani da iska mai iska a baya.
Baya ga ƙananan hanyoyin numfashi, akwai wasu gabobin ciki da suka shafi gastrointestinal tract, hanta da koda waɗanda za su iya kamuwa da cutar a cikin mummunan yanayi, yawanci tare da haɗarin cytokine wanda zai iya zama mummunan rauni ga marasa lafiya da ke fama da cutar.
An fara gano cutar ne daga wani dan uwa na wani mai cutar da ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga lokacin, an yi ƙoƙari sosai wajen nazarin cutar HCoV.
A karshen shekarar 2004, an tattara HCoV-NL63 daga wani jariri mai watanni 7 a Netherlands.
Wannan ya kasance a cikin ƙananan yara, tsofaffi, da marasa lafiya masu rashin numfashi waɗanda ke da rashin ƙarfi.
Coriza, tashin idanu, zazzabi da cututtukan da aka saba da su ta hanyar HCoV-NL63 a cikin cutar ta bronchiolitis.
Wani bincike na daban ya bayyana tarin wannan kwayar cutar daga cikin samfurin hanci na wani dan shekara 8 da haihuwa da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a cikin Netherlands, yana da yawa a duniya.
An kiyasta cewa HCoV-NL63 yana haifar da kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma yana da mafi yawan lokuta a lokacin bazara, bazara da farkon hunturu.
HCoV-NL63 yana da alaƙa da laryngitis na ɓoye, wanda aka fi sani da rukuni.
A wannan shekarar, an tattara HCoV-HKU1 daga wani mutum mai shekaru 71 da haihuwa a Hong Kong wanda ke fama da cutar pneumonia da bronchiolitis.
Baya ga cutar pneumonia da aka samu a cikin rukuni da kuma bronchiolitis, HCoV-HKU1 an ruwaito yana da alaƙa da cutar sankarar zuciya.
HCoV-HKU1 wanda yayi kama da HCoV-NL63, HCoV-229E, da HCoV-OC43 an samo shi a duniya, wanda shine dalilin rashin lafiyar numfashi.
Dukkanin waɗannan nau'ikan HCoVs huɗu sun daidaita da mutane sosai kuma suna da ƙarancin yiwuwar canzawa don haifar da cututtukan cututtuka masu cutarwa, kodayake akwai wasu haɗari da ba a sani ba, kamar su wani nau'in cutarwa mai cutarwa na HCoV-NL63 wanda kwanan nan aka ruwaito yana haifar da mummunan kamuwa da cutar huhu a China.
Yawanci, lokacin da waɗannan nau'ikan HCoVs suka sami ikon yin aiki da kyau da kuma ci gaba da kasancewa cikin daidaituwa tsakanin mutane, suna zama masu cutarwa ko masu cutarwa.
A shekarar 2012, an fara tattara MERS-CoV daga huhu na wani mutum mai shekaru 60 da haihuwa wanda ya kamu da cutar huhu mai tsanani da kuma rashin karfin jini a Saudiyya.
Duk da yake yawancin abubuwan da aka tabbatar da su a cikin dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an ruwaito wasu lokuta daga kasashen waje, tare da yaduwar mataki na biyu a cikin kusanci a wasu ƙasashen Turai da Tunisia.
A shekarar 2015 an samu wani barkewar cutar ta biyu a Koriya ta Kudu inda aka samu mutum 186 da suka kamu da cutar.
MERS yana nuna bayyanar cututtuka na SARS, wanda ke nuna ciwon huhu mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da cutar MERS sun sami mummunan cututtukan koda, wanda ya kasance na musamman ga MERS a cikin cutar da HCoV ke haifarwa.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun cututtukan ciki kamar fitsari da kumburi.
A ranar 14 ga Fabrairu, 2020, fiye da dakunan gwaje-gwaje 2500 sun tabbatar da cewa akwai adadin mutuwar fiye da 34.4%, wanda ya sa MERS-CoV ya zama ɗayan mafi munin ƙwayoyin cuta ga jikin mutum.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano nau'ikan marasa lafiya da ke fama da cutar huhu a Wuhan, lardin Hubei, China, saboda an danganta al'amuran da suka faru da kamuwa da cutar SARS-CoV-2.
Hukumar lafiya ta duniya ta bayyana barkewar cutar ta kasa da karfin numfashi da ta haifar da SARS-CoV-2 a matsayin dokar ta baci ta duniya da ke damun jama'a, kuma ta sanya sunan cutar COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duniya, tare da jimlar mutuwar 3.4%.
A kasar Sin, adadin mutuwar Huawei ya kai kashi 4.2%, amma a waje da haka ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV, waɗanda aka gabatar a matsayin zazzabi, tari da rashin numfashi.
Wasu marasa lafiya suna fama da ciwon ciki.
Nyon jini yana daya daga cikin alamun cututtukan da suka fi tsanani kuma yana iya saurin ci gaba zuwa mawuyacin yanayin numfashi.
Duk da yake sun yi kama da SARS-CoV da SARS-CoV-2 saboda yawan halayen halayen kwayoyin halitta na 82% na ƙasa, suna rarraba su cikin rassan rassan.
A bayyane yake, SARS-CoV-2 ba shi da cutarwa sosai amma yana da yawa fiye da SARS-CoV da MERS-CoV.
An bayar da rahoton cewa SARS-CoV-2 ya kamu da rashin bayyanar cututtuka kuma yana iya taimakawa wajen saurin yaduwar duniya.
Idan aka kwatanta SARS-CoV-2 da sauran HCoV shida, akwai kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, lokaci na farko na cutar da kuma lokacin da cutar HCoV ke gudana suna kama da juna.
A wannan yanayin, SARS-CoV-2 ya bi al'amuran sauran HCoV shida.
Na biyu, an samu ci gaban bayyanar cututtukan COVID-19 bayan an samu SARS-CoV da HCoVs hudu masu kamuwa da cutar (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 yana nuna halaye waɗanda galibi ana gani tare da bayyanar da ba ta da kyau, haske ko ma ba tare da alamun bayyanar cututtuka ba yayin kamuwa da cutar HCoV-samuwar jama'a.
A gefe guda kuma, a cikin ƙananan ƙananan lokuta na COVID-19 akwai alamun kamuwa da cutar SARS-CoV, kodayake adadin ya ɗan ragu.
Na uku, SARS-CoV-2 ya nuna alamun halayyar HCoVs da aka samu da SARS-CoVs.
A gefe guda, kamuwa da cutar SARS-CoV-2 ya yi daidai da na HCoVs da aka mamaye a rukuni.
A gefe guda, har yanzu ana buƙatar tabbatar da ko za a iya samun karuwar kamuwa da cutar a SARS-CoV-2 kamar yadda ya faru da SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurin kwayar cutar.
Har yanzu ana bukatar a tabbatar da cewa, a kalla a wasu yanayi, cutar SARS-CoV-2 tana taka muhimmiyar rawa wajen kamuwa da cutar ta SARS-CoV-2.
Akwai matukar sha'awa a kan ko SARS-CoV-2 yana nuna irin wannan yanayin na yanayi kamar yadda HCoVs na al'umma ke nunawa.
Duk da haka, halaye na SARS-CoV-2 da suka hada da kamuwa da cutar, kamuwa da cutar, da kuma ci gaba da yaduwa bayan an watsa shi zuwa mutane zasu iya rinjayar sakamakon barkewar COVID-19.
HCoVs hudu masu saukin kamuwa da cutar sun daidaita da mutane sosai.
A wani bangare kuma, zai iya zama gaskiya cewa mutane sun dace da HCoVs guda hudu.
A wasu kalmomi, dukansu na iya zama zuriyar cutar HCoV ta farko.
An kashe mutanen da ke haifar da cutar HCoV a cikin mutane da kuma mutanen da suka sami cutar HCoV mai tsanani.
Don haka, HCoVs dole ne su samar da kwafin da ya isa a cikin mutane don adana nau'ikan masu dacewa waɗanda ke yaƙar abubuwan da ke haifar da iyakancewar mai ba da mafaka.
A wannan ma'anar, yayin da cutar SARS-CoV-2 ta daɗe kuma mutane da yawa suka kamu da ita, zai fi dacewa da daidaitawa da mutane gaba ɗaya.
Idan aka daidaita shi da kyau, zai yi wuya a hana shi shiga cikin jikin mutum ta hanyar killacewa ko wasu matakan hana kamuwa da cutar.
A cikin shekaru da yawa, nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ukan nau'ikan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan
Wadannan kwayoyin ba sa bukatar wani tushen dabba.
A akasin haka, SARS-CoV da MERS-CoV masu cutarwa ba su da kyau a cikin mutane kuma ba za su iya ci gaba da kamuwa da su a cikin mutane ba.
Suna buƙatar kiyayewa da faɗaɗa su a cikin tushen su na zoonotic kuma suna neman damar da za su iya faɗaɗa su zuwa ga maƙasudin ɗan adam mai ɗorewa ta hanyar ɗaya ko fiye na matsakaici da haɓaka.
SARS-CoV-2 yana da halaye waɗanda suke kama da SARS-CoV / MERS-CoV da HCoVs huɗu na al'umma, duka biyu.
Aƙalla har zuwa yanzu, yana da matukar yaduwa kamar HCoV na al'umma.
Amma, yana da cutar fiye da tarin HCoVs da aka samu a rukuni, kuma ba shi da cutar fiye da SARS-CoV ko MERS-CoV.
Dole ne a duba ko ya dace da mutane sosai kuma ya ci gaba da yadawa cikin mutane ba tare da wani tushe ko kayan dabba na tsakiya ba.
Kafin mu tattauna asalin dabbobi na HCoV, za mu amfana idan muka tattauna ma'anar da kuma halaye na masu ba da gudummawa na HCoV, na halitta, na asali, na matsakaici da na faɗaɗa.
Dabba tana aiki a matsayin mai haɓaka HCoV idan ta ba da mafaka ga ƙawancen da ke da alaƙa ta hanyar raba homology a matakin matakin nucleotide.
Kwayar cutar ta asali tana da kyau sosai a jikin wannan mai ba da mafaka kuma ba ta da cutar.
Hakazalika, mai ba da mafaka na Aadhaar yana ba da mafaka ga HCoV a kai a kai kuma na dogon lokaci.
A duka biyun, masu ba da mafaka suna kamuwa da cutar ta halitta kuma suna da mafaka ta halitta ga HCoV ko kuma cutar mai kare ta.
Akasin haka, idan HCoV ya fara ganowa da mai ba da kulawa na matsakaici kafin ko kusa da mutum, ba zai dace da sabon mai ba da kulawa ba kuma galibi yana da cutarwa.
Wannan matsakaiciyar mai ba da mafaka na iya zama tushen dabba na kamuwa da cutar ta mutum kuma yana iya zama mai ba da mafaka na ɗan lokaci don sake kwayar cutar ta ɗan lokaci sannan kuma ya faɗaɗa yawan kamuwa da cutar ta hanyar kamuwa da cutar ta mutum.
Idan HCoV bai iya ci gaba da watsawa tsakanin masu ba da mafaka ba, za a iya hana yaduwar.
A akasin haka, HCoVs na iya daidaitawa da ƙwayoyin halitta na tsakiya kuma su fara barkewar cutar na dogon lokaci.
A wannan yanayin, kayan aikin matsakaici sun zama kayan aikin halitta.
Bayanai na ilimin cututtuka sun nuna cewa SARS yana nuna cewa dabbobi masu haɗuwa da cutar suna da tarihin hulɗa da cutar.
Binciken da aka yi a baya ya nuna cewa akwai karin yaduwar cutar anti-SARS-CoV IgG a tsakanin masu sayar da dabbobi fiye da talakawa.
A cikin kasuwar dabbobi na Gandhog (Paguma larvae) da kuma na dabbobi, an fara gano wani kare raccoon don ɗaukar kwayar cutar kamar SARS-CoV wanda ya yi kama da SARS-CoV.
Wannan ya goyi bayan bayanan da aka samu cewa babu wani sanannen cutar SARS bayan an kashe dukkan 'yan tsiraru a kasuwannin.
Koyaya, an gano cewa ɓoye ɓoye na dabba na daji ko na gonaki ba tare da haɗuwa da kasuwar dabba ba sun kasance masu ƙyama ga SARS CoV, wanda ke nuna cewa ɓoye ɓoye na dabba zai zama mai ɗaukar hoto na matsakaici kawai ba a matsayin tushen halitta na SARS-CoV ba.
Abin lura, tun da kashi 80% na kasuwar Guangzhou ke da anti-SARS-CoV antibodies ga nau'ikan dabbobi daban-daban, ba za a iya ƙyale yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa na iya zama masu haɓaka haɓaka tsakanin SARS-CoV ba.
Dukkanin waɗannan ana ganin su ne masu ɗaukar SARS-CoV.
Wani bincike na gaba kan yanayin dabbobin SARS-CoV  suka yi ya bayyana wani nau'in bat CoV mai alaƙa da SARS, wanda ake kira SARS-Rh-BatCoV HKU3, wanda ke cikin nau'in doki na kasar Sin. Wani bincike na gaba ya bayyana wani nau'in bat CoV mai alaƙa da SARS, wanda ake kira SARS-Rh-BatCoV HKU3, wanda ke cikin doki na kasar Sin.
Wadannan kumfa sun kasance masu kyau ga antibody na SARS-CoV da kuma tsarin kwayoyin halitta na SARSr-Rh-BatCoV HKU3.
Waɗannan da sauran ƙwayoyin cuta na CoV suna da kashi 88-92% na tsarin homology na nucleotide tare da SARS-CoV.
Wannan binciken ya kafa sabon ra'ayi cewa kunar bakin wake tana ba da mafaka ga cututtukan mutum masu tasowa.
An gano wasu nau'ikan CoV (SL-CoV) kamar SARS daga gizo-gizo, amma ba a iya tattara su a matsayin mai rai ba sai dai a cikin wani ƙirar WIV1.
An san mutum da ƙwayoyin cuta na angiotensin mai canzawa 2 (ACE2) a matsayin mai karɓar SARS-CoV .
An nuna cewa ana amfani da warts, ciwo, da kuma ACE2 na mutum a matsayin masu karɓar shiga cikin kwayoyin WIV1 daga samfurin naman alade.
Abin sha'awa, an kashe WIV1 a cikin kwayoyin cutar SARS a cikin marasa lafiya da ke warkewa.
Ya zuwa yanzu, WIV1 yana wakiltar magabatan SARS-CoV mafi kusanci a cikin tsutsotsi, wanda ke raba 95% na homology na nucleotide.
Duk da yake akwai babban matakin homology tsakanin waɗannan ƙwayoyin, ana yawan yarda cewa WIV1 SARS-CoV ba kwayar cutar mahaifa ta kai tsaye ba ce kuma kunar bakin wake ba ta zama mai ba da mafaka ta kai tsaye ga SARS-CoV ba.
Nazarin phylogenetic ya sanya MERS-CoV cikin rukuni guda kamar bat CoV-HKU4 da bat CoV-HKU5.
Bat CoV-HKU4 da MERS-CoV suna amfani da wannan mai karɓar mai karɓar, Dipptidyl peptidase 4 (DPP4) don shigar da kwayar cutar.
RNA polymerase sequences na MERS-CoV mai dogara da RNA suna da alaƙa da phylogenetically tare da kwatancen bat beta-CoVs da aka gano daga Turai da Afirka.
Har zuwa yanzu, babu wani kwayar cutar MERS-CoV da aka gano a cikin fararen fata.
MERS-CoV da kuma mafi kusantar zumunta CoV-HKU25 suna da kashi 87% na homology na nucleotide.
Saboda haka, ƙura ba za su iya zama tushen tushen MERS-CoV ba.
A wani bangare kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman da ke da ƙuƙwalwa guda ɗaya suna da ƙwayar cutar MERS-CoV, kamar yadda raƙuman da ke Gabas ta Tsakiya suke da su a ƙasashen Afirka da yawa.
An tattara wani nau'in MERS-CoV mai kama da wanda aka samo a cikin mutane daga naman kaza mai ƙwanƙwasa, wanda ya nuna cewa raƙuman suna aiki a matsayin ainihin tushen tushen MERS-CoV.
Ya kamata a lura cewa kwayoyin da aka kamu da su da cutar MERS-CoV suna da alamun bayyanar cututtuka, amma suna da alamun bayyanar cututtuka.
Abin lura, raƙuman da suka kamu da cutar ba kawai ta hanyar numfashi ba, har ma ta hanyar fitsari da kuma bakin, wanda shine babban hanyar watsa cutar daga farar fata.
Duk da haka, tambayoyi sun ci gaba saboda yawancin mutanen da suka tabbatar da cutar MERS ba su da tarihin hulɗa da kwayoyin kafin bayyanar cututtuka, wataƙila na mutum-zuwa-mutum ko na hanyar kamuwa da wasu nau'ikan dabbobi da ba a sani ba waɗanda ke ɗaukar MERS-CoV.
Rhinololophus affinis ya sami 96.2% na daidaituwa tsakanin CoV RaTG13 da nucleotide homology na SARS-CoV-2.
Kamar yadda yake a SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 yana da yawa don ƙayyade alaƙar iyaye.
Wannan yana nufin cewa idan ba a gano kusan dukkanin kwayoyin cuta na CoV ba a nan gaba, ƙura ba za ta iya zama ainihin tushen SARS-CoV-2 ba.
Wataƙila, Hunan Seafood, mai ba da mafaka ga dabbobi a cikin SARS-CoV-2, ya kamata ya kasance daga cikin namun daji da aka sayar da su a cikin kantin sayar da abinci, wanda ya danganta da yawancin farkon COVID-19, wanda ke nuna yiwuwar kamuwa da mutum daga dabba.
Yawancin binciken da aka yi kwanan nan bisa ga tsarin matsin lamba sun nuna cewa wata ƙungiya ta ƙananan dabbobi masu haɗari da ake kira bonruis (Manis Javanika) na iya ɗaukar SARS-CoV-2 da ke da alaƙa da beta-CoVs.
Wannan labari na nuna cewa kashi 85-92% na kwayoyin halittar kwayoyin halitta na kwayoyin halitta na SARS-CoV-2 sun kasance masu kama da kwayoyin halitta na CoV.
Duk da haka, suna da alaƙa da RaTG13 daidai da kusan 90% na daidaito a matakin jerin nucleotides.
Suna ɗaure ƙwayoyin cuta zuwa ƙananan ƙwayoyin cuta guda biyu kamar SARS-CoV-2 a cikin itacen da aka tsara, ɗayan yana raba yanki mai ɗaurewa (RBD) iri ɗaya tare da gano 97.4% amino acid sequence tare da SARS-CoV-2.
A akasin haka, RBDs na SARS-CoV-2 da RaTG13 sun fi rarrabewa, duk da cewa tsarin homology na jini yana da girma sosai.
Wani binciken da aka yi a kan Bonuwei mai rashin lafiya ya kuma nuna cewa an gano jerin cututtukan cutar daga samfurori na huhu, wanda ya tabbatar da cewa yana da alaƙa da SARS-CoV-2.
Wannan binciken ya ɗauki hanyoyi daban-daban na taro da kuma gabatarwar hannu don ƙirƙirar jerin kwayoyin halitta na ɓangare tare da kusan kashi 86.3% na jimlar kwayar cuta.
Ba za mu iya kawar da yiwuwar cewa pangolin yana cikin masu ciyar da dabbobi na SARS-CoV-2.
Duk da haka, a halin yanzu babu wata hujja da ke tallafawa asalin SARS-CoV-2 kai tsaye daga SARS-CoV-2 saboda bambancin tsari tsakanin SARS-CoV-2 da SARS-CoV-2 masu alaƙa da beta-CoV-2s.
Bugu da kari, nesa tsakanin SARS-CoV-2 da RaTG13 ya fi na SARS-CoV-2 da kuma beta-CoV-sungiyoyin da ke da alaƙa da SARS-CoV-2 karami.
Har yanzu ba a kafa hanyar juyin halitta na SARS-CoV-2 a cikin tsutsotsi, pangolins da sauran masu shayarwa ba.
Duk da yake an gano mafi yawan homologues tsakanin SARS-CoV-2 da RBDs na Burundi, SARS-CoV-2 da ke da alaƙa da beta-CoV-sams, SARS-CoV-2 da RaTG13 suna da mafi yawan homologues na bin-jin.
Yana da matukar ban mamaki cewa babban kamanceceniya tsakanin beta-CoVs da ke da alaƙa da RBD na SARS-CoV-2 da SARS-CoV-2 na Bunruwe yana motsawa ta hanyar juyin halitta na tsakiya mai tsakiya.
An gabatar da wani shawarwari na anti-anti-SARS a cikin nau'in na uku na namun daji don sake haɗuwa tsakanin SARS-CoV-2 da kuma beta-CoV na RaTG13.
A matsayin mai motsa juyin halitta, sake haɗuwa tsakanin beta-CoVs ya faɗaɗa.
Har yanzu ba a san ainihin asalin dabba na SARS-CoV-2 ba.
Baya ga HCoVs masu cutarwa, an kuma yi nazarin tushen dabba na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar phylogenetic ta nuna cewa HCoV-NL63 da HCoV-229E sun samo asali ne daga CoVs na bat, kodayake an gano ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin beraye.
An ruwaito cewa wani nau'in CoV mai suna ARCoV.2 (Appalachian Ridge CoV), wanda aka gano a cikin kwayar cutar HCoV-NL63 a cikin kwayar cutar ta Arewacin Amurka, ya nuna dangantaka ta kusa.
A gefe guda, HCoV-229E yana da alaƙa da wani nau'in CoV mai suna Hippocydrosis / Ghanakowam /19/2008, ko da yake ana zargin cewa camellids ma suna da alaƙa da shi.
Don nuna gaskiya, an taƙaita tushen ilimin halin yanzu game da HCoVs a cikin Figure 1 da Table 2.
Nazarin jinsi ya ba da tabbacin abubuwan da suka faru na kamuwa da cutar ta CoV a cikin tarihin.
A cikin 1890s, lokacin da HCoV-OC43 ya wuce jinsunan kuma ya kamu da mutane daga dabbobi, an sami annobar numfashi.
Tarihin kamuwa da cutar HCoV-229E tsakanin jinsuna ba shi da tabbas.
An gano alpha-CoVs na kumfa da ke da alaƙa da HCoV-229E.
Daga cikin su akwai wani cutar Alpha-Alpha CoV.
Akwai shaidu da dama da suka goyi bayan yaduwar cutar daga kumfa zuwa mutum.
Na farko, a cikin yanayin muhalli mai rabawa, za a iya samunsa daga tuntuɓar da ake yi da mutane amma ba tare da alpacas ba.
Maimakon haka, mutane suna da dangantaka mai kyau da Alpacar.
Na biyu, cutar HCoV-229E-ta shafi cutar ta alf-CoV-ta bambanta da rashin lafiya a cikin alf-CoV-tabbataccen alf-CoV, yayin da alf-CoV-tabbataccen alf-CoV ke haifar da barkewar cutar numfashi a cikin dabbobi.
A ƙarshe, ba a samu Alpha-CoV a cikin namun daji ba.
Saboda haka, ba za a iya ƙyale yiwuwar cewa alpacas sun sami alpha-CoV dangane da HCoV-229E daga mutane ba.
A gaskiya, gizo-gizo sune ainihin tushen cututtukan mutum, ciki har da cutar Rabies, Ebola, Nipah, da kuma cutar Hendra.
Saboda haka ba abin mamaki bane cewa kunar bakin wake na iya watsa HCoV-229E kai tsaye zuwa ga mutane.
A gefe guda, kunar gizo-gizo tana aiki a matsayin gene pool na alpha-CoV-cluster HCoV-229E, amma alpacas da raƙuman raƙuman ruwa na iya zama masu ba da mafaka na tsakiya waɗanda ke watsa kwayar cutar a cikin mutane, kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV misali ne mai kyau na yaduwar kamuwa da kwayoyin halitta daga kamun daji zuwa kamun daji da kuma daga kamun daji zuwa mutane.
An gano asalin asalin MERS-CoV daga gizo-gizo a farkon ganowa kuma an tabbatar da shi ta hanyar bincike na gaba.
A bayyane yake cewa, kunar bakin wake tana samar da tushen tushen wadataccen nau'in kwayar cutar don musayar kwayoyin halitta da kuma cututtukan da ke tsakanin jinsuna.
Tsawon rayuwarta, da kuma zamanta a cikin ƙasa, da kuma kyakkyawar zamantakewar jama'a da kuma iyawar tashi, suna da kyau sosai don zama 'yan fashin kwamfuta masu yaduwa.
A wani bangaren kuma, cutar ta MERS-CoV ta zo ne daga wata farar fata shekaru da dama da suka gabata.
Yana da kyau ya dace da waɗannan raƙuman da suka zama mai ba da mafaka na matsakaici zuwa mai ba da mafaka na kwanciyar hankali da na halitta.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙarancin yaduwar cutar a cikin waɗannan dabbobi.
Yaduwar cutar a cikin mutane shine haɗari kuma mutane sun kasance mafaka ta ƙarshe ga MERS-CoV saboda ba za a iya hana kamuwa da ita ba.
Ba kamar yadda raƙuman ke da tasiri a kan kamuwa da cutar MERS-CoV2 ba, akwai bambanci tsakanin matsayin pangolin a kamuwa da cutar SARS-CoV-2.
Musamman, pangolin beta-CoV yana da matukar cutarwa ga pangolin.
Suna iya zama mafaka ta ƙarshe ga beta-CoVs masu alaƙa da SARS-CoV-2 kamar yadda suke da ƙwayoyin cuta a cikin SARS-CoV.
Za a iya haɗa ko soke yiwuwar watsa SARS-CoV-2 daga dabbobi zuwa mutane a cikin nazarin nan gaba.
Na farko, kunyar gizo-gizo na iya zama tushen mafaka ga SARS-CoV-2 wanda ya yi kama da SARS-CoV-2.
Mutane za su iya raba yanayin muhalli da dabbobi ta hanyar yin hayaki ko kuma yin hakar ma'adinai.
Na biyu, Bonrouis na iya kasancewa cikin masu ba da mafaka na matsakaici inda aka gabatar da sabon kwayar cutar da ta shafi SARS-CoV-2.
Mutane suna kamuwa da cutar ta hanyar cin nama da cin nama.
Yana yiwuwa cewa dabbobi masu shayarwa da yawa, ciki har da dabbobi masu gida, ba su da kariya daga SARS-CoV-2.
An tabbatar da binciken dabbobi da namun daji don maganin rigakafi.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaita SARS-CoV-2 na iya faruwa a cikin nau'in na uku wanda ke da alaƙa da tsutsotsi da pangolin.
Ana ci gaba da binciken asalin dabba na SARS-CoV-2.
Ban da masu ba da mafaka na dabbobi daban-daban, manyan dalilai guda uku na cutar suna da mahimmanci wajen taimaka wa CoVs su shawo kan shingen da ke tsakanin jinsuna.
Na farko, RNA yana da yawan jujjuyawar kwayoyin halitta.
"Kamar sauran kwayoyin RNA guda ɗaya (Stranded), ana iya la'akari da ƙididdigar canjin CoV-supplement rate daga ""mai matsakaici"" zuwa ""mai girma"" dangane da ƙididdigar canjin CoV na sabon abu, kuma matsakaicin canjin rate ~10-4 zai zama 2 a kowace shekara a kowace maye gurbin site".
CoVs suna da ƙididdigar ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Abin sha'awa, an gano cewa wannan exoribonuclease na nucleotide analogue remdesivir yana haifar da CoV replicas ta hanyar rage RNA-based RNA polymerization.
Reddecivir yana daya daga cikin abubuwan da ke da tasiri a kan cutar SARS-CoV-2 da aka gwada a cikin gwajin gwaji.
Duk da haka, yawan kamuwa da cutar ta CoV ya ninka na masu bada tallafi kusan sau miliyan daya.
Bugu da ƙari, sau da yawa, yawan canji yana da yawa idan CoVs ba su iya daidaitawa da al'ada ba.
Idan aka kwatanta da SARS-CoV tare da yawan adadin watsawa, yawan watsawa na SARS-CoV-2 ya kasance ƙasa da ƙasa, wanda ke nuna cewa mutane sun fi dacewa da su.
Wataƙila, ta riga ta daidaita da wani mai ba da mafaka kusa da mutane.
A cikin SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
A ka'idar, akwai yiwuwar cewa ƙwayar halitta ta SARS-CoV-2 za ta iya sa alluran rigakafi da maganin rigakafi su zama marasa inganci da sauri.
Na biyu, babban RNA na CoV yana amfani da ƙarin sassauci a cikin canjin kwayoyin halitta don canzawa da sake haɗuwa, yana ba da damar haɓaka tare da haɗuwa, wanda ke ba da damar haɓaka tarin CoV lokacin da yanayi ya dace.
Yana da babban fayil na buɗewa da aka rubuta a ƙarshen 3′ na genomes kuma yana tallafawa aikin furotin.
"Na uku, CoV-suna canza samfuran yayin da suke kwafin RNA ta hanyar bazuwar kuma sau da yawa ta hanyar "sake-sake" tsari na musamman".
Sau da yawa a cikin matattarar CoV RNA, mai ba da mafaka wanda ke aiki a matsayin tukunya mai haɗawa yana canzawa.
Hakanan, RNA mai tsawon lokaci mai girma da kuma subgenome na iya sake haɗuwa don ƙirƙirar sabon CoV-sets.
An gano shaidar phylogenetic na sake daidaitawa ta halitta tsakanin HCoV-HKU1 da HCoV-OC43 da kuma tsakanin nau'ikan CoV na dabba kamar su Bat SL-CoV da batCoV-HKU9.
Hadin gwiwar ƙwayar cuta-mai karɓar ƙwayar cuta
Baya ga abubuwan da aka ambata a sama, musayar kwayar cuta tare da mai karɓar mai karɓar wani babban abin da ke haifar da kamuwa da kwayar cuta tsakanin jinsuna.
Daga cikin wadannan, an dauki sake dawo da SARS-CoV a matsayin misali mai kyau, wanda kuma ya nuna hujja na zaɓi mai kyau yayin da kamuwa da nau'in ke faruwa.
Bisa ga bincike na kwatanta tsakanin tarin SARS-CoV na mutum da na mutum, an yi tunanin cewa SARS-CoV na iya daidaitawa da sauri tare da juyin halitta na RBD na S-protein musamman tsakanin masu ba da mafaka daban-daban.
RBD yana hulɗa da masu karɓar kwayoyin halitta a cikin furotin S na CoV kuma yana da ƙarfi ta hanyar amsawar antibody.
A cikin SARS-CoV, RBD yana da amino acid na 318 zuwa 510 a cikin sashin S1 wanda ke ɗaure da corceptors don shiga cikin kwayar cutar tare da ACE2 na mutum.
RBD na SARS-CoV na iya gane masu karɓar ACE2 a cikin dabbobi daban-daban, gami da farar fata, cloves, mice, da kuma karnuka na raccoon, wanda zai iya haifar da kamuwa da cutar tsakanin jinsuna.
A zahiri, an gano cewa ragowar amino acid 6 ne kawai suka bambanta da masu ƙanshi na ƙwayoyin cuta a cikin mutum da RBD, kuma 4 daga cikinsu suna cikin ƙirar mai amfani don hulɗa da mai amfani da ACE2.
Ciwon SARS-CoV RBD yana da bambance-bambancen K479N da S487T, wanda zai iya haɓaka kusanci na musayar spike proteins tare da masu karɓar ACE2 a cikin mutane.
A wasu kalmomin, maye gurbin amino acid biyu na iya zama mai tsanani ga kamuwa da cutar a cikin mutane.
Yana da mahimmanci cewa masu amfani da kwayoyin halitta na SARS-CoV da SARS-CoV-2 suna da kama.
Bambanci na 30% tsakanin S1 na SARS-CoV-2 da S-protein na SARS-CoV yana nuna cewa yanayin haɗewar S-protein tare da ACE2 na mutum na iya canzawa.
A gaskiya ma, binciken CREO-EM ya nuna cewa an yi amfani da nau'in haɗin kai tsakanin kwayoyin ACE2 na mutum da SARS-CoV S sau 10 zuwa 20 fiye da na masu amfani.
Yana da mahimmanci a gano ko ana buƙatar wani mai karɓar SARS-CoV-2 don kamuwa da cutar.
Abin damuwa, HCoV-NL63 yana da alaƙa da ACE2 amma tare da wani ɓangare na S.
Akwai sauran masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E da 9-O-acetylated silica acid don HCoV-OC43.
Suna iya zama sanadin nasarar kamuwa da wannan nau'in CoV a cikin mutane bayan an kamu da su daga mai kare su zuwa nau'in.
Baya ga masu karɓar kwayoyin halitta, sakamakon kamuwa da cutar HCoV-samuwar jini yana sarrafawa ta hanyar dogaro da dalilai na iyakancewa akan sauran masu ba da mafaka.
Rarraba waɗannan furotin masu baƙo tsakanin mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna mazauna.
HCoVs dole ne su mallaki abubuwan da ke haifar da dogaro da mai ba da gudummawa don samun nasarar kamuwa da nau'in.
A wannan yanayin, har yanzu akwai sauran abubuwa da za a iya ganowa da kuma bayyana halaye na waɗannan mahimman abubuwa na musayar cutar-mai cutar.
Yin amfani da fasahar CRISPR ta zamani na iya kawo sakamako mai kyau na binciken da aka yi na rashin daidaito da kuma iyakancewar masu ba da mafaka ga SARS-CoV-2.
Fitowar sabon nau'in HCoV: Komawa inda ya fara
Bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin
A wannan ma'anar, bat yana aiki a matsayin tarin kwayoyin halitta na CoV-Cluster HCoV.
Bugu da kari, saurin maye gurbin da kuma sake haɗuwa da kwayoyin halitta suna haifar da juyin halittar HCoV kuma suna aiki a matsayin muhimman matakai biyu a cikin wannan tsari.
Alal misali, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Daga cikin sunadarai masu alaƙa da SARS-CoV, an gano ORF8 yana da mahimmanci wajen daidaitawa da mutane saboda an tattara bat viruses masu alaƙa da SARS-CoV amma an ga sun encode sunadarai daban-daban na ORF8.
An gano wani nau'in SARS-CoV na 29 wanda ke kawar da nucleotide a cikin nau'ikan da aka tattara a farkon annobar ɗan adam.
Wannan cirewa ya raba ORF8 zuwa ORF8a da ORF8b kuma yana da alama shine canjin da ya dace wanda ke ƙarfafa canjin mafaka.
Bugu da kari, akwai tarihin yiwuwar sake haɗuwa da SARS-CoV tare da rukuni na alpha da gamma-CoV, inda aka gano manyan ƙananan yankunan sake haɗuwa a cikin RNA-dogara RNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin sassan nsp9, mafi yawa nsp10 da nsp14.
Hakazalika, an nuna cewa cutar ta MERS-CoV ta shiga cikin sake haɗuwa tsakanin kabilu, wanda ya faru a cikin wata uwar gida a Saudiyya.
Baya ga SARS-CoV da MERS-CoV, an lura da sake haɗuwa da wasu HCoVs, inda HCoVs ke sake haɗuwa da CoVs na wasu dabbobi a cikin kwayoyin da ba su da tsari.
Ya kamata kuma a yi gargadi cewa zaɓin wucin gadi na iya ba da gudummawa ga canje-canje na ɓoye a cikin kwayoyin halitta na kwayar cuta, mai yiwuwa sakamakon sakin ƙwayoyin cuta daga matsin lamba kamar tsarin rigakafin maraba.
Misali na irin wannan tasirin shine rasa cikakken tsawon ORF4 a cikin HCoV-229E samfurin saboda cirewar nucleotides biyu.
Duk da yake ana iya ganin rashin lalacewa na ORF4 HCoV-229E a cikin ƙwayoyin cuta da ƙwayar cuta na raƙumi, Alpha-CoV na Alpha-CoV yana nuna sanya nucleotide guda ɗaya a ciki, sakamakon yana nunawa a cikin tsarin.
A ƙarshe, an yi amfani da matsin lamba don juyin halitta na HCoVs na zamani.
Lokacin da aka kamu da cutar ta CoV, an gano cewa kunar bakin wake ba ta da wata alama ko kuma sun sami alamun bayyanar cututtuka kawai, wanda ke nuna daidaitawa tsakanin tarin CoV da kunar bakin wake.
An gano cewa kunar bakin wake suna da kyau wajen daidaitawa da CoVs ta asali da kuma ta jiki.
Alal misali, rashin nasarar kunna amsa don jawo kumburi a cikin tsutsotsi yana rage cututtukan da ke tattare da CoV-cluster.
Bugu da ƙari, an matsa wa ayyukan kwayoyin halitta na kwayoyin halitta na fungi saboda ƙananan matakan bayyanawa na kwayoyin cuta masu hanawa NKG2/CD94 da kuma manyan kwayoyin da ke cikin tsarin tsarin tsarin lissafi na gaba.
Bugu da ƙari, hana kwayar cutar CoV mai karɓa ta hanyar ƙwayoyin cuta masu karɓa (ROS) da ke fitowa daga ayyukan ƙwayoyin cuta masu yawa na kumfa da kuma tasiri ga ƙwayoyin cuta ta hanyar exoribonuclease na iya yin duka, don haka samar da matsin lamba na zaɓin da ake buƙata don samar da nau'ikan cutar yayin da suke hulɗa da sabon mai masaukin baki.
Hakanan za'a iya haɓaka ƙarin nau'ikan CoV masu cutarwa ta hanyar sake haɗuwa wanda ke haifar da sabon furotin ko kuma furotin don daidaitawar mai masauki.
Saboda haka, yiwuwar fitowar sabbin HCoVs guda uku a cikin shekaru biyu da suka gabata ba zato ba tsammani bane.
CoVs ba su da lafiya ko kuma suna haifar da alamun bayyanar cututtuka a cikin masu ba da tallafi kamar su farar fata da raƙuma.
Sun yi girma sosai ba tare da wani mai ba su gida ba.
Wannan shi ne asirin dalilin da ya sa babu alamun cutar da kuma abin da ke haifar da cututtukan cututtukan mutum.
Alamun cututtuka suna haifar da yawan kunnawa na maganin rigakafi da kuma bugun cytokine inda tasirin rigakafi ya fi karfi, lalacewar huhu ta fi tsanani.
Akasin haka, a cikin masu dauke da cutar ba tare da wata alama ba, an bambanta amsawar rigakafi daga na CoV.
Hanyar da ta dace da hana rigakafin cutar ta iya samun sakamako mai kyau a maganin anti-SARS-CoV-2.
Maganin interferon yana da ƙarfi sosai a cikin kumfa.
Saboda haka, amfani da Type I interferon ya kamata ya kasance mai amfani a kalla a farkon matakin kamuwa da cutar SARS-CoV-2 a cikin mutane.
Bugu da ƙari, NLRP3 yana da lahani a cikin farfadowa a cikin farar fata.
Ta wannan hujjar, maganin NLRP3 mai hana ciwon kumburi, wanda ya hada da MCC950, na iya zama mai tasiri wajen magance COVID-19.
SARS-CoV-2 ya samo asali ne daga abubuwan da suka haifar da SARS-CoV da MERS-CoV.
A daya bangaren an gano cewa beta-CoV yana musayar 95% na nucleotide homology tare da SARS-CoV, a wani bangaren kuma akwai bat-CoV wanda ke musayar 96% na nucleotide homology tare da SARS-CoV-2.
Ko da yake an ruwaito cewa dabbobi masu kama da SARS-CoV sun kasance a cikin gidajen gidaje na gandun daji da sauran dabbobi a kasuwa, ba a gano masu ba da mafaka na yanzu don SARS-CoV-2 ba.
An gano wani nau'in beta-CoV na Bonrui wanda ya dace da SARS-CoV-2, wanda ke nuna cewa Bonrui zai yi aiki a matsayin ɗayan masu ba da mafaka na tsakiya ko kuma zai iya ba da gudummawar kwayar gene ga sigar ƙarshe na SARS-CoV-2 na Bonrui beta-CoV-Cov.
Duk da cewa akwai tambayoyi, babu wata hujja cewa SARS-CoV-2 ta kasance da gangan ko ta hanyar mutum.
A sakamakon barkewar cutar SARS-CoV-2, CoVs sun sake zama batun tattaunawa.
Nazarin CoVs a cikin farar fata da sauran dabbobi ya canza tunaninmu game da muhimmancin tushen dabba da tushen dabba na HCoVs a cikin kamuwa da cutar mutum.
Akwai wadataccen hujja cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da tushen kumburi kuma suna kamuwa da mutane ta hanyar masu ba da mafaka.
Tun da yake kamuwa da cutar SARS-CoV ta fito ne daga haɗuwa tsakanin mutane da kuma ganye a kasuwa, kashe ganye a cikin kasuwar wanka zai iya kawo ƙarshen cutar SARS.
A cikin wannan hujjar, ya kamata a cire pangolin daga cikin kasuwannin da ake amfani da su don hana yaduwar dabbobi a cikin yanayin gano wasu nau'ikan nau'ikan beta-CoV-samsun da ke da alaƙa da SARS-CoV-2.
Koyaya, har yanzu ana buƙatar bayyanawa a cikin binciken da za a yi a nan gaba game da menene SARS-CoV-2 da kuma yadda ake watsawa ta hanyar daji da sauran masu shayarwa zuwa mutane.
A gefe guda, MERS-CoV ya kasance a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Ban da kasancewa muhimmin kayan sufuri, raƙuman suna zama babban tushen nama, madara, fata da kuma fur don mazauna yankin.
Suna da yawa a Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a yi hadaya da dukan raƙuman don hana MERS ba, kamar yadda aka yi a kasuwar dabbobi ta daji ta kasar Sin don hana SARS-CoV da SARS-CoV-2.
Don hana barkewar cutar MERS, ya kamata a yi amfani da tsarin hadin gwiwa don samar da alluran rigakafi masu inganci ga kwayoyin cuta na MERS-CoV don kwayoyin cuta a hade da sauran matakan hana kamuwa da cutar.
Ba za mu iya kawar da waɗannan ƙwayoyin ba, kuma hakan zai iya haifar da sabon nau'in kwayoyin halitta.
Akwai nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'
Musamman, akwai bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin
Akwai yiwuwar cewa wadannan CoVs masu cutarwa za su iya karuwa da kuma sake haɗuwa, wanda zai iya haifar da sabon CoVs wanda zai iya zama mafi yaduwa da / ko mummunar cutar a cikin mutane a nan gaba.
Don rage hulɗa da dabbobi tsakanin mutane da dabbobi, ya kamata a yi watsi da cin dabbobi a wasu yankunan kasar Sin.
Tare da gwajin wuta na SARS, MERS da COVID-19, ya kamata a sami shiri da kuma shirin amsawa mafi kyau.
Yawancin ƙwayoyin cuta sun daɗe suna zaune a duniya.
Suna rayuwa ne a kan nasu yanayin har sai sun samu damar yadawa.
Ko da yake akwai halaye da yawa na kunkuru da ke taimakawa wajen yada kwayar cutar, ana iya rage damar da mutane ke da ita na yin hulɗa da kunkuru da sauran jinsunan dabbobin daji idan aka wayar da kan mutane game da guje musu.
Don samun kyakkyawar fahimta game da tarin CoVs da yanayin rayuwarsu na asali, ana buƙatar ci gaba da saka idanu kan dabbobi masu shayarwa, wanda zai tabbatar da tasiri wajen hana yaduwar dabbobi zuwa mutane da kuma barkewar cutar a nan gaba.
A ƙarshe, hanya mafi inganci don hana cututtukan dabbobi a cikin mutane ita ce ta nisantar da yanayin yanayin da ke cikin asalin ƙwayoyin dabbobi.
Har yanzu akwai wasu abubuwa da suka ɓace game da asalin dabba na SARS-CoV-2.
Da farko, idan kunyar gizo-gizo ta kamu da cutar SARS-CoV-2 a cikin daji, to, za a ga a wane yanayi ne kunyar gizo-gizo da kunyar gizo-gizo zasu iya raba wuri guda na muhalli.
Na biyu, idan kunyar gizo-gizo ta fi kai tsaye ga kamuwa da cutar, to, ya kamata a yi la'akari da yadda mutane ke fuskantar kunyar gizo-gizo.
Na uku, idan wani mai shayarwa na uku ya zama ainihin matsakaici, to ya kamata a bayyana yadda yake hulɗa da jinsuna daban-daban, gami da mutane, bats da pangolins.
A ƙarshe, tun da yake dabbobi masu shayarwa da yawa, ciki har da dabbobi masu rai, na iya zama masu saurin kamuwa da SARS-CoV-2, dole ne a yi bincike da gwaji.
Idan kun kasance wani dabba ne, penguin ko wani dabba mai shayarwa, ana sa ran SARS-CoV-2 ko kusan dukkanin kwayoyin halitta masu kama da shi za a gano su a cikin kayan halitta a nan gaba.
Ci gaba da bincike a wannan yanayin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, wanda zai haifar da tasiri mai mahimmanci a cikin rigakafi da sarrafa COVID-19 a cikin mutane.
Ana bukatar sabunta ma'aunin gano wadanda suka kamu da cutar COVID-19 da kuma wadanda suka kamu da cutar.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta fitar da jagorar shawara mai sauri don ganowa da magance kamuwa da cutar Coronavirus 2019 (2019-nCoV) kuma wannan jagorar ta ba mu ƙwarewarmu da kuma samar da kyakkyawan tunani don magance cutar a duniya.
Koyaya, COVID-19 (Covid-19) sabon cuta ne, kuma a hankali muna samun wayar da kan jama'a game da shi kuma muna samun ilimi dangane da binciken da ake samu a ci gaba da bincike da kuma kwarewar asibiti.
A cikin wannan wasikar, mun amsa wani tsokaci game da jagororinmu kuma mun samar da sabon ma'aunin ganowa na mutum da mutum a cikin sabon sanarwa na COVID-19 da kuma tabbatar da cutar, bisa ga sabon umarnin da kwamitin kiwon lafiya na kasar Sin ya bayar.
A watan Disamba na shekarar 2019, an kamu da cutar coronavirus ta 2019 (2019-nCoV), wanda aka sake suna da cutar coronavirus Disease 2019 (COVID-19) da kuma cutar da aka sake suna da cutar ta SARS-CoV-2 (Civir Acute Respiratory Syndrome Coronavirus 2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don yaki da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta kirkiro jagorar shawara mai sauri kuma an buga ta a cikin binciken likita na soja a kan layi a ranar 06 ga Fabrairu, 2020.
Tun bayan fitowar, an samu karbuwa sosai.
Ka tuna, COVID-19 sabon cuta ne, kuma a hankali muna samun wayar da kan jama'a da ilimi dangane da binciken bincike da ke gudana da kuma kwarewar da aka samu a cikin asibiti.
Misali, an fitar da jerin nau'ikan bakwai na jagororin bincike da magani na COVID-19 da kwamitin kiwon lafiya na kasar Sin ya bayar (http://www.nhc.gov.cn/), a tsakanin 16 ga Janairu da 3 ga Maris, 2020, tare da wasu canje-canje masu mahimmanci a kowane.
Yanzu da Zhou da abokan aikinsa suka yi tsokaci kan ka'idarmu, sun ba da shawarar yin saurin yin amfani da gwajin su bisa ga kwarewarsu ta asibiti.
Ayyukan su sun kara sabbin hujjoji ga jagororinmu kuma sun samar da muhimmin tunani ga annobar a duniya.
Muna godiya da kuma amincewa da irin aikin da suka yi.
Duk da haka, dole ne a sabunta ayyukansu bisa ga sabon tsarin bincike da magani na COVID-19 (ƙaddara ta bakwai) da kuma binciken da aka yi kwanan nan.
A cewar fitowar ta bakwai (3 ga Maris, 2020), don tabbatar da shari'ar da ake zargi, dole ne a sami alamun asibiti guda biyu tare da ɗayan halaye na tarihi na cutar don cikakken bincike, ko kuma idan babu tarihin cutar da aka bayyana, dole ne a cika alamun asibiti guda uku don haka.
Tarihin annobar: (1) tarihin mazauna birnin Wuhan da kewaye da shi ko kuma na tafiya zuwa wurin, ko wasu al'ummomin da aka ruwaito shari'o'in COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin samun damar yin hulɗa da shari'o'in da ke dauke da SARS-CoV-2 (suna samun sakamako mai kyau a gwajin nucleic acid); (3) tarihin samun damar yin hulɗa da marasa lafiya da zazzabi ko alamun cutar a birnin Wuhan ko yankunan da ke kusa da shi, ko kuma wasu al'ummomin da aka ruwaito shari'o'in COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) tarihin samun damar yin hulɗa da kananan cututtuka (ko kuma a cikin makonni 2 da kuma a cikin makonni 2 da suka gabata, kamar a ofis, makaranta, aji da sauransu, da kuma karamin kamuwa da cutar ta iska).
Bayanan asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da siffofin hoto na kamuwa da COVID-19; (3) jimlar adadin fararen kwayar jini a farkon matakin tashi yana nuna yawan adadin lymphocytes na al'ada, raguwa ko raguwa.
Don tantance wani tabbataccen hali bisa ga abin da ake zargi, dole ne a sami wata daga cikin cututtukan cututtuka ko kuma sakonnin cututtuka masu zuwa: (1) samun tabbataccen gwajin PCR na ainihin lokacin SARS-CoV-2; (2) samun babban homogenization ko kama da sanannen kwayar cutar coronavirus a cikin cikakken gene sequencing na cutar; (3) samun tabbataccen IgM antibody da IgG antibody na SARS-CoV-2 a cikin gwajin magani; ko samun tabbataccen canji daga cutar IgG antibody mai cutar SARS-CoV-2 zuwa cutar IgG mai cutar, da kuma samun karuwa ≥4 sau fiye da matakan tsanani na ci gaba da ci gaba.
Mun gano cewa, a cikin na biyu (18 Janairu 2020) da na uku (22 Janairu 2020) an samu gwajin PCR na ainihi da kuma samfurori na jini na gano nucleic acid a cikin numfashi.
An kara da cewa an gano cutarwa a cikin jini a cikin bugu na hudu (27 ga Janairu, 2020) da na biyar (8 ga Fabrairu, 2020); sannan kuma an kara da cewa an kara da tabbacin cutar a cikin bugu na bakwai.
Waɗannan canje-canje sun dogara ne akan ci gaba da aikin masu bincike na samfurori na numfashi tare da samfurin jini don neman ingantaccen kayan gano nucleic acid don saurin ganewa, wanda ke haɓaka wadatar samfurori daban-daban kuma wanda ke taimakawa wajen kawo sakamako mai kyau na antibody zuwa tabbataccen ma'auni.
Bugu da ƙari, an samu ƙarin hujjoji da ke tunatar da mu mu yi hankali da marasa lafiya da ba su da alamun cutar.
Saboda haka, Zhou da abokansa ya kamata su sabunta jerin abubuwan da ke faruwa, saboda sun sanya mutanen da ba su da alamun asibiti a matsayin masu haɗarin haɗari.
Ana buƙatar tabbatar da tsarin a cikin ayyukan asibiti da karatu na gaba.
A ƙarshe, muna fatan cewa akwai ƙarin hujjoji kai tsaye kuma masu karatu za su yi kira don yin tsokaci.
Don gano wadanda suka kamu da cutar da kuma gano wadanda suka kamu da cutar, muna bada shawara mu gano su kuma mu bi sabon jagororin kasarmu.
Ƙungiyarmu za ta sabunta jagororinmu a kan lokaci don taimaka.
Bangladesh ta ba da rahoton sabbin mutuwar biyar na yau da kullun na COVID-19.
Jiya, Bangladesh ta tabbatar da wasu mutane biyar da suka mutu a wannan rana saboda COVID-19.
Wannan shi ne adadin mutuwar da aka samu a rana daya.
A jiya, Cibiyar Nazarin Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton cewa, daga cikin wadanda aka rubuta akwai mutane 114 da suka kamu da cutar da kuma 33 da suka warke daga cutar da suka kamu da cutar da suka kasance a gida.
An samu mutuwar mutane 17 a total.
A wani rahoto na kan layi, Daraktan IEDCR, Dr Meerjady Sabrina Flora, ta ce, mutane hudu da mace sun mutu.
Dangane da Dr. Mirzadi, mutane biyu da suka kamu da cutar sun fi shekaru 60, biyu suna tsakanin shekaru 51 da 60 da kuma daya yana tsakanin shekaru 41 zuwa 50.
Ya kuma ce, daga cikin wadanda aka kashe akwai biyu daga Dhaka.
Hukumar lafiya ta duniya (WHO) ta bayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa wani kamfanin dillancin labaran kasar Anadolu cewa, daya daga cikin wadanda suka mutu shi ne Jalal Saiful Rahman, darektan hukumar yaki da cin hanci da rashawa a bangalore, wanda aka kula da shi a asibitin Kuwait Maitri.
A wani sakon da aka wallafa a shafin yanar gizo a ranar Asabar, Ministan Sufuri da Sassan Hanyar Hanyar Bangladesh, Obaidul Kadir ya ce, har zuwa ranar Asabar, za a dakatar da zirga-zirgar jama'a fiye da yadda aka shirya.
An fara rufe zirga-zirgar jama'a a ranar 26 ga Maris kuma an shirya kammala shi a ranar Asabar, 4 ga Afrilu.
Har ila yau, ana ba da izinin jigilar kayayyaki masu mahimmanci kamar su magani, makamashi da abinci.
An samu kamuwa da COVID-19 na farko a Bangladesh a tsakanin mutane biyu da suka dawo daga Italiya da matar daya daga cikinsu a ranar 8 ga Maris.
A ranar 19 ga Maris, dukansu uku sun warke.
Mutane miliyan daya ne suka kamu da cutar SARS-CoV-2 a duniya
Bayanai daga Jami'ar Johns Hopkins sun nuna cewa jimlar adadin masu kamuwa da cutar SARS-CoV-2 a duniya ya wuce miliyan a ranar Alhamis.
Akalla mutuwar 52,000 an danganta su da cutar COVID-19, wanda ya haifar da cutar coronavirus.
Wannan muhimmin abu ya faru a ranar da Malawi ta tabbatar da kamuwa da cutar ta farko da kuma mutuwar farko da ta shafi cutar ta cutar a Zambia.
Koriya ta Arewa ta yi ikirarin cewa ta kasance daya daga cikin 'yan kasashen da suka rage ba tare da kamuwa da cutar ba har zuwa ranar Alhamis.
Har zuwa jiya, WHO ta yi rahoton mutane 1,051,635 da suka kamu da cutar, ciki har da mutane 79,332 a cikin awanni 24 da suka gabata a tsakiyar Turai (0800 UTC) da safe 10 na ranar 4 ga Afrilu.
A Amurka, an samu karin kamuwa da cutar coronavirus 244,000, wanda ya hada da mutuwar 5,900.
Labarin CBS News ya ruwaito cewa, a ranar Laraba, fiye da mutane 1,000 ne suka mutu a Amurka sakamakon kamuwa da cutar coronavirus, bisa ga bayanan da Jami'ar Johns Hopkins ta bayar.
A duk faɗin duniya, ƙasashe sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow, Sergei Sobanin ya kara dokar kulle a garin Sobanin har zuwa ranar 1 ga Mayu.
A kasa, Shugaba Vladimir Putin ya sanar da cewa za a ci gaba da biyan bashin har sai da 30 ga Afrilu idan Rasha ta ƙi aiki.
Majalisar dokokin Portugal ta amince da tsawaita dokar ta baci ta kasa na kwanaki 15, ta amince da kuri'u 215, ta ƙi kuri'u 10, kuma ta yi ta kada kuri'u daya.
Saudiyya ta kara dokar hana fita a birnin Makka da Madina, inda ta shafe tsawon yini, tun daga karfe 3 na yamma zuwa 6 na safe.
Thailand ta shirya aiwatar da dokar hana fita tsakanin 10 na dare da 4 na safe.
Gwamnan jihar Ohio, Mike DeWine ya sanar da cewa jihar ta tsawaita dokar ta hana zama a gida har zuwa 1 ga Mayu.
A Ostiraliya, shaguna sun rage yawan takardar wanka a kowane ma'amala
A ranar Lahadi da Asabar da yamma, an rage iyakancewar sayen takardar wanka a duk shagunan da ke cikin Walworth da Coles a duk faɗin ƙasar, a cikin biyu da ɗaya a cikin kunshin, bi da bi.
Bugu da kari, ALDI ta kaddamar da iyakar fakitin guda a ranar Juma'a.
An sanya waɗannan ƙuntatawa a matsayin saƙonni a cikin rajistar rajista da kuma shafukan Facebook na sarkar.
An ruwaito cewa masu sayayya suna tsoron COVID-19 suna tunanin idan mutane zasu ware kansu.
A ranar Laraba, kamfanin Woolworths ya kuma rage sayar da takardar wanka don isar da gida.
Waɗannan canje-canjen sun biyo bayan iyakancewar fakitin guda huɗu bayan ma'amaloli na baya waɗanda Walworth da Coles suka ƙaddamar a ranar 4 da 5 ga Maris, bi da bi.
"A ranar 8 ga watan Maris, Coles ya bayyana cewa an yi amfani da takunkumin takunkumi guda hudu a wurare daban-daban, amma ""akwai shaguna da yawa da har yanzu suna sayar da komai a cikin sa'a daya na samarwa"", inda suka bayyana bukatar da cewa ""ba ta da kyau"" kuma a wani shafin Facebook a ALDI a ranar Talata sun bayyana cewa ""ba a zata ba""".
Wani kakakin kamfanin Wolworths ya ce, tallace-tallace sun karu sosai a makon da ya gabata.
An kuma ba da izinin kantin sayar da kayan kwalliya a Canberra don fakitin biyu a makon da ya gabata.
Don rage ƙarancin, Coles ta ba da umarni ga manyan fakiti daga masu samarwa kuma ta ƙara yawan yawan sake dawo da kayayyaki, Woolworths ta ba da umarni ga ƙarin hannun jari, inda ALDI ta ba da hannun jari a gaba don ranar Laraba ta musamman da aka tsara.
Russell Zimmerman, babban darektan kungiyar 'yan kasuwar Australiya, ya ce, 'yan kasuwa suna kokarin kara yawan kayayyakin, amma takunkumin da majalisar dokokin kasar ta kafa kan lokacin da ake bayarwa ta hanyar motoci ya sanya batun ya zama da wuya.
Yayin da masu samar da kayayyaki ke kokarin biyan bukatar, ya yi tsammanin farashin samarwa zai karu.
ALDI ta sanar a ranar Talata cewa bayan da ta bar hannun jari, wasu shaguna ba za su iya gudanar da siyarwar musamman a ranar Laraba ba.
A wani rahoto daga News.com.au, wani masanin sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, Dr. Gary Mortimer ya ce, shaguna suna cika kayayyakin su a kowace rana.
Ya ce, takardar bayan gida abu ne mai nauyi wanda ke sa tarin ta zama ƙasa da yawa kuma idan aka sayar da shi, babban ɗakunan ajiya ya zama komai, yana ƙara ƙarfafa rashin.
"A cewar ABC News, "Coles da Woolworths sun ce idan sun sayi abubuwa da yawa, kamar kayan wanka da kuma kayan wanka, kuma sun kasance a yalwace, to, wataƙila za a rage wannan tsoro", in ji Russell Zimmerman.
Kamfanin da ke kera takardar bayan gida da aka sake amfani da ita, Who Gives a Crap, ya ce a ranar Laraba cewa za su ƙare.
Kamar yadda News.com.au ta ruwaito, Kimberly-Clark, wanda ke yin kayan aikin gidan wanka na Clinix da kuma takarda mai tsabtace rana wanda ke samar da kayan aiki, ya tabbatar da cewa suna aiki 24/7 don kula da wadata.
Wani shafin yanar gizon gidajen ƙasa Domain.com ya ruwaito cewa wasu masu sayar da dukiya suna ba da takardar wanka kyauta ga masu yin hayar farko a cikin gwanjon a Melbourne, wasu daga cikin dalilan da suka haifar da wasu gwanjo shine saboda masu sayarwa sun sami hutu a karshen mako na ranar aiki.
A wannan ranar Alhamis, jaridar NT News, da Darwin ke buga a kowace rana, an ba da shafi takwas don yin amfani da shi a matsayin takarda ta gidan wanka.
A wani rahoto da aka samu daga ABC Australia a ranar 3 ga Maris, ya ce shagunan sun kasance da matukar damuwa da sanya takunkumi, inda suka ce ba su da shirin sanya takunkumi kan cinikayya.
Russell Zimmerman ya ce akwai bukatar kayayyaki da yawa, kamar su masks, sanitizers, kayan bushewa, wanka da gari.
Hakazalika, ana iyakance sayar da takarda da ake amfani da ita don wanka a cikin babban kanti na Burtaniya na Okadawa a kowace Lahadi da yamma a waje da Ostiraliya zuwa fakitin 12 na takarda.
Hukumar lafiya ta duniya ta bayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana cutar COVID-19 a matsayin annobar cutar ta cutar ta SARS-CoV-2 a cikin annobar COVID-19.
"Ko da yake kalmar nan ""matsananci"" ba ta nufin yadda hatsarin wasu lokuta yake ba amma ta nuna yadda cutar ta yadu, WHO ta nuna bukatar gwamnatoci su dauki mataki:"
"Dukkanin kasashe na iya canza yanayin annobar duniya".
"Sakatare Janar na WHO Adam Gebreissas ya ce idan jihohi za su iya ganowa, za su iya gwadawa, magance su, ware su, gano su, da kuma haɗa su".
"Muna matukar damuwa da yadda cutar ke yaduwa da kuma yadda ake samun rashin aiki".
"Daga tsohon darektan cibiyar kula da cututtuka da rigakafin Amurka, Dokta Tom Freuden, annobar ta duniya "ba a taɓa gani ba".
"A cikin wata sanarwa a CNN a watan Fabrairu, ya ce, ""Ba a lura da tsawon lokacin da cutar ta kamu da cutar ta hanyar numfashi ta kasance a duniya ba, banda cutar mura".
Gabrasas ya ce, "Ba mu taɓa ganin annobar cutar coronavirus ba".
Ya ce, "Ba mu taɓa ganin annobar duniya da za a iya sarrafawa a lokaci guda ba".
Sabuwar sanarwa ta zama annoba ta duniya ta biyo bayan shawarar WHO ta sanar da barkewar cutar a matsayin gaggawa na lafiyar jama'a na duniya a watan Janairu.
"Darakta Anthony Fauci, darektan Cibiyar Kula da Cututtuka da Cututtuka ta Kasa a Amurka, ya ce game da barkewar cutar, ""a gaskiya, yanayin zai kara muni".
Associated Press ta ruwaito a ranar Alhamis cewa, a duniya akwai akalla mutane 126,000 da suka kamu da COVID-19 wanda ya haifar da mutuwar sama da 4,600.
Wannan annoba ta 2019-20 ta kamu da cutar coronavirus ta cutar coronavirus ta 2019 (COVID-19), wanda ya haifar da cutar ta SARS-CoV-2 (Covid-19), wanda ke haifar da cutar ta SARS-CoV-2 (Covid-19).
An gano cutar a Wuhan, China a watan Disamba na 2019, wanda aka ayyana a matsayin gaggawa na lafiyar jama'a na kasa da kasa a ranar 30 ga Janairu, 2020, kuma aka amince da shi a matsayin annobar duniya a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a cikin kasashe 210 da Yankin Tarayya, wanda ya haifar da kusan mutuwar 97,000.
Mutane 364,000 ne suka warke.
A kasar Sin, an kiyasta cewa adadin mutuwar mutane ya kai kashi 4 cikin dari, yayin da a duniya, adadin ya kai daga kashi 13.04 cikin 100 a Algeria zuwa 0.08 cikin 100 a New Zealand.
Alamomin da aka fi sani da su sun haɗa da zazzabi, tari da kuma rashin numfashi.
Abubuwan da ke tattare da wannan cuta na iya zama pneumonia da kuma acute respiratory distress syndrome.
Lokaci daga bayyanar cututtuka zuwa bayyanar cututtuka yana da kwanaki biyar, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Babu allurar rigakafi ko maganin rigakafi na musamman.
Maganin farko shine maganin bayyanar cututtuka da taimako. Abubuwan da aka ba da shawarar na rigakafin sun haɗa da wanke hannu, rufe fuskarka yayin tari, kiyaye nesa da sauran mutane, da saka idanu da keɓewa ga mutanen da suke tsammanin suna da cutar.
Hukumomi a duniya sun amsa da dokar hana fita ta tafiye-tafiye, killacewa, dokar hana fita, hana haɗari a wurin aiki da kuma rufe wuraren aiki.
Cutar ta haifar da mummunan rikice-rikice na tattalin arziki da zamantakewar duniya, an soke wasanni, addinai, siyasa da al'adu, da kuma cin kasuwa saboda tsoro, wanda ya haifar da ƙarancin wadata.
Makarantu da jami'o'i sun rufe a kasa da kasa a kasashe 193, wanda ke shafar kashi 99.4 cikin dari na yawan daliban duniya.
An samu rashin fahimta game da cutar ta yanar gizo, kuma an samu wasu mutane daga China, Gabas da kudu maso gabashin Asiya da kuma wasu daga yankunan da aka gano cutar, dangane da jinsi da bayyanarsu.
Saboda dakatarwar tafiye-tafiye da masana'antu masu nauyi, an rage yawan gurɓataccen iska da kuma fitar da carbon.
A Wuhan, China (babban birnin lardin Hubei), hukumomin lafiya sun sanar da wata ƙungiya ta kamu da cutar pneumonia a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin lokuta sun kasance suna da alaƙa da kasuwar sayar da abincin teku na Hunan kuma saboda haka ana tsammanin cutar ta fito ne daga dabbobi.
An gano sabon kwayar cutar da ta haifar da cutar da ake kira SARS-CoV-2, wanda ke da alaƙa da cutar coronavirus ta gizo-gizo, kwayar cutar Coronavirus da SARS-CoV. Mutumin da aka fara gano alamun cutar a ciki, daga baya an sanar da cewa ya kamu da cutar a ranar 1 ga Disamba, 2019; kuma daga baya ba a gano cewa mutumin yana da alaƙa da rukunin Wet Market ba.
A watan Disamba na 2019, an gano cewa kasuwar ta haɗu da kashi biyu bisa uku na farkon tarin cututtuka.
Wani rahoto da aka fitar a shafin yanar gizon South China Morning Post a ranar 13 ga Maris, 2020, ya nuna cewa wataƙila a ranar 17 ga Nuwamba, 2019, ne aka fara gano wani abu, wanda ya faru ne a cikin wani mutum mai shekaru 55 daga lardin Hubei. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa sabon kamuwa da cuta a China ya ragu, amma ya karu da sauri a Italiya, Iran da Koriya ta Kudu, kuma adadin sababbin lokuta a waje da China ya zarce adadin sababbin lokuta a cikin China a karon farko.
Yawan cututtuka na iya zama ƙasa, musamman a cikin waɗanda ke da alamun bayyanar cututtuka.
A ranar 26 ga watan Fabrairu, an samu rahoton ƙananan lamuran matasa, mafi yawansu a ƙarƙashin shekaru 19, kuma ana samun kashi 2.4% na waɗannan a duk duniya. Patrick Valence, babban mai ba da shawara kan kimiyya a Burtaniya, ya kiyasta cewa kashi 60% na yawan jama'ar Burtaniya suna buƙatar kamuwa da cutar kafin su sami rigakafi.
A cewar tsarin hukuma, ana nufin adadin mutanen da suka gwada COVID-19 kuma suka sami sakamako mai kyau.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da 3% na yawanta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain da Switzerland sun kafa ƙa'idodi na yau da kullun na ƙin gwada waɗanda ke da alamun bayyanar cututtuka kawai.
Wani binciken da aka fitar a ranar 16 ga Maris ya nuna cewa har zuwa 23 ga Janairu, kusan kashi 86% na kamuwa da cutar COVID-19 ba a gano su a China ba, kuma wannan kamuwa da cutar da ba a yi rajista ba ita ce tushen kamuwa da kashi 79% na shari'o'in da aka yi rajista.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya nuna cewa adadin kamuwa da cuta a Italiya ya fi yawan adadin kamuwa da cuta da aka samu a cikin asusun gwamnati.
Matsayin farko na yawan haihuwa (R0) na COVID-19 a farkon shine 1.4 zuwa 2.4.
Wani binciken da cibiyar kula da cututtuka ta Amurka ta wallafa ya nuna cewa yana iya zama 5.7.
Yawancin mutanen da suka kamu da COVID-19 sun warke.
A cikin wadanda ba su da cutar, lokacin mutuwa daga ci gaban bayyanar cututtuka ya kasance daga kwanaki 6 zuwa 41, wanda shine mafi yawan kwanaki 14.
Kimanin mutuwar 97,000 da aka yi a ranar 10 ga Afrilu 2020 an danganta su da COVID-19.
A kasar Sin, kashi 80 cikin dari na mutuwar mutane sun wuce shekaru 60 a duniya har zuwa 5 ga Fabrairu, kuma kashi 75 cikin dari na mutanen sun riga sun kamu da cututtukan zuciya da kuma ciwon sukari.
COVID-19 na iya haifar da mutuwar da yawa, saboda ba za ta iya haɗa da waɗanda suka mutu ba tare da gwaji ba - kamar gidaje, gidajen jinya, da sauransu.
Wasu bayanai daga Italiya sun nuna cewa adadin mutuwar da aka yi a lokacin annobar ya ninka na COVID sau 4-5 fiye da na gwamnati.
"Wani mai magana da yawun Cibiyoyin Kula da Cututtuka da Rigakafin Amurka (CDC) ya yarda da ""Mun san cewa [ƙididdigar mutuwar da aka bayyana] ba ta da tabbas fiye da ainihin adadin"", wanda rahotanni suka bayar da rahoton cewa ba a dogara da bayanan ƙididdiga a cikin Amurka. Irin wannan ƙididdigar ta faru sau da yawa a cikin annobar duniya, kamar annobar 2009 H1N1 na ruwan sama. An tabbatar da mutuwar farko a Wuhan a ranar 9 ga Janairu, 2020".
A ranar 1 ga watan Fabrairu, Philippines ce ta fara samun mutuwar a waje da kasar Sin, kuma a ranar 14 ga watan Fabrairu, Faransa ce ta fara samun mutuwar a waje da Asiya.
A ranar 28 ga watan Fabrairu, an samu mutuwar mutane fiye da goma sha biyu a kasashen waje kamar Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga watan Maris, an samu rahoton mutuwar a kasashe da yankuna sama da arba'in a duk nahiyoyin duniya, ban da Antarctica.
Yawan adadin ya bambanta ta yankuna, kuma yawan gwaji, ingancin tsarin kiwon lafiya, zaɓin magani, lokacin da aka yanke tun farkon barkewar cutar, da kuma halaye na yawan mutane kamar shekaru, jinsi, da lafiyar gaba ɗaya suna nuna cewa adadin mutuwar da kamuwa da cuta a cikin wani lokaci ya nuna yawan adadin mutuwar da aka rarraba ta yawan shari'o'in da aka gano.
Bisa ga kididdigar daga Jami'ar Johns Hopkins, yawan mutuwar da cututtuka a duniya ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Yawan adadin ya bambanta daga yanki zuwa yanki.
A kasar Sin, adadin mutuwar da yawan cututtuka ya ragu daga kashi 17.3% (wanda ya kamu da cututtuka tsakanin 1-10 ga Janairu na 2020) zuwa kashi 0.7% (wanda ya kamu da cututtuka na farko tun daga 1 ga Fabrairu na 2020). Sauran matakan rigakafi sun kasance - CFR, wanda ke nuna yawan mutanen da aka gano sun mutu saboda wani cuta, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (masu gano ko ba a gano ba) da suka mutu saboda wani cuta.
Wadannan kididdigar ba su da iyaka a kowane lokaci kuma suna biye da wani yanki na al'umma daga kamuwa da cuta ta hanyar nazarin hali.
Masana da yawa sun yi ƙoƙari su ƙidaya waɗannan lambobin don ƙayyadaddun alƙaluma.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar cutar ta cutar ta kasance tsakanin 0.1% zuwa 0.39% a cikin duka.
Lissafin da ke sama da wannan zangon ya dace da nazarin kididdiga na gwajin farko na allopathic na COVID-19 a Jamus da kuma nazarin tasirin gwajin akan hasashe na CFR.
WHO ta ce za a iya sarrafa cutar.
Matsakaicin iyaka da kuma lokacin ƙarshe na barkewar cutar ba su da tabbas kuma suna iya bambanta ta wurin wuri.
"MacKeyes Bonnie na Jami'ar Penn State ya ce, ""Yayin da cutar ta tashi daga cutar, cutar ta zama mai rinjaye kuma ta fara lalacewa idan cutar ta rasa mai masaukin ta".
Amma a yanzu, ba za a iya yin wani tunani ba game da lokacin da hakan zai faru.
"Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin, Zhang Nanshang, ya yi jayayya cewa idan aka haɗa dukkan ƙasashe don bin shawarar WHO don hana yaduwar cutar, "za a iya kawo karshen wannan a watan Yuni".
"A ranar 17 ga watan Maris, Adam Kucharski na Makarantar Lafiya da Magunguna ta London ya ce SARS-CoV-2 ""zai iya ci gaba da yaduwa na shekara guda ko biyu".
"A cewar wani bincike da aka gudanar da kwalejin Imperial karkashin jagorancin Neil Ferguson, wajibi ne a kiyaye nesa da sauran matakan jiki har sai an samu wani allurar rigakafi (mai yiwuwa watanni 18 ko fiye)".
"William Sheffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa cutar ta coronavirus ta kamu da cutar da sauri sosai, don haka za ta ɓace gaba ɗaya kuma za ta iya zama cuta ta yanayi, ta dawo kowace shekara".
Matsayin dawowa zai dogara ne akan rigakafin dabba da kuma yawan watsawa.
Alamun COVID-19 na iya zama ba a ƙayyade su ba, kuma waɗanda suka kamu da cutar ba su da alamun cutar.
Abubuwa biyu da suka fi kowa a cikin cututtukan su ne zazzabi (88%) da kuma tari (68%).
Alamu da ba su da yawa sun haɗa da: rashin ƙarfi, rashin numfashi (kafi), rashin numfashi, rashin numfashi, ciwon tsoka da jijiyoyin jiki, kumburi, ciwon kai, sanyi, vomiting, kofi, hawan jini, ko ciwon ciwon huhu. WHO ta ce mutum ɗaya cikin shida yana rashin lafiya sosai kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta lissafa numfashi, ciwon kirji ko damuwa, damuwa, farkawa da kuma fuskar blue ko lebe a matsayin alamun gaggawa; idan akwai waɗannan alamun, ana ba da shawarar samun taimakon likita nan da nan.
Wasu daga cikin wadanda suka kamu da cutar na iya zama marasa alamar cututtuka, amma sakamakon gwajin ya tabbatar da cewa suna dauke da cutar, saboda haka masu bincike sun ba da shawarar cewa a lura da su kuma a gwada su daga mutanen da suka kamu da cutar don kauce wa kamuwa da cutar.
China ta kiyasta cewa adadin marasa lafiya ba su da alamun cutar ba, kuma sun kai 44%.
A cikin misali na rashin tabbas, kashi 30% na mutanen da ke da COVID-19 da suka fara samun wari sun kai 15% na mutanen da suka fara samun wari.
Har yanzu ana gano wasu bayanai game da yadda cutar ke yaduwa.
An yi imanin cewa cutar tana yaduwa ne ta hanyar ƙananan saukad da ke faruwa a lokacin da aka yi hulɗa da su da kuma lokacin da suke tari, suna tari ko magana; kasancewa a tsakanin mita 1 zuwa 2 (ƙaffi 3 zuwa 6) don yin hulɗa da su.
Bincike ya nuna cewa daga wani buɗe cough, ruwan zai iya kaiwa daga mita 4.5 zuwa mita 8.2.
Wasu sun ce za a iya kamuwa da cutar ta hanyar saukad da ruwa mai sauƙi wanda zai iya faruwa yayin magana wanda ke cikin iska na dogon lokaci. Hakanan ana iya haifar da lalaras na numfashi yayin numfashi, gami da magana, kodayake wannan cutar ba ta da iska.
Za su iya shiga cikin bakinsu ko hancin waɗanda suke kusa da su ko kuma su shiga cikin huhu ta hanyar numfashi.
Wasu hanyoyin magani kamar intubation da cardiopulmonary resuscitation (CPR) na iya haifar da numfashi da aka fitar da iska zuwa aerosols kuma sakamakon haka ana iya yada shi ta iska.
Yana iya yaduwa idan mutum ya taɓa wani gurɓataccen wuri, har da fata, sannan ya taɓa idanunsa, hanci ko fuskarsa.
Ko da yake akwai damuwa cewa zai iya yadawa ta hanyar mall, ana ganin cewa haɗarin yana da ƙananan.
Gwamnatin kasar Sin ta musanta yiwuwar kamuwa da cutar ta SARS-CoV-2 ta hanyar magana da baki. A cikin kwanaki uku na farko da bayyanar cututtuka, cutar ta fi kamuwa da cutar.
Mutane da yawa sun sami sakamako mai kyau kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya kamuwa da cutar kafin bayyanar cututtuka.
Akwai rahotanni kaɗan na marasa alamun alamun cutar da aka tabbatar da su a cikin dakin gwaje-gwaje, amma wasu ƙasashe sun gano rashin alamun cutar yayin binciken ganowa.
Cibiyoyin Turai don Rigakafin Cututtuka da Kulawa (ECDC) sun ce ba a san yadda cutar ke yaduwa ba, amma mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar cutar tana rayuwa a farfajiya na tsawon sa'o'i zuwa kwanaki.
A cikin wannan yanayin, ana iya samun cutar a cikin filastik (polypropylene) na tsawon kwanaki uku, 304 bakin karfe, a cikin kwali na kwana ɗaya, da tagulla na tsawon awanni huɗu.
Wannan ya bambanta dangane da zafi da zafin jiki. Dabbobin gida da sauran dabbobi sun tabbatar da COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya yada cutar a cikin mutane, ko da yake hukumomin Burtaniya sun ba da shawarar wanke hannu bayan sun haɗu da dabbobi, kamar yadda ake yin ta bayan sun taɓa wasu farfajiyar da mutum ke da cutar.
Coronavirus 2 (SARS-CoV-2) wanda ke da alamun cututtukan numfashi mai tsanani, sabon kwayar cuta ce, wanda aka fara ganowa daga cikin mutane uku da ke fama da cutar huhu da ke da alaƙa da ƙungiyar cututtukan numfashi a Wuhan.
Ana ganin dukkan halaye na sabon SARS-CoV-2 a cikin dukkan coronavirus masu alaƙa da su da aka samo a cikin yanayi. A waje da jikin mutum, kwayar cutar tana mutuwa ta hanyar sabulu na gida saboda ta karya tsarin rigakafin cutar. SARS-CoV-2 yana da alaƙa da ainihin SARS-CoV.
Ana ganin akwai wata cuta da ke tattare da dabbobi.
Binciken kwayoyin halitta ya nuna cewa cutar ta corona ta haɗu da nau'in da aka samo daga fuka-fuki biyu a cikin subgenus serbecovirus (lineage B) tare da nau'in da aka samo daga strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain strain
A cikin wani samfurin cutar coronavirus na wani ɗan daji (BatCov RaTG13) matakin cikakken kwayoyin halitta ya kai kashi 96 cikin ɗari.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa bambancin amino acid daya ne kawai a cikin wasu sassan tsarin kwayoyin halitta tsakanin kwayar cutar da ke cikin Bonnui da kwayar cutar da ke cikin jikin mutum.
A cikin binciken da aka yi a yanzu, an gano cewa akwai 92% na kamanceceniya tsakanin kwayar cutar coronavirus da SARS-CoV-2 wanda bai isa ya tabbatar da cewa kwayar cutar ta kasance mai karɓar bakuncin ba.
Ana iya gano kamuwa da cutar ta hanyar cutar ta hanyar bayyanar cututtuka na ɗan lokaci, amma a ƙarshe tabbatar da maɓallin watsawa na polymerase chain reaction (rRT-PCR) ko CT imaging na lalacewar da ke kamuwa da cutar.
Wani binciken da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT tana da matukar damuwa fiye da PCR, amma ba ta da cikakkiyar ma'ana, kuma yawancin halaye na daukar hoto suna dacewa da sauran cututtukan cutar huhu da cututtuka.
"A watan Maris na shekarar 2020, Kwalejin Radiology ta Amirka ta ba da shawarar cewa ""ba za a yi amfani da CT a matsayin gwajin farko ba don gano COVID-19"."
WHO ta fitar da wasu hanyoyin gwajin RNA don SARS-CoV-2, na farko daga cikinsu an fitar da shi a ranar 17 ga Janairu.
Gwajin ya yi amfani da rikitarwa ta hanyar amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta hanyar yin amfani da rikitarwa ta.
Ana iya gwada shi a kan numfashi ko kuma a kan jini.
A cikin 'yan sa'o'i da kwanaki ne sakamakon zai bayyana.
Ana yin gwajin ne a kan wani na'urar motsa jiki, amma ana iya yin amfani da na'urar motsa jiki. Wasu dakunan gwaje-gwaje da kamfanoni suna shirya gwaje-gwaje na serological wanda ke gano antibodies.
A ranar 6 ga Afrilu, 2020, babu wani daga cikin waɗannan da aka tabbatar da cewa ya dace da isa don a amince da shi don amfani mai nisa.
An ba da izinin amfani da gwajin sirrological da Chelsex ta yi a Amurka don amfani da shi a cikin gaggawa a cikin wuraren da aka yarda da su.
Abubuwan da ke nuna hoton daukar hoto a cikin radiograph da computed tomography (CT) na mutanen da ke da cututtuka sun haɗa da rashin tsabta na gilashin ƙasa na waje da rashin tsabta.
Kungiyar Radiological ta Italiya tana tattara wani shafin yanar gizo na duniya na hotunan hotunan da aka samu daga gwajin da aka tabbatar da cutar.
An hana yin hoto da gano COVID-19 ta hanyar PCR ba tare da tabbaci ba don haɗuwa da sauran cututtuka kamar adenovirus.
Wani babban bincike a kasar Sin ya kwatanta PCR da sakamakon CT na kirji kuma ya bayyana cewa, ko da yake yin hotunan wannan kamuwa da cuta yanzu ba shi da tabbas, yana da sauri kuma yana da mahimmanci wanda ya ba da shawarar yin la'akari da shi azaman kayan aikin bincike a yankunan da cutar ta shafa.
An kirkiro cibiyar haihuwar ilimin kere kere wanda ke samar da halaye na cutar ta hanyar radiographs da CT.
Hanyoyi na hana yaduwar cutar sun haɗa da kiyaye tsabta ta mutum, wanke hannu, kada ku taɓa idanu, hanci ko fuska da hannuwanku da ba a wanke ba, da kuma yin tari ko tari a cikin nama da kuma jefa wannan nama a cikin kwandon shara.
An shawarci wadanda suka riga sun kamu da cutar su sa abin rufe fuska a fili.
Ana kuma ba da shawarar kiyaye nesa ta jiki don hana kamuwa da cuta. Gwamnatoci da yawa sun ba da shawara ko kuma suka hana duk wani tafiya mara kyau daga ƙasashe da yankuna da cutar ta shafa.
Amma cutar ta riga ta kai ga yaduwar jama'a a yawancin duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin jama'a kuma wasu mutane a cikin jama'a ba su san inda suka kamu ba ko kuma yadda suka kamu. Ana ba da shawarar cewa masu ba da sabis na kiwon lafiya da ke kula da waɗanda za su iya kamuwa da cutar su yi amfani da tabbaci na gargaɗi, gargadi game da kamuwa da cutar da kuma kariya ta ido.
Amincewa da Duniya da kuma kungiyoyi sama da 100 sun yi kira ga gwamnati ta yi amfani da bayanan wurin wayoyin hannu don wannan dalili, inda suka yi kira ga iyakance irin wannan sa ido.
An aiwatar da aikace-aikacen hannu da yawa ko kuma an ba da shawarar yin amfani da su a kan sadaukarwa, kuma har zuwa 7 ga Afrilu, 2020, fiye da ƙungiyar ƙwararrun ƙwararru suna aiki akan ingantaccen bayani game da sirri, kamar amfani da Bluetooth don shiga wayar hannu ta kusa da mai amfani.
Bayan haka, masu amfani za su sami saƙo idan sun haɗu da wani mutum mai cutar COVID-19. Akwai wasu ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar.
Babu allurar rigakafin COVID-19, duk da cewa kamfanoni da yawa suna aiki don samar da ita.
An shawarci a wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa a wasu lokatai mutane su wanke hannayensu da sabulu da ruwa na akalla na tsawon dakika 20, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun kasance da tsabta a fili; kafin cin abinci; kafin su wanke hanci, lokacin da suke tari, ko lokacin da suke yin numfashi.
Domin ana iya kashe kwayar cutar ta hanyar sabulu na gida a waje da jikin mutum, wanda ke lalata kumfa mai kare cutar.
CDC ta ba da shawarar cewa a lokacin da sabulu da ruwa ba su samuwa a hannu, a maimakon haka, a yi amfani da aƙalla kashi 60% na kayan tsabtace jiki.
WHO ta shawarci jama'a kada su taɓa idanunsu, hancinsu ko fuskokinsu da hannayensu marasa tsabta.
Za a iya tsabtace farfajiya ta hanyar wasu abubuwa (a cikin minti daya bayan haɗuwa da ƙwayoyin cuta a cikin farfajiya na bakin karfe), wanda ya haɗa da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Sauran magunguna kamar benzalkonium chloride da chloroxydine gluconate ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko an tabbatar da wani hali na COVID a wani wuri kamar ofishi ko wurin kula da rana, dole ne a kashe kayan lantarki na ofishi, wanka, wuri na kowa, kayan aiki na lantarki, kamar kwamfutar hannu, allon taɓawa, keyboard, na'urorin sarrafawa na nesa, da na'urorin ATM da marasa lafiya ke amfani da su.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa a lokacin da mutum yake tari ko kuma ya yi tari, ya kamata ya rufe fuskarsa da hancinsa da kuma hancinsa da kwano ko kuma ya rufe kayan da takarda ke rufewa, kuma ya zubar da kayan da ya dace.
Ana ba da shawarar cewa waɗanda ke cikin haɗarin kamuwa da cutar su sa abin rufe fuska na tiyata. Yin amfani da abin rufe fuska zai iya sarrafa adadin ƙwayoyin da aka fitar yayin magana, yin tari ko kuma tari.
WHO ta fitar da jagora kan lokacin da kuma yadda za a sa abin rufe fuska.
"A cewar masanin cututtukan cututtuka na jami'ar Leeds, Stephen Griffin, ""masks na iya rage yawan mutane da ke taɓa fuskarsu, wanda shine babban tushen kamuwa da cuta ba tare da tsabtace hannu ba". "An kuma bada shawarar yin amfani da masks ga mutanen da ke kula da waɗanda za su iya kamuwa da cutar".
WHO ta shawarci mutane masu lafiya su sa abin rufe fuska ne kawai idan suna da haɗari mai yawa, kamar waɗanda ke kula da wani wanda ke da COVID-19, duk da cewa sun yarda cewa yin amfani da abin rufe fuska zai iya taimakawa wajen hana mutane taɓa fuskarsu.
Wasu kasashe sun fara karfafawa jama'a su yi amfani da abin rufe fuska.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na waje wanda ba na likita ba. China ta ba da shawarar musamman ga mutanen da ke da lafiya su yi amfani da abin rufe fuska na likita, musamman idan sun zo kusa da wasu mutane (1 m (3 ft) ko ƙasa da haka).
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska na tiyata yayin tafiya a cikin jigilar jama'a ko lokacin zama a wuraren da mutane da yawa suke.
Jami'an lafiya na Thailand na karfafa mutane su sanya fuska a gida da kuma wanke su a kullum.
A cikin Jamhuriyar Czech da Slovakia an haramta yin amfani da abin rufe fuska ko rufe hanci da fuska ba tare da rufe fuska ba yayin fita.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya saka abin rufe fuska yayin da take tafiya zuwa wuraren da mutane suke da yawa don kare kansa da kuma wasu.
Gwamnatin Austria ta ba da umarni cewa dole ne a saka abin rufe fuska a kowane kantin sayar da kayayyaki.
Isra'ila ta bukaci dukan mazaunan ta su sa abin rufe fuska a duk lokacin da suka fita.
Taiwan, wadda ta samar da kusan miliyan goma na masks a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjoji su saka fuska a kan jiragen kasa da bas na kasa don tafiya a ranar 1 ga Afrilu.
Panama ta sanya sanya sanya abin rufe fuska a duk lokacin da suka fita waje kuma ta ba da shawarar cewa waɗanda ba za su iya siyan abin rufe fuska su sanya abin rufe fuska na gida ba.
An yi amfani da masks a Japan, Koriya ta Kudu, Malaysia da Singapore.
Kula da nesa ta zamantakewa (wanda ake kira kula da nesa ta jiki) ya haɗa da rage kusanci tsakanin mutane ta hanyar rage yawan yaduwar cutar ta hanyar rage yaduwar cutar.
Hanyoyi sun haɗa da: kasancewa cikin killacewa; hana tafiya; rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko shagunan kasuwa.
Mutane na iya yin amfani da hanyoyin da za su iya sanya nesa ta zamantakewa ta hanyar kasancewa a gida, ta hanyar iyakance tafiya, kauce wa yankunan da ke da yawan jama'a, gaisuwa ba tare da taɓawa ba, da kuma kiyaye nesa da juna ta jiki.
Gwamnatoci da dama yanzu suna tilasta ko kuma bada shawara a kiyaye nesa da jama'a a yankunan da cutar ta bulla.
A cewar hukuma da kuma cibiyoyin kiwon lafiya na Amurka, matsakaicin adadin mutane da aka tattara ya ragu daga 250 (idan ba a san cewa COVID-19 ta bazu a yankin ba) zuwa 50 da kuma 10 daga baya.
"A ranar 22 ga Maris, 2020 Jamus ta haramta taron jama'a na mutane fiye da biyu. Manya da mutanen da ke da cututtukan da ke tattare da cututtukan cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma cutar da ke damun su suna fuskantar haɗarin kamuwa da cuta mai tsanani da rikitarwa, kuma CDC ta ba da shawarar cewa a wuraren da cutar ta barke a cikin al'umma su zauna a gida kamar yadda ya kamata. A ƙarshen Maris na 2020, WHO da sauran kungiyoyin kiwon lafiya sun fara maye gurbin kalmar ""tsaron zamantakewa"" da ""tsarewar jiki", don bayyana cewa manufarta ita ce kiyaye jiki ta jiki daga nesa ta zamantakewa ko kuma kula da zamantakewar zamantakewa".
"Amfani da kalmar ""rashin zamantakewa"" ya shafi yadda mutane ke motsa su su kasance tare da wasu ta hanyar da ba ta dace ba, maimakon haka ya haifar da cikakken keɓewa ta zamantakewa. Wasu hukumomi sun ba da umarnin game da lafiyar jima'i don amfani a lokacin annobar".
Wannan ya ƙunshi yin jima'i da wanda yake zaune tare da ku, wanda ba shi da cutar ko kuma ba shi da alamun cutar.
An ba da shawarar keɓe kai a gida ga waɗanda ke da COVID-19 da waɗanda suka yi shakkar cewa sun kamu da cutar.
Hukumomi da dama sun ba da umarni ko kuma sun ba da shawarar yin keɓewa ga duk mazaunan da ke zaune a yankunan da abin ya shafa.
An bayar da umarnin da suka fi tsaurara don keɓe kansu ga kungiyoyin da ke da haɗari sosai.
An shawarci mutanen da suka haɗu da wani mutum da ke da cutar COVID-19 da kuma waɗanda suka yi tafiya zuwa wata ƙasa ko yanki da ke da ci gaba da kamuwa da cutar kwanan nan su kasance cikin keɓewa na kwanaki 14 daga lokacin da suka yi hulɗa da su.
Aikin sarrafawa na fashewa shine kiyayewa da kuma kawar da cutar.
Ana gudanar da matakan dakile cutar a farkon fasalin barkewar cutar, kuma an yi niyyar fara wasu hanyoyin hana kamuwa da cutar da kuma yin allurar rigakafi ban da ganowa da ware mutane masu kamuwa da cutar a cikin sauran jama'a don hana yaduwar cutar.
Lokacin da babu wata hanyar da za a iya hana yaduwar cutar, ana yin ƙoƙari don ragewa: ana ɗaukar wasu magunguna don rage yaduwar ta da kuma rage tasirin ta akan tsarin kiwon lafiya da al'umma.
A lokaci guda, ana iya ɗaukar ma'aunin haɗuwa na riƙewa da ragewa.
Ana buƙatar ƙarin matakan dakile don juyawa da zagaye na annoba zuwa ƙasa da 1 don samun adadin haihuwa na farko. Rage iyakar annobar shine ɓangare na magance barkewar cutar ta annoba, wanda aka sani da daidaitawar cutar ta annoba.
Wannan ya rage hadarin da ke tattare da kula da lafiya da kuma ba da lokaci don yin allurar rigakafi da kuma inganta magani.
Sauran hanyoyin da za a iya sarrafa barkewar cutar ba tare da magani ba sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da keɓe kanka; matakan jama'a don kiyaye nesa ta jiki, kamar rufe makarantu da soke taron jama'a; karɓar sauran irin waɗannan hanyoyin da kuma shiga cikin jama'a; kuma matakan muhalli, kamar tsabtace farfajiya. Bayan an nuna tsananin barkewar cutar, an ɗauki ƙarin tsauraran matakai don dakile barkewar cutar a China kamar sanya keɓewar birni gaba ɗaya da sanya tsauraran takunkumi kan tafiya.
Wasu ƙasashe sun kuma ɗauki ƙa'idodi da yawa don rage yaduwar cutar.
Koriya ta Kudu ta fara gudanar da bincike na jama'a da killace mutane a gida, kuma ta ba da gargadi game da motsi na mutanen da suka kamu da cutar.
Singapore ta ba da tallafi ga wadanda suka kamu da cutar da suka yi wa kansu killacewa kuma ta yi wa wadanda suka kasa yin hakan manyan tarar.
Taiwan ta kara yawan samar da masks da kuma karfafa tarar da tsabar kudi kan cin hanci da rashawa na kayayyakin kiwon lafiya.Yin kokarin da Birtaniya da Amurka ke yi ya nuna cewa ragewa (an rage amma ba a hana yaduwar cutar ba) da kuma dakilewa (ƙaruwa a cikin annobar) suna da babban kalubale.
Ko da yake manufofin kawar da mafi yawan buƙatu na iya rage yawan buƙatun kiwon lafiya da kashi biyu cikin uku da mutuwar da aka rage, har yanzu ana samun rashin lafiya saboda mutuwar miliyoyin.
Dakatar da cutar na iya zama hanya mafi kyau amma dole ne a ci gaba da kiyaye ta har sai an sami cutar a cikin mutane (ko kuma har sai an sami rigakafi, idan ya zo da farko), saboda idan an sassauta matakan, in ba haka ba za a iya dawo da kamuwa da cutar da sauri.
Dukan matakan da aka dauka na dindindin na dakile annobar na haifar da lalacewar zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19 da aka amince da shi, amma ana ci gaba da ci gaba da ci gaba da gwajin maganin da ake samu.
Yin amfani da maganin sanyi, shan ruwa, da kuma hutawa a kan kantin zai iya magance cututtukan.
Dangane da yadda rashin lafiyar yake, ana iya buƙatar maganin oxygen, ruwa (ta hanyar intravenous) da kuma taimakon numfashi.
Yin amfani da kwayoyin cuta zai iya haifar da sakamako mafi muni.
Akwai wasu magungunan da aka amince da su a baya don magance wasu cututtukan kwayar cutar da ake gudanar da bincike don amfani da su a maganin COVID-19.
WHO ta kuma bayyana cewa wasu magungunan gargajiya da na gida suna taimakawa wajen magance alamun cutar SARS-CoV-19.
WHO ta bayyana karuwar iko da kuma karbar wuraren kiwon lafiya ga marasa lafiya na COVID-19 a matsayin matakin rigakafi na farko don hana barkewar cutar.
ECDC da WHO na Turai na Yankin sun ba da jagora ga Asibitoci da Cibiyoyin Kula da Farko cewa dole ne a cire hanyoyin da yawa, wanda ya haɗa da haɓaka kulawar aikace-aikacen gwajin COVID-19, haɓaka yawan sa ido ta hanyar keɓewa da keɓewar marasa lafiya masu COVID-19, da kuma horar da ma'aikata, da yawan iska da gado da ke akwai.
Akwai ra'ayoyi daban-daban game da inda farkon lamarin (wanda ake kira Patient Zero) ya samo asali.
An gano mutum na farko da ya kamu da cutar korona a Wuhan, Hubei, China, a ranar 1 ga watan Disamba, 2019.
A cikin wata daya, adadin masu dauke da cutar ta coronavirus a Hubei ya karu a hankali.
Yawancin su sun shafi kasuwar sayar da abinci ta teku ta Hunan, inda ake sayar da dabbobi masu rai, kuma a ka'idar daya, cutar ta fito ne daga wani irin dabba; ko kuma, a wata ma'ana, yana da asalin dabba. An lura da tarin cutar huhu na wani abu da ba a san shi ba a ranar 26 ga Disamba, kuma likita Zhang Jixian ya yi maganin shi a Hubei Provincial Hospital, wanda ya sanar da CDC a Wuhan a ranar 27 ga Disamba.
"A ranar 30 ga watan Disamba, wani rukuni na likitoci a Wuhan Central Hospital sun gargadi abokan aikin su game da wani "SARS-like coronavirus".
Likitoci takwas da suka hada da Li Wenliang sun yi wa 'yan sanda zargi da yada jita-jita, kuma wasu malamai sun yi wa Dr. I Fan ba'a don ya yi gargadin.
Bayan haka, Hukumar Lafiya ta Wuhan ta fitar da sanarwar a ranar 31 ga watan Disamba, kuma ta sanar da Hukumar Lafiya ta Duniya.
A farkon watan Janairu, an gabatar da wasu lokuta na cutar pneumonia a Wuhan wanda ba a sani ba, wanda ke da bincike. A farkon matakin barkewar cutar, adadin mutane ya ninka kusan sau bakwai da rabi a kowace rana.
A farkon da tsakiyar shekarar 2020, cutar ta yada zuwa sauran yankunan China, tare da ƙaurawar sabuwar shekara ta kasar Sin da kuma yadda Wuhan ta zama cibiyar sufuri da kuma babbar hanyar jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta bayyana cewa, an samu sabbin mutane 140 a rana daya, daga cikinsu akwai mutane biyu daga Beijing da kuma daya daga Shenzhen.
Bayanai na gwamnati na gaba sun nuna cewa mutane 6174 sun riga sun nuna alamun cutar a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta ga mafi yawan adadin mutane da aka tabbatar da cutar a duniya, bayan China da Italiya. A ranar 9 ga Afrilu, 2020, an ruwaito fiye da miliyan 1.61 na cutar a duniya; sama da mutane 97,000 sun mutu kuma sama da mutane 364,000 sun warke.
Akwai aƙalla wani kamuwa da cutar a cikin kusan ƙasashe da yankuna 200.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun ƙuntata motsi da kuma sanya takunkumin kan iyakoki.
Sakamakon haka ya hada da wasu matakan hanawa kowa da kowa zaman kadaici (wanda ake kira dokar hana fita ko dokar hana fita) da kuma dokar hana fita. A ranar 2 ga watan Afrilu, kimanin mutane miliyan 300, ko kashi 90 cikin dari na yawan jama'a, a Amurka suna cikin wani irin dokar hana fita, fiye da mutane miliyan 50 a Philippines, kimanin mutane miliyan 59 a Afirka ta Kudu da kuma mutane biliyan 1.3 a Indiya suna cikin dokar hana fita.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna karkashin wani irin dokar kulle, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu - kusan kashi ɗaya bisa uku na yawan duniya.
A Wuhan, an gano mutum na farko da ya kamu da cutar COVID-19 a ranar 1 ga Disamba, 2019; amma a cewar wani rahoto da ba a tabbatar da shi ba, an fara samun mutum a ranar 17 ga Nuwamba.
Likita Zhang Zijian ya lura da tarin cutar huhu a ranar 26 ga watan Disamba saboda dalilai da ba a sani ba, bayan haka asibitin ya sanar da Wuhan Jianghan CDC a ranar 27 ga watan Disamba.
Gwajin farko na kwayoyin halitta na marasa lafiya da aka yi a ranar 27 ga Disamba, 2019 ya nuna cewa akwai wani coronavirus kamar SARS.
A ranar 31 ga watan Disamba, Hukumar Lafiya ta Wuhan ta fitar da sanarwar da ta bayyana.
WHO ta sanar da hakan a wannan rana.
"Bayan an fitar da sanarwar, 'yan sanda sun yi gargadin cewa likitoci a Wuhan za su yi "fitowa" game da barkewar cutar".
"Kwamishinan lafiya na kasar Sin sun fara da'awar cewa babu "babban shaida" na kamuwa da cutar daga mutum zuwa mutum.
"A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yakin neman zabe wanda shi ne babban sakataren jam'iyyar kwaminis ta kasar Sin, Shi Jinping, ya bayyana shi a matsayin "yaƙin jama'a" don hana yaduwar cutar".
"An sanar da dakatar da zirga-zirga da tafiye-tafiye a Wuhan a ranar 23 ga Janairu, wanda aka bayyana a matsayin ""babban killace a tarihin 'yan adam", wanda aka fadada zuwa birane 15 a Hubei kuma ya shafi kusan mutane miliyan 57".
An haramta amfani da motocin sirri a cikin birni.
An soke bikin sabuwar shekara ta kasar Sin a wasu wurare.
Jami'ai sun kuma sanar da cewa an gina asibitin wucin gadi, wato Hyoshansan, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti don kula da marasa lafiya na yau da kullum bayan asibitin Leisenshun.
Bugu da kari ga sabbin asibitoci, China ta mayar da wasu cibiyoyi 14 a Wuhan kamar Cibiyar Taron Duniya da kuma Filin wasa zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta dauki wasu matakai don hana barkewar COVID-19, ciki har da sanarwar lafiya ga masu yawon bude ido da kuma tsawaita hutun bazara.
An kuma rufe jami'o'i da makarantu a fadin kasar.
Ƙasar Hong Kong da Macau sun ɗauki matakai daban-daban, musamman a kan makarantu da jami'o'i.
A wasu yankunan kasar Sin, an yi amfani da ayyukan nesa.
An sanya dokar hana zirga-zirga a cikin gida da waje.
An sauya tsarin sufuri na jama'a a duk faɗin China kuma an rufe gidajen tarihi na wucin gadi.
"An sanya takunkumin hana zirga-zirgar jama'a a garuruwa da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (sama da rabin yawan jama'a) sun fuskanci takunkumi a kan yin tafiya a waje. Bayan barkewar cutar ta shiga duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana cutar daga "ƙaddamarwa" daga wasu ƙasashe".
Alal misali, Beijing ta ba da sanarwar cewa duk matafiya na duniya da suka shiga birnin suna bukatar su keɓe kansu na kwanaki 14. Kashi guda daya ne kawai aka samu a cikin gida a babban yankin China a ranar 23 ga Maris, kwanaki biyar da suka gabata.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya bayyana cewa an hana yaduwar kamuwa da cutar a cikin gida kuma an hana cutar a kasar Sin.
Bayan watanni biyu da dokar ta baci ta fara, an sauƙaƙa ƙa'idodin tafiye-tafiye zuwa Hubei a ranar da ta gabata, ban da Wuhan. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da izinin shiga ga mutanen da ke da biza ko izinin zama daga ranar 28 ga Maris, kuma ba ta ba da cikakken bayani game da lokacin da wannan manufar za ta ƙare ba.
Duk wanda ya so ya shiga kasar Sin dole ne ya nemi takardar izinin shiga ofishin jakadancin kasar Sin ko kuma ofishin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa kamfanoni da masana'antu su sake budewa a ranar 30 ga watan Maris, tare da samar da wani kudade mai karfafa gwiwa ga kamfanoni. Majalisar Dinkin Duniya ta sanar da ranar makoki wanda ya fara da minti uku na shiru a fadin kasar a ranar 4 ga watan Afrilu da misalin karfe 10:00 na safe, ranar da bikin Qingming ya kasance, duk da cewa gwamnatin tarayya ta ce a yi wa iyalai ladabi ta yanar gizo yayin da suke kiyaye nesa ta jiki don kauce wa sabon barkewar COVID-19.
An tabbatar da cewa COVID-19 ta bazu daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar kula da lafiyar kasar ta ruwaito a ranar 20 ga watan Fabrairu cewa an samu karuwar adadin wadanda suka kamu da cutar, wadanda suka fi mayar da alhakin sabon addinin Yahudanci da ake kira Shincheongji Church, wato, Dayagur.
Masu zuwa coci na Shinchangji daga Wuhan zuwa Dayagu sun yi zargin cewa sun kasance tushen cutar.
A ranar 22 ga Fabrairu, 1,261 daga cikin mabiya 9,336 na Ikilisiya sun ba da rahoton alamun cutar, ko kusan kashi 13 cikin ɗari. Koriya ta Kudu ta ba da sanarwar mafi girman matakin gargadi a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an samu karin kamuwa da cutar 2,000 a Koriya, daga 3,150 zuwa 29 ga watan Fabrairu.
An ware dukkan sansanonin sojin Koriya ta Kudu bayan an tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shafi jadawalin jirgin sama kuma saboda haka an canza shi. Koriya ta Kudu ta kaddamar da shirin da ake ganin shi ne mafi girma da kuma mafi kyawun tsari a duniya don gwada mutane don cutar da ware mutane da kuma ganowa da killace waɗanda suka yi hulɗa da su.
Ana bukatar kara karfin gwajin a kan sabbin masu shigowa duniya ta hanyar wayar hannu, gwajin gwajin kwayar cutar da aka samu a rana mai zuwa, da kuma gwajin mutane 20,000 a kowace rana.
Ko da yake ba a sanya birane a cikin cikakken killace ba, an dauki shirin a Koriya ta Kudu a matsayin nasara wajen hana barkewar cutar.
Yawancin 'yan Koriya sun yi ikirarin cewa an yi amfani da cutar a hukumance kuma sun sanya hannu kan takardar neman a yi watsi da Moon ko kuma su yaba da yadda ya amsa.
A ranar 23 ga watan Maris, an ruwaito cewa Koriya ta Kudu ta samu mafi karancin adadin wadanda suka kamu da cutar a cikin mako hudu.
A ranar 29 ga watan Maris, an sanar da cewa, daga ranar 1 ga watan Afrilu, za a killace duk wani sabon mutum da ya zo daga kasashen waje na tsawon makonni biyu.
A ranar 1 ga watan Afrilu, kafofin yada labarai sun ruwaito cewa Koriya ta Kudu ta karbi buƙatun gwajin cutar daga kasashe 121 daban-daban.
Iran ta sanar da cewa ta samu kamuwa da cutar SARS-CoV-2 ta farko a Qom a ranar 19 ga Fabrairu, inda mutane biyu suka mutu a ranar, a cewar ma'aikatar kiwon lafiya da ilimin likitanci.
Wasu daga cikin matakan da gwamnatin ta dauka sun hada da soke bukukuwa da sauran bukukuwa da wasanni, da kuma rufe makarantu da jami'o'i da kuma cibiyoyin ilimi.
Iran ta ba da tiriliyan biyar na riyal don magance cutar.
A ranar 26 ga watan Fabrairun 2020, Shugaba Hassan Rouhani ya ce babu wani shiri na killace yankunan da cutar ta shafa, kuma za a killace mutane ne kawai.
An sanar da shirin hana tafiya tsakanin birane daban-daban a watan Maris, duk da cewa akwai ci gaba da yawan zirga-zirga tsakanin birane yayin da Farisa ta kasance a gaban Sabuwar Shekara.
Sha'anin addinin Shia a Kome ya kasance a bude har zuwa 16 ga Maris, 2020.
A tsakiyar da'awar rage yawan barkewar cutar a Iran, fiye da kasashe goma sun gano Iran a matsayin tushen kamuwa da cutar a ranar 28 ga Fabrairu, wanda ke nuna cewa adadin kamuwa da cutar ya fi adadin kamuwa da cutar 388 da gwamnatin Iran ta bayar da rahoton zuwa wannan ranar.
A ranar 3 ga watan Maris, majalisar ta rufe bayan da aka samu gwajin cutar a 23 daga cikin 'yan majalisa 290 na kasar Iran.
A ranar 12 ga watan Maris, mai kula da kare hakkin dan Adam ya nemi jami'an kurkuku na Iran su saki masu cin zarafin da ake tsare da su saboda rashin jituwa da suka yi da zaman lafiya, tare da sakin duk fursunonin da suka cancanci hakan.
An ce cibiyoyin da aka kulle kamar gidajen yari suna da haɗarin yaduwar cutar, wanda kuma ba shi da isasshen sabis na likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton cewa an kashe mutane 100 a cikin rana daya, wanda shine mafi yawan mutuwar da aka samu a kasar tun lokacin da cutar ta fara.
Akalla 'yan siyasa da jami'an gwamnati 12 na Iran sun mutu daga cutar har zuwa ranar 17 ga watan Maris.
A ranar 23 ga watan Maris, a Iran, ana samun karin mutum 50 a kowace awa da kuma mutuwar mutum daya a kowane minti 10 saboda cutar.
Wani jami'in WHO ya ce, Iran na iya samun sau biyar na yawan wadanda suka kamu da cutar fiye da yadda aka samu.
Ban da haka ma, an yi hasashen cewa takunkumin da Amurka ta yi wa Iran zai iya lalata karfin tattalin arzikin kasar wajen magance wannan annoba.
Babban Kwamishinan Majalisar Dinkin Duniya kan Hakkokin Dan Adam ya yi kira da a cire takunkumin tattalin arziki ga kasashen da suka fi fama da cutar, ciki har da Iran.
An tabbatar da cewa cutar ta bazu a Italiya a ranar 31 ga Janairu, lokacin da aka gwada gwajin SARS-CoV-2 na biyu daga cikin masu yawon bude ido na kasar Sin a Rome.
An fara samun karin mutane a cikin lamarin, wanda ya sa gwamnatin Italiya ta dakatar da dukkan jiragen da ke zuwa daga China da kuma yin dokar ta baci a kasar.
A ranar 21 ga Fabrairu, an gano tarin marasa tsari na COVID-19 a Lombardy bayan an tabbatar da shari'o'i 16 a ranar. A ranar 22 ga Fabrairu, majalisar Ministoci ta fitar da sabuwar doka game da annobar, inda aka ware mutane sama da 50,000 daga garuruwa 11 a arewacin Italiya.
A cewar Firayim Minista, an hana masu shiga da fita daga wuraren da ake fama da cutar.
"An riga an katse ayyukan a waɗannan yankuna kuma an dakatar da ayyukan wasanni. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a matakin ƙasa yayin da mutuwar Italiya ta kai 100".
Duk da cewa an shirya dukkan manyan wasanni, gami da wasan kwallon kafa na Serie A, don a takaita su har zuwa watan Afrilu, duk wasanni an dakatar da su gaba daya na akalla wata guda a ranar 9 ga Maris.
A ranar 11 ga watan Maris, Firayim Minista ya ba da umarnin rufe kusan dukkanin ayyukan kasuwanci a Kantin, sai dai manyan kantuna da kantunan magani. A ranar 6 ga watan Maris, Kwalejin Italiyanci ta Anesthesia, Analexia, Resuscitation and Intensive Care (SIAARTI) ta ba da shawarar manufofin likita game da yarjejeniyar Trias that can be deployed.
A ranar 19 ga watan Maris, Italiya ta yi nasarar wucewa kasar Sin a matsayin kasar da ta fi yawan mutuwar coronavirus a duniya, inda ta samu mutuwar 3,405 sakamakon annobar.
A ranar 22 ga watan Maris, Rasha ta tura jiragen saman soja tara zuwa Italiya tare da kayan aikin likita.
A ranar 5 ga watan Afrilu, an samu karin mutane 128,948 da suka kamu da cutar a Italiya, mutane 15,887 sun mutu kuma mutane 21,815 sun warke, wadanda suka fi yawa a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa, yawan tsofaffi a Italiya da kuma rashin iyawar da aka samu na gano cewa mutane da yawa suna dauke da cutar sun kai ga yawan mutuwar.
Da farko dai, Burtaniya ta kasance mafi sassauci a cikin ƙasashen da cutar ta shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya wani tsari na kiyaye nesa ta zamantakewa ko sanya keɓewa a kan 'yan ƙasa ba.
A sakamakon haka, gwamnati ta fuskanci zargi da yawa saboda rashin fahimtar yadda cutar ke shafar mutane. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya sanar da cewa an hana duk tafiye-tafiye marasa mahimmanci, tarurruka na zamantakewa kuma ya shawarci kowa da kowa ya zauna a gida ya yi aiki a duk inda zai yiwu kuma ya umarci ya guji wuraren shaguna, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnatin ta sanar da cewa dole ne a rufe dukkan wuraren shakatawa kamar wuraren shakatawa da wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin biyan albashi na 80% na ma'aikata har zuwa £2,500 a kowane wata don hana rashin aikin yi a wannan lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan kiyaye nesa da zamantakewa, ya hana taron mutane fiye da biyu, da kuma iyakance tafiya da ayyukan waje kawai ga waɗanda za a ɗauka da mahimmanci.
Ba kamar yadda aka yi a baya ba, 'yan sanda sun yi amfani da waɗannan ka'idojin, ta hanyar ba da tarurruka da kuma kawar da tarurruka.
"An ba da umarnin rufe yawancin kasuwancin, gami da manyan kantuna, kantunan magani, bankuna, shagunan kayan aiki, tashoshin mai da garages, sai dai waɗanda aka ɗauka a matsayin "mafi mahimmanci".
A ranar 20 ga watan Janairu, an tabbatar da farkon kamuwa da COVID-19 a cikin mutum daya da ya dawo daga Wuhan a ranar 15 ga watan Janairu a jihar Pacific Northwest na Washington.
An kafa rundunar aikin White House Coronavirus a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta sanar da dokar ta baci ta kiwon lafiya ta jama'a kuma ta sanya takunkumi kan shigar da masu yawon bude ido daga China.
A ranar 28 ga Janairu, 2020, cibiyar kula da cututtuka ta Amurka, babbar hukumar kula da lafiyar jama'a ta Amurka, ta sanar da cewa ta samar da kayan gwajin ta kanta.
Duk da haka, Amurka ta yi gwajin da ya yi jinkiri sosai, wanda ya sa adadin masu kamuwa da cutar ta gaske ya kasance daga hayaki a lokacin barkewar cutar.
Ba a ba da izinin gwamnati ga kayan gwajin da gwamnati ta samar da su a watan Fabrairu da kuma na masu zaman kansu (ma'aikata, kamfanoni da asibitoci) a ƙarshen watan Fabrairu, da kuma cancantar mutum na kulawa don cancanta don gwaji har zuwa farkon Maris (wanda daga bisani ake buƙatar umarnin likita) ya hana gwajin.
A ranar 27 ga watan Fabrairu, jaridar Washington Post ta ruwaito cewa a Amurka za a yi gwaji kasa da 4,000.
A ranar 13 ga watan Maris, jaridar The Atlantic ta ruwaito cewa an gwada kasa da 14,000.
A ranar 22 ga watan Maris, Associated Press ta ba da sanarwar: "Mutane da yawa da ke da umarnin likita da alamun cutar sun jira awanni da yawa ko kwanaki don yin gwaji. Bayan samun rahoton mutuwar farko a jihar Washington, Amurka, a ranar 29 ga Fabrairu, Gwamna Jay Insley ya ba da sanarwar dokar ta baci a jihar, wani mataki da sauran jihohi suka bi nan da nan.
Makarantun yankin Seattle sun rufe aji na 3 a ƙarshen Maris kuma makarantu a duk faɗin ƙasar suna rufewa a hankali a tsakiyar Maris. A ranar 6 ga Maris, 2020, wasu masana a fannin cututtukan cututtuka na Imperial College, London, sun ba da shawara ga Amurka game da tasirin sabon coronavirus a cikin ƙasar da kuma hasashensa.
A wannan ranar ne Shugaba Trump ya sanya hannu kan dokar karbar kayan aikin Coronavirus Prep and Response Supplement, wadda ta samar da dala biliyan 8.3 na kudaden gaggawa ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni sun sanya takunkumi kan tafiye-tafiyen ma'aikata, sun soke tarurruka, kuma sun karfafa ma'aikata su yi aiki daga gida.
A ranar 11 ga watan Maris, Trump ya sanya takunkumin hana tafiye-tafiye na kwanaki 30 a kusan dukkanin Turai, banda Burtaniya, daga ranar 13 ga watan Maris.
A rana ta gaba, ya kara fadada takunkumin zuwa Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya sanar da dokar ta baci a fadin kasar, wanda ya ba da damar samun karfin kudaden tarayya don magance matsalar.
Tun daga ranar 15 ga Maris, da yawa daga cikin kasuwancin da ke fadin Amurka sun rufe ko kuma sun yi aiki a cikin gajeren lokaci don kokarin rage yawan yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a cikin jihohi 50 da kuma District of Columbia. A ranar 23 ga Maris, an ruwaito cewa New York City ta sami shari'o'in cutar coronavirus 10,700, wanda ya fi yawan adadin mutanen Koriya ta Kudu.
A ranar 25 ga watan Maris, Gwamnan ya ce, ana ganin cewa manufofin kiyaye nesa na zamantakewa suna aiki tunda ƙididdigar ninka adadin mutane ya ragu daga 2.0 zuwa 4.7 a cikin kwanaki.
A ranar 28 ga watan Maris, New York City ta samu adadin kamuwa da cutar 32,308 da mutuwar mutane 672 daga cutar. A ranar 26 ga watan Maris, Amurka ta samu adadin kamuwa da cutar coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya.
Rahotanni sun bayyana cewa, a ranar 30 ga watan Maris, shugaban Amurka, Donald Trump, ya yanke shawarar tsawaita dokar ta hana yin jima'i har zuwa ranar 30 ga watan Afrilu.
A wannan rana, jirgin asibiti mai dakuna 1,000 na USNS Comfort ya sauka a birnin New York.
A ranar 3 ga watan Afrilu, an samu mutuwar mutane 884 a Amurka a cikin awanni 24 da suka gabata.
A ranar 3 ga Afrilu, adadin mutane a jihar New York ya wuce 100,000. An soki fadar White House don hana aika saƙonni ta hanyar umarnin jami'an lafiya da masana kimiyya don watsi da wannan alamar rashin jin daɗi da kuma daidaita sanarwa da wallafe-wallafen da suka shafi cutar a ofishin mataimakin shugaban kasa Mike Pence.
An yi watsi da amincewar Trump da tsarin kula da rikicin, har da jawabin da jam'iyyar ta yi.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu mahimmanci daga China, ciki har da abubuwan da ake bukata na likita.
An yi amfani da nazarin tsarin tafiye-tafiye don tsarawa da kuma hango ko hasashen yanayin yaduwar cutar kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar watan Janairu 2020.
A shekarar 2018, an samu bayanai daga kungiyar sufuri ta kasa da kasa cewa, mutane da dama daga birnin Wuhan ne suka fi tafiya a Bangkok, Hong Kong, Tokyo da Taipei.
Dubai, Sydney da Melbourne sun kuma zama sanannun wuraren da masu yawon bude ido daga Wuhan suka ziyarta.
A cikin jerin shahararrun shahararrun 20 da aka fi sani da sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunadadadad a sunad a sunadad a sunad a sunad a sunad a sunad a sunad da aka bayyana sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sunay sun
An bayyana cewa akwai sauran abubuwa da yawa da za a gano game da COVID-19 kuma Australia za ta ba da ƙarin haske kan kula da iyaka da sadarwa a cikin amsawa ga annobar.
A ranar 21 ga watan Maris, an sanar da dokar ta baci ta mutum a Australia.
Saboda dokar hana fita ta zirga-zirga a birnin Wuhan da kuma Hubei, da farko da izinin gwamnatin kasar Sin, da kuma jiragen da aka yi wa lasisi a kasarsu, kasashe da dama suna shirin kwashe 'yan kasarsu da jami'an diflomasiyyarsu daga yankin.
Kasashen da suka fara shirin dawo da 'yan kasar su su ne Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand.
Pakistan ta ce ba za ta fitar da wani dan kasar daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta fitar da 'yan Brazil 34 ko kuma danginsu, ban da 'yan kasar Sin guda hudu da kuma 'yan Indiya.
'Yan ƙasar Poland, China da Indiya sun sauka a Poland inda jirgin Brazil ya ɗauki wani lokaci kafin ya tashi zuwa Brazil.
An killace 'yan kasar Brazil da suka je Wuhan a sansanin soja kusa da Brazil.
A wannan rana, an kwashe Canadians 215 (mutanen 176 daga jirgin farko da 39 daga jirgin biyu da gwamnatin Amurka ta ba da izini) daga Wuhan zuwa C.F.B. Trenton kuma an keɓe su na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama na Kanada mai fasinjoji 185 ya sauka daga Wuhan zuwa CFB Trenton.
Hukumomin Australia sun ceto 'yan kasar 277 a ranar 3 da 4 ga Fabrairu, inda suka ajiye su a Cibiyar Hadin Kan tsibirin Kirsimeti, wanda aka yi amfani da shi don sabon manufar sanya su cikin killace, inda suka zauna har tsawon kwanaki 14.
Jirgin da ke tafiya daga New Zealand ya isa Auckland a ranar 5 ga Fabrairu; an tsare fasinjojinsa (ciki har da wasu daga Australia da Pacific) a wani tashar jiragen ruwa a Waangaparua, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta fitar da mutanen Amurka da ke cikin jirgin Diamond Princess Promoda.
A ranar 21 ga Fabrairu, wani jirgin fasinjoji yana dauke da 'yan Kanada 129 da suka tashi daga Diamond Princess suka sauka a Trenton, Ontario.
A farkon watan Maris, Gwamnatin Indiya ta fara dawo da 'yan asalin Indiya daga Iran. A ranar 14 ga Maris, wani jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta karɓa ya dawo da' yan asalin Afirka ta Kudu 112.
An yi bincike na likita kafin tafiya kuma an bar mutane hudu na Afirka ta Kudu da suka kamu da cutar coronavirus don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka samu sakamako mara kyau ne kawai aka mayar da su.
Sakamakon gwajin ya tabbatar da cewa duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matuka, ma'aikatan otal, 'yan sanda da sojoji, waɗanda ke da hannu a wani aikin jin kai, sun kasance cikin shiru kuma an sanya su a cikin keɓewa na kwanaki 14 a cikin gidan shakatawa na Ranch a matsayin hanyar gargadi.
A ranar 20 ga watan Maris, Amurka ta fara janye sojojinta daga Iran, a wani ɓangare saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin sun haɗu a Jami'ar Amurka don aika taimako zuwa wuraren da cutar ta kamu da cutar a kasar Sin. Tare da su, wata ƙungiya daga yankin Chicago ta haɗu da su ta aika da masks na N95 50,000 zuwa asibitoci a yankin Hubei a ranar 30 ga Janairu.
"A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da kyautar dala miliyan 100 ga WHO don tallafawa bincike da kokarin maganin rigakafi da kuma kare ""mutane da ke cikin hatsari a Afirka da kuma Kudancin Asiya".
Interaction ta bayyana cewa, a ranar 6 ga watan Fabrairu, gwamnatin kasar Sin ta ba da masks 200,000 ga Philippines bayan Sanata Richard Gordon ya kai masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta tura tallafi mai darajar dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da masks miliyan daya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayan aikin likita fiye da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da kayan aikin likita miliyan 18 ga China, Jamus ta ba da kayan aikin likita da suka haɗa da kayan aikin hazamet 10,000, kuma Amurka ta ba da kayan aikin likita tan 17.8 ga China da kuma alƙawarin ƙarin tallafi na kuɗi na dala miliyan 100 ga ƙasashe da suka sha wahala.
A watan Maris, kasar Sin da Cuba da Rasha sun tura kayan aikin likita da kwararrun masana don taimakawa wajen magance barkewar cutar coronavirus a Italiya.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1 zuwa Addis Ababa, Habasha, da fuska miliyan 6, da kuma kayan kariya 60,000 don rarraba a Tarayyar Afirka.
Daga bisani ya tura kayan gwaji 5,000, masks 100,000 da kuma na'urori masu iska 5 zuwa Panama.
Ma'a ta kuma kawo kayayyakin kiwon lafiya a Kanada. ta yi ikirarin cewa sun yi shakkar masks da kuma kayan gwajin da kasar Sin ta Netherlands, Spain, Turkiyya, Georgia da Czech Democratic Republic suka yi.
Misali, Spain ta janye kayan gwajin coronavirus 58,000 da kasar Sin ta shirya tare da daidaito na 30% kawai, Netherlands ta dawo da masks na fuska 600,000 na kasar Sin, wadanda suka zama masu lahani.
Belgium ta dawo da masks 100,000 da ba za a iya amfani da su ba, waɗanda aka yi zaton sun fito ne daga China, amma a gaskiya sun fito ne daga Colombia.
A bangaren biyu, an yi amfani da tsarin gaggawa na gaggawa don tallafawa kasashe masu tasowa a ranar 2 ga Afrilu.
WHO ta yaba wa kokarin da jami'an kasar Sin ke yi wajen hana cutar da kuma gudanar da ita.
WHO ta nuna bambanci tsakanin barkewar cutar SARS a shekara ta 2002-2004, inda aka zargi hukumomin kasar Sin da tsare sirri da suka hana gudanar da ayyukan rigakafi da kuma hana su, da kuma rikicin da ke faruwa a yanzu, inda gwamnatin tarayya ta ba da sabuntawa akai-akai don kauce wa firgita kafin hutun sabuwar shekara.
"A ranar 23 ga Janairu, a cikin martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da takunkumin sufuri a Wuhan, wakilin WHO, Goden Galley, ya ce ""WHO ba ta ba da shawarar da ta dace ba", kuma wannan "yana da matukar muhimmin alama ga alƙawarin dakile cutar a duniya a inda ta fi yawa, kuma ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan an tabbatar da kamuwa da cutar daga mutane zuwa waje da China da kuma karuwar adadin abubuwan da suka faru a wasu ƙasashe, WHO ta ayyana cutar a matsayin gaggawa ta gaggawa ta gaggawa ta duniya (PHEIC) ta duniya, wanda shine na farko tun lokacin da ta ayyana cutar ta Sinawa a duniya a shekarar 2009".
"Darakta Janar na WHO ya ce dalilin PHEIC shi ne ""hadarin yaduwar duniya ya fi girma a ƙasashen da ke da ƙananan da matsakaitan kudade inda babu ingantaccen tsarin kiwon lafiya".
"A cikin martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya ce ""babu wani dalili na irin wannan matakin da zai hana ba dole ba tafiye-tafiye na kasa da kasa da kuma kasuwanci"" kuma ya ce ""WHO ba ta bada shawarar hana kasuwanci da kuma ayyukan"."
A ranar 5 ga watan Fabrairu, WHO ta nemi al'umma ta duniya ta ba da dala miliyan 675 don samar da shiri na gaggawa a ƙasashen da ke da ƙananan kuɗaɗe, kuma ta ambata cewa za a ba da taimakon gaggawa ga ƙasashen da ba su da wata hanyar sanin ko su wane ne suka kamu da cutar a yankin ko da sun kamu da cutar.
"Tedros ya kara da cewa, ""mun kasance da karfi kamar yadda mafi rauni na asali"" kuma ya bukaci al'ummar kasa da kasa da "su zuba jari a yau ko kuma su biya karin kudi daga baya". WHO ta gabatar da sunan cutar a matsayin COVID-19 a taron manema labarai a ranar 11 ga Fabrairu".
A wannan rana, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya "ba da damar ba da iko ga dukkan tsarin Majalisar Dinkin Duniya a cikin martani".
"A sakamakon haka, an kunna tawagar kula da rikicin UN, wanda ya ba da damar daidaita ayyukan Majalisar Dinkin Duniya, wanda a cewar WHO zai ba su damar "daidaita kansu kan mayar da hankali kan maganin lafiya, kuma sauran hukumomi suyi amfani da kwarewarsu wajen magance tasirin zamantakewa, tattalin arziki da ci gaban ci gaban cutar".
A ranar 14 ga watan Fabrairu, kungiyar WHO ta jagoranci wata kungiya ta hadin gwiwa da kasar Sin don kawo tawagar masana ta duniya da WHO zuwa kasar Sin domin taimakawa wajen gudanar da aikin gida da kuma tantance tsanani da kuma karfin cutar ta hanyar tarurruka da manyan kungiyoyin kasa da kasa da kuma ziyartar wuraren da suka dace don tantance tasirin da martani ga ayyukan da ke faruwa a larduna da larduna da yankuna, ciki har da birane da karkara.
"Domin amsawa ga karuwar annobar a Iran, WHO ta aika da wata ƙungiya ta hadin gwiwa don tantance halin da ake ciki a wurin. A ranar 28 ga Fabrairu, WHO ta sanar da cewa za a ƙara kimanta cutar coronavirus a duniya, daga ""mafi"" zuwa ""mafi girma"" wanda shine matakin mafi girma na gargadi da kimanta haɗari".
"Mike Ryan, darektan zartarwa na shirin gaggawa na WHO, ya yi gargadin a cikin wata sanarwa cewa, ""Wannan gwaji ne mai matukar muhimmanci ga kowace gwamnatin duniya: tashi".
"Wataƙila cutar tana nan kusa kuma dole ne ku kasance a shirye, "in ji shi, "idan an yi amfani da shi yadda ya kamata, zai iya taimaka wa duniya ta kauce wa "mafi muni".
"Ryan ya ci gaba da cewa bayanan da ake samu a yanzu ba su ba da hujja da za ta sa jami'an lafiya na duniya su bayyana cewa annobar ta zama annoba ta duniya ba, kuma ya ce irin wannan sanarwar za ta nuna cewa ""Mun yarda da cewa duk mutane a duniya za su fuskanci cutar".
A ranar 11 ga watan Maris, WHO ta ayyana barkewar cutar korona a matsayin annoba.
"Darakta mai gudanarwa ya ce WHO ta "daure da damuwa game da yaduwar cutar da kuma yadda ta ke yaduwa da kuma matakin rashin aikinta. WHO ta fuskanci tsauraran ra'ayoyi saboda rashin isasshen matakan da za a iya dauka wajen sarrafa cutar, wanda ya hada da jinkirin sanar da dokar ta baci ta kiwon lafiya da kuma sanya cutar a matsayin annobar".
Sakamakon rashin amincewa ya hada da wani takarda da aka yi na neman murabus daga mukamin shugaban hukumar WHO, Tedros Adam, wanda mutane 733,000 suka rattaba hannu a ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, wasu masana na Majalisar Dinkin Duniya sun bayyana cewa ana girmama hakkin kowa a lokacin COVID-19.
Kungiyar ta ce kowa yana da hakkin yin amfani da rayukan mutane kuma gwamnati ce ke da alhakin hakan.
Jam'iyyar ta jaddada cewa rashin albarkatu ko rashin inshorar lafiya ba zai taɓa zama hujja ba don nuna bambanci ga wani rukuni.
Masana sun kara da cewa nakasassu, 'yan tsiraru, tsofaffi, marasa gida, masu gudun hijira, wadanda ke rayuwa cikin matsanancin talauci, wadanda ke fursuna, 'yan gudun hijira da sauran kungiyoyin da ke bukatar tallafi daga gwamnati, suna da hakkin samun lafiya.
Hukumomin duniya suna magance tasirin tattalin arziki da zamantakewar al'umma na rikicin COVID-19.
Kungiyar Tattalin Arziki da Ci gaban Tattalin Arziki (OECD) ta kaddamar da dandamali don samar da bayanai masu dacewa da cikakkun bayanai game da martani na manufofi a cikin ƙasashe a duniya, da kuma ra'ayoyi da shawarwari.
Tattalin Arziki na Duniya ya haɗa da mai bin manufofin gida don magance tasirin kula da lafiya, tafiye-tafiye, ƙuntatawa na cibiyar dijital da kulle-kulle, da kuma taimaka wa ƙasashe su koya daga juna da kuma sauƙaƙe haɗin gwiwar duniya don amsa ƙalubalen coronavirus.
Gwamnatin Amurka, Ministan Birtaniya Michael Gove don ofishin majalisar dattijai, da Eduardo Bolsonaro, dan shugaban Brazil, Yair Bolsonaro, sun soki gwamnatin China kan yadda ake magance annobar, wadda ta fara ne daga yankin Hubei na kasar Sin.
An kori wasu jami'an jam'iyyar kwaminis ta kasar Sin (CPC) a matakin larduna saboda kokarin da suka yi na ware mutane a yankin China ta tsakiya wanda a fili ya nuna rashin jin dadin kungiyoyin siyasa da ke mayar da hankali kan barkewar cutar a wadannan yankuna.
Wasu masu sukar sun ce wannan matakin na kare Shi Jinping, Sakataren Janar na jam'iyyar kwaminis ta kasar Sin daga fushin jama'a da ke fama da annobar cutar korona.
Wasu jami'an kasar Sin kamar Zhao Lijian sun yi watsi da wani da'awar da aka yi a baya game da farkon barkewar cutar a Wuhan, game da ka'idar makirci game da COVID-19 da asalinsa Amurka ko Italiya.
"Gwamnatin Donald Trump ta Amurka ta bayyana coronavirus a matsayin ""Cinese Virus"" ko ""Wuhan Virus"" cewa "censorship na China ya yi watsi da wani virus wanda yanzu ya zama annoba ta duniya", wanda wasu masu sukar suka soki a matsayin wariyar launin fata, kuma suka ce ""yana kokarin yaudarar gwamnatin sa daga gazawar cutar ta hana cutar".
"The Daily Beast ta yi jawabi game da yadda gwamnatin Amurka ke gudanarwa wanda ya bayyana tsarin dabarun sadarwa tare da kafofin da aka bayyana a Majalisar Tsaro ta Kasa, inda aka ambata dabarun da ake kira ""duk abin da ke da alaƙa da China".
"An gaya mana mu yi kokarin yada wannan sakon ta kowace hanya da za mu iya, ciki har da taron manema labarai da kuma halartar tarho. " "Kayan tallace-tallace kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da kasar Sin ke yi na tura tallafi ga kasashen da cutar ta shafa na wani ɓangare na yakin neman tasiri a duniya".
"Joseph Borel, shugaban harkokin wajen EU ya yi gargadin cewa akwai wani bangare na siyasa da yanayin kasa wanda ya hada da "gwagwarmayar yin labarun da kuma "yawan siyasa na rashin tausayi" don samun tasiri".
"Borrell ya kara da cewa, "China tana tura sakon da karfi cewa, sabanin Amurka, ita ce mai daukar nauyi da kuma amintacciyar abokiyar tarayya".
Kasar Sin ta bukaci Amurka da ta dakatar da bayar da tallafi ga kasashen Syria da Venezuela da Iran bayan da aka samu labarin cewa ita kanta ce ke tura tallafi ga kasashen biyu na baya.
A ranar 3 ga watan Afrilu, Amurka ta dakatar da bayar da mask 100,000 na Jack Ma ga Cuba.
An zargi hukumomin Amurka da amfani da taimakon da aka bayar ga wasu ƙasashe don amfanin nasu.
A wasu kasashen kamar Jamus, Austria da Switzerland, da kuma Jamhuriyar Czech da Italiya, an samu rikici game da abin rufe fuska.
Turkiyya ta kuma kwace daruruwan masu iska da aka keɓe don Spain.
A farkon watan Maris, gwamnatin Italiya ta soki Italiya saboda rashin haɗin kai na Tarayyar Turai da cutar coronavirus.
Jakadan Italiya a cikin Tarayyar Turai, Maurizio Masari, ya ce, kasar Sin ce kawai ta amsa a hanya ta biyu.
"Wannan ba alama ce mai kyau ga hadin kan Turai ba".
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya rundunar sojin Rasha ta tura kayan aikin soja, motocin kashe kwayoyin cuta da sauran kayan aikin likita zuwa Italiya.
"A cikin jaridar La Stampa ta Italiya, wani ba a san shi ba ya ba da labarin wani "babban jami'in siyasa" ya bayyana cewa kashi 80 cikin dari na taimakon Rasha "ba su da amfani ko kuma ba su da amfani ga Italiya".
"Source ya zargi Rasha da yin wani yunkuri na "jiha-siyasa da kuma diplomasiyya" don faranta wa duniya rai".
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Mio sun yi watsi da rahotannin kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma tura wani jirgin sama mai dauke da kayayyakin kiwon lafiya zuwa Amurka.
"Maganar Kremlin Dmitry Peskov ya ce, ""Lokacin da ya zo ga taimaka wa abokan aikin Amurka, [Putin] ya yi zaton cewa idan masana'antun kayan aikin likita na Amurka suka samu wasu ci gaba, za su iya biya".
"An shirya shirin NATO na "Defender 2020" a Jamus, Poland da Baltic States, wanda shine mafi girma a NATO daga karshen Cold War, a cikin raguwa".
"Sakatare Janar na Kamfen don Kashe Makamai na Nukiliya, Kate Hudson, ta ce game da atisayen Defender 2020: ""A cikin rikicin kiwon lafiyar jama'a na yanzu, ba wai kawai zai shafi rayuwar sojojin da ke cikin Amurka da sauran kasashen Turai ba, har ma da rayuwar mazaunan kasashen da suke sarrafawa". "Gwamnatin Iran ta sami mummunan tasiri daga cutar, wanda ya shafi 'yan majalisa biyu da kuma wasu manyan' yan siyasa goma sha biyar".
A ranar 14 ga watan Maris, 2020, shugaban Iran Hassan Rouhani ya rubuta wata wasika mai budewa ga shugabannin duniya yana neman taimako, inda ya ce Amurka ta yi wa Iran taƙama saboda rashin samun damar shiga kasuwannin duniya ga kasarsa.
Masu nazarin siyasa sun yi hasashen cewa hakan zai iya shafar yiwuwar sake zaben Donald Trump a zaben shugaban kasa na 2020. Dangantakar diplomasiyya tsakanin Japan da Koriya ta Kudu ta lalace a lokacin annobar duniya.
"Bayan kasar Japan ta sanar da cewa za a killace duk wani mutumin da ya zo daga Koriya ta Kudu a inda gwamnatin kasar ta ba shi izinin kwana biyu, Koriya ta Kudu ta soki Japan da "ƙoƙarin killace ba tare da fahimta ba".
A farkon shekarun da suka gabata, al'ummar Koriya ta Kudu sun kasance a kan matakai biyu masu banbanci game da yadda Shugaba Moon Jae-in ya amsa matsalar.
Da yawa daga cikin 'yan Koriya sun sanya hannu kan takardar neman a sallami Moon, suna da'awar gwamnati ta yi rashin kula da barkewar cutar.
Wasu masu magana da yawun sun nuna damuwa cewa hakan zai iya ba gwamnati damar karfafa karfinta kan iko.
A Hungary, majalisa ta ba wa Firayim Minista Viktor Urban ikon yin mulki na har abada, ta ba shi damar dakatar da majalisa ko gudanar da zaɓen, da kuma hukunta waɗanda suka yi watsi da yadda cutar ta kamu da cutar da kuma yadda gwamnati ke magance matsalar.
An danganta barkewar cutar korona da karancin kayayyaki, karuwar amfani da kayan aikin yaki da annobar a duniya, haifar da firgici da kuma hana masana'antu da kayan aiki aiki.
Hukumar Kula da Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita saboda karuwar bukatar masu siye da kuma katsewar masu samarwa.
Akwai wasu wuraren da ake samun cin kasuwa saboda tsoro, wanda ya sa mutane suka sayi kayan abinci da kayan abinci masu mahimmanci kamar kayan wanka da ruwa a kwalban, wanda ya haifar da karancin abinci.
Musamman masana'antun fasaha sun yi gargadin cewa ana jinkirta aika kayayyakin lantarki.
A cewar Darakta Janar na WHO, Tedros Adam, bukatar kayan kariya ta mutum ta karu sau 100.
Wannan bukatar ta kara farashin farashin sau 20 na yau da kullum kuma ta kawo jinkiri na watanni shida daga samar da kayayyakin kiwon lafiya.
Wannan ya haifar da karancin kayan kariya na mutum a duniya, kuma WHO ta yi gargadin cewa zai sa ma'aikatan kiwon lafiya cikin hadari.
Wannan annoba a Australia ta ba da sabuwar dama ga masu sayar da kayayyaki na Daegu don sayar da kayayyakin Australiya zuwa China.
Wannan aikin ya haifar da rashin isasshen kayan abinci a wasu manyan kantuna, kuma daga bisani gwamnatin Ostiraliya ta yi sanarwa game da haramta. Duk da yawan adadin COVID-19 a arewacin Italiya da yankin Wuhan, duk da cewa an tabbatar da matsanancin bukatar abinci, yankunan biyu sun sami damar kiyaye kansu daga mummunan karancin abinci.
China da Italiya sun yi nasara wajen hana kayayyakin da ake bukata da kuma cinikin da ba a yi ba, wanda ya hana samun abinci mai yawa da ake tsammani a Arewacin Amirka ba kawai a Turai ba.
Ko da yake ba a samu raguwar da ta dace a cikin amfanin gona a arewacin Italiya ba, masana'antun masana'antu sun ce farashin zai iya tashi.
Lokacin da jami'an gwamnatin kasar Sin suka bar naman alade da aka tattara don samar da isasshen abinci ga jama'a, ko da a birnin Wuhan sun fara fuskantar ɗakunan abinci marasa abinci.
A Italiya, akwai irin wannan dokar ta kasa da ta bukaci masu samar da abinci su ajiye abinci don irin wannan gaggawa.
An ji rauni a tattalin arzikin duniya a China: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin China ya yi mummunan rauni a farkon watanni biyu na 2020, saboda matakan da gwamnati ta dauka na rage yaduwar cutar, kuma sayar da kayayyaki na kiri ya ragu da kashi 20.5%.
Tuni dai cutar ta yi barazanar haifar da babban rashin kwanciyar hankali a tattalin arzikin duniya, saboda babban yankin China yana taka muhimmiyar rawa a matsayin cibiyar tattalin arziki da samarwa.
A cewar wani rahoto da aka fitar daga kamfanin na Economist Intelligence Unit, Agathe Demarais, kasuwanni za su kasance masu canji har sai an bayyana wani karin hoto game da sakamakon da zai iya faruwa.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa bala'in tattalin arziki da annobar ta haifar a duniya zai iya wuce barkewar cutar SARS ta 2002-2004.
Wani masanin jami'ar Washington a St. Louis ya kiyasta cewa, an yi asarar fiye da dala biliyan 300 a sarkar samar da kayayyaki a duniya, wanda zai iya wuce shekaru biyu.
"Kungiyar kasashen da ke fitar da man fetur (OPEC) ta ce ta "rufe kan ta" bayan farashin mai ya ragu sosai saboda karancin bukatar da ake samu daga kasar Sin.
Kasashen duniya sun fadi a kasuwar jari a ranar 24 ga watan Fabrairu saboda karuwar COVID-19 a waje da Mainland China.
A ranar 27 ga Fabrairu, saboda karuwar damuwa game da barkewar cutar coronavirus, yawancin alamun jari na Amurka, gami da NASDAQ-100, S&P 500 index, da Dow Jones Industrial Average, sun buga mafi muni daga 2008, tare da Dow da aka saka maki 1,191, wanda shine mafi girma a cikin rana ɗaya daga lokacin rikicin kudi na 2007-08.
Dukkanin alamun sun wuce kashi 10 cikin 100 a karshen mako.
A ranar 28 ga watan Fabrairu, Scope Ratings GmbH ta tabbatar da darajar darajar darajar kasar Sin, amma ta ci gaba da yin mummunan ra'ayi.
Kasuwa ta koma cikin koma baya a ranar 16 ga watan Maris, saboda tsoron cutar Corona.
Mutane da yawa suna tunanin yiwuwar koma bayan tattalin arziki.
Masanin tattalin arziki Muhammad El-Arian ya yaba da tsarin gaggawa na Bankin Tsakiya da na jihar.
Babban bankin ya yi nasara a kan wannan matakin fiye da yadda ya yi a lokacin rikicin kudi na 2008.
Ya kasance daga cikin sassan da yafi fama da matsalar yawon bude ido sakamakon haramcin yawon bude ido ga dukkan wuraren da ke da yawan jama'a, gami da wuraren yawon bude ido masu jan hankali da kuma takunkumin gwamnati kan duk wani irin tafiya a duniya.
A sakamakon haka, kamfanonin jiragen sama da dama, ciki har da British Airways, China Eastern Airlines da Qantas sun soke jirage saboda karancin bukatar da aka samu, bayan da kamfanin jirgin saman yankin na Burtaniya Flybe ya fadi.
Wannan mummunan tasiri a kan masana'antar tafiye-tafiye ta teku ba a taɓa gani ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da dama.
Lokacin da babban lokacin tafiya zuwa China ya fara ne a lokacin hutun Sabuwar Shekara ta Sin, lokacin da annobar ta fara a China.
Yawancin lokuta da yawa da za su iya kasancewa da yawa kamar bukukuwan Sabuwar Shekara na shekara-shekara da sauransu an rufe su ta hanyar gwamnatoci na ƙasa da na yanki.
Don hana jama'a, an dakatar da bukukuwan sabuwar shekara da kuma taron yawon bude ido da yawa na kasar Sin, ciki har da bikin birni da wuraren ibada na gargajiya a Beijing.
A larduna 24 da kananan hukumomi da yankuna 24 a cikin larduna 31 na kasar Sin, jami'ai sun tsawaita hutun sabuwar shekara har zuwa 10 ga Fabrairu, kuma sun ba da umarnin kada a sake bude yawancin wuraren aiki har zuwa wannan ranar.
Wadannan yankuna suna wakiltar kashi 80% na GDP na kasar da 90% na fitarwa.
Hong Kong ta kara yawan yadda take amsawa ga cututtukan cututtuka masu yaduwa, ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta soke bikin bikin sabuwar shekara. Kasuwancin kiri a duniya ya sha wahala daga raguwa a lokacin bude shaguna ko rufewa na wucin gadi.
A Turai da Latin Amurka, yawan ziyarar shaguna ya ragu da kashi 40 cikin dari.
Kasashen Arewacin Amirka da Gabas ta Tsakiya sun ga raguwar kashi 50-60%.
Wannan ya haifar da raguwar yawan masu siye a cikin shagon a watan Maris da kashi 33 43% idan aka kwatanta da Fabrairu.
Masu gudanar da shagunan duniya sun sanya ƙarin matakan, kamar inganta tsarin kiwon lafiya, sanya masu binciken zafin jiki don bincika yanayin zafi na masu siye, da soke abubuwan da suka faru. Bisa ga kimantawar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki da ya barke a duniya na iya jefa mutane 14 zuwa 22 miliyan cikin matsanancin talauci fiye da yadda yanayin Latin Amurka zai kasance idan ba a sami annobar duniya ba.
A cikin watan Janairu da Fabrairu na shekarar 2020, kusan mutane miliyan biyar a kasar Sin sun rasa ayyukansu a Wuhan, a lokacin da annobar ta kai ga ƙarshe.
Yawancin 'yan gudun hijira na kasar Sin da ke cikin karkara kusan miliyan 300 sun fada cikin rashin taimako a gidajensu a cikin yankunan cikin gida ko kuma sun makale a lardin Hubei. A watan Maris na 2020, fiye da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
A cewar kididdigar da aka yi daga Bankin Tsaro na St. Louis, cutar coronavirus na iya haifar da asarar ayyuka ga mutane miliyan 47 a Amurka, kuma rashin aikin yi zai iya kaiwa kashi 32%. A sakamakon lockdown a Indiya, miliyoyin ma'aikatan da ke ƙaura zuwa Indiya (wanda ake biya su a kowace rana) sun zama marasa aiki. Binciken da aka yi daga Cibiyar Angus Red ya nuna cewa kashi 44% na iyalai na Kanada suna fama da rashin aikin yi a wasu nau'i.
A cikin rabin watan Maris, ma'aikata 4 miliyan na Faransa sun nemi amfanin rashin aikin wucin gadi na wucin gadi, kuma ma'aikata 1 miliyan na Burtaniya sun nemi shirin bashi na kowa. Kimanin rabin miliyan na kamfanonin Jamus sun tura ma'aikatansu zuwa ga tsarin aiki na gajeren lokaci na tallafi na gwamnati wanda aka sani da Kurtzersbet.
Faransa da Birtaniya sun amince da shirin na biyan bashin gajeren aiki na Jamus.
Masana'antu da al'adun gargajiya na wasan kwaikwayon sun yi mummunan rauni daga annobar, wanda ya shafi ayyukan kamfanoni da kuma mutane - masu sana'a da masu zaman kansu - a duk duniya.
Cibiyoyin fasaha da al'adu sun yi ƙoƙari su ci gaba da ayyukansu (galibi na gwamnati) don ba da damar shiga al'adun al'adu a cikin al'umma, don kula da lafiyar ma'aikatan su da jama'a, da kuma tallafawa masu fasaha a duk inda zai yiwu.
A cikin watan Maris na 2020, a duk faɗin duniya da kuma a wurare daban-daban, gidajen tarihi, dakunan karatu, gidajen kallo da sauran cibiyoyin al'adu sun rufe har abada ta hanyar soke ko jinkirta nunin su, abubuwan da suka faru, da kuma ayyukan su.
Wani sakamako na kwanan nan da ke saurin ƙaruwa na cutar shine soke ayyukan addini, manyan abubuwan wasanni da sauran abubuwan zamantakewa kamar bukukuwa da kide kide da kide-kide, tarurrukan fasaha da kuma nunin salon.
A cikin makon karshe na lokacin tuba na Kirista, Vatican ta sanar da soke bikin mako mai tsarki a Roma.
Yawancin dioceses sun ba da shawarar dattawa su zauna a gida maimakon zuwa watan Lahadi; wasu majami'u suna ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kai tsaye ta kan layi ko talabijin, wasu kuma suna gudanar da ibada ba tare da sauka daga mota ba.
Yayin da Roman Catholic Diocese of Rome ta rufe majami'un da ɗakin sujada, kuma ta kawar da masu hawan hajji na Kirista a St. Peter's Square, sauran majalisun addinai sun soke ayyukan kuma sun iyakance taron jama'a a coci, masallaci, majami'u, haikalin, da gurduka.
Ma'aikatar lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa, kuma daga bisani an rufe wuraren ibada, kuma Saudiyya ta haramta shigar da baƙi da mazauna ƙasar zuwa wuraren alfarma na Makka da Madina.
Wannan annoba ce ta haifar da babbar bala'i a cikin kalandar wasanni a duniya tun bayan yakin duniya na biyu.
Yawancin manyan wasanni, gami da gasar zakarun Turai ta 2019-20, gasar Premier ta 2019-20, UEFA Euro 2020, 2019-20 NBA Season, da kuma 2019-20 NHL Season an soke su ko kuma an dakatar da su.
"Wannan barkewar cutar ta rushe shirin gasar Olympics ta 2020 da aka shirya a karshen watan Yuli; kwamitin Olympics na duniya ya sanar a ranar 24 ga Maris cewa taron zai "ba za a sake shirya shi ba bayan 2020 ba, amma bayan lokacin rani na 2021". Gidajen caca da sauran wuraren wasanni a duniya suna rufe kuma an dakatar da ko kuma an soke wasannin karta na rayuwa".
Rahotanni na gagarumin karuwar sabbin sa hannu a shafukan caca sun nuna cewa wannan ya haifar da yawan masu caca da yawa zuwa kan layi. Don dakatar da ko soke yawon shakatawa na wasu kungiyoyin kiɗa, masana'antar nishaɗi ma ta sha wahala.
Yawancin manyan gidajen wasan kwaikwayo kamar su Broadway sun soke duk wani wasan kwaikwayon.
"Wasu masu fasaha sun ci gaba da yin zane-zane da kuma raba su ta hanyar Intanet a matsayin wani zaɓi don al'adun gargajiya na rayuwa, kamar yin raye-raye na kiɗa ko ƙirƙirar "ƙungiyoyi" na yanar gizo, don masu fasaha su iya yin, rarraba da tallata ayyukansu".
A kan layi, an yi amfani da ƙwayar cuta mai yawa a cikin ƙwayar cuta ta yanar gizo wanda ke da ban dariya kuma yana kawar da hankali daga wannan lokacin rashin tabbas.
Tun bayan barkewar COVID-19, an lura da karuwar tsoratarwa, tsoron baƙi da nuna wariyar launin fata ga mutanen da ke fitowa daga China da Gabashin Asiya, da kuma mutanen da ke cikin yankunan da ke da zafi a Turai, Amurka da sauran ƙasashe.
Akwai tsoro, shakku da kuma rashin jituwa a ƙasashe da dama, musamman a Turai, Gabashin Asiya, Arewacin Amirka da kuma Asiya Pacific.
Rahotanni daga watan Fabrairu sun nuna cewa a duniya akwai wasu kungiyoyin 'yan kasar Sin da ke nuna wariyar launin fata, inda ake zargi da cewa sun cancanci kamuwa da cutar ko kuma abin da ake yi musu a matsayin fansa mai kyau.
Wasu ƙasashen Afirka sun kuma nuna rashin amincewa da kasar Sin.
Ya ce an nuna bambanci ga mazauna Wuhan da Hubei da yawa bisa ga yanayin yankin.
Akwai goyon baya ga Sinawa a kan layi da kuma wajen layi, da kuma goyon baya ga mutanen da ke yankunan da cutar ta shafa.
Kasashen Italiya da ke fuskantar mummunan annobar COVID-19 a matsayin ƙasa ta farko a Turai a cikin ci gaban annobar a cikin sabbin ƙasashe masu zafi na iya zama abin shakku da tsoro na ƙasashen waje.
A Japan, hashtag #ChineseRajaJapanAskDon't shine mafi mashahuri.
An samu karuwar hare-haren da ake yi wa 'yan kasar Sin da sauran 'yan Asiya a Birtaniya da Amurka da kuma a wasu kasashen Asiya.
"Shugaban Amurka Donald Trump ya fuskanci sukar kiranta coronavirus a matsayin ""Cinese virus"", saboda masu sukar sun dauki kalmar a matsayin mai nuna wariyar launin fata da kuma adawa da kasar Sin".
'Yan adawa a Ukraine sun kai hari kan bas din da ke dauke da fasinjoji daga Wuhan zuwa Novi Sanzahari.
An ruwaito cewa daliban da ke karatu a manyan biranen Indiya daga arewa maso gabashin Indiya, wanda ke da iyaka da China, sun sha wahala daga cutar coronavirus.
"Shugaban jam'iyyar Bharatiya Janata Party, Jihar West Bengal, Dilip Ghosh, ya ce, 'Shugabannin kasar Sin sun lalata yanayi kuma shi ya sa Allah ya yi musu rashawa.'
A lokacin da ake fama da cutar, an kara nuna rashin jin daɗi da nuna wariyar launin fata a kan mazaunan da ba 'yan kasar Sin ba. An bayyana 'yan kasashen waje a matsayin 'yan kasashen waje da kuma sanya su a matsayin' yan iska.
Akwai wasu jaridu da suka cire su daga ɗaukar hoto na coronavirus, gami da Paywall.
Yawancin wallafe-wallafen da suka shafi kimiyya sun samar da wallafe-wallafen da suka shafi barkewar cutar wanda ke samuwa a cikin budewa.
Wasu masana kimiyya sun fi son su bayyana sakamakon su cikin sauri a kan sabbin sabobin kamar BioRX.
cututtukan cututtuka masu tasowa cututtuka masu tasowa, wanda galibi ya zama sabon abu ko sabon abu a cikin yanayin yaduwar cutar ko yanayin kamuwa da cutar
Ƙasa da cututtuka - Gabatarwa game da duniya da cututtuka
Jerin annoba da annoba Jerin mutuwar da ake samu daga cututtuka masu yaduwa
Dandalin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da ke tattare da fataucin da fataucin da ke tattare da fataucin da fataucin da fataucin da ke tattare da fataucin da fataucin da fataucin da fataucin da fataucin da fataucin da fataucin da fataucin da fataucin da fataucin da fataucin da fataucin da fataucin da fata.
Gwajin gwaje-gwaje na Coronavirus Disease 2019 (COVID-19) da kuma SARS-CoV-2 da ya danganci ya haɗa da hanyoyin da za su gano kasancewar cutar da kuma gano maganin rigakafi da aka samar a cikin amsa ga kamuwa da cuta.
Ana tabbatar da kasancewar cutar a cikin samfurori ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin yana da mahimmanci kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cututtuka na kwanan nan ko na aiki.
Ana iya amfani da gano rigakafi (serology) don tantance cututtuka da kuma sa ido kan jama'a.
Gwajin rigakafi ya nuna yawan mutanen da suka kamu da cutar, ciki har da waɗanda suka yi rashin lafiya sosai ko kuma ba su da cutar.
Sakamakon gwajin zai iya tantance ainihin mutuwar cutar da kuma rigakafin rukuni a cikin al'umma.
Saboda karancin gwajin, babu wata ƙasa da ta sami tabbataccen bayani game da barkewar cutar a cikin al'ummarsu har zuwa Maris 2020.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin 100 na yawan jama'arta, kuma akwai bambanci sosai a cikin yawan gwajin da aka yi a ƙasashe daban-daban.
Wannan bambancin zai iya tasiri tasirin mutuwar da aka ruwaito, wanda zai iya zama mai mahimmanci a wasu ƙasashe.
Ana iya gwada samfurori na numfashi da aka samu ta hanyoyi daban-daban, ciki har da swabs na nasopharyngeal ko samfurori na huhu ta amfani da real-time reverse transcription polymerase chain reaction (rRT-PCR).
A cikin 'yan sa'o'i da kwanaki biyu ne sakamakon zai bayyana.
Gwajin RT-PCR da aka yi tare da swat na wuya yana da inganci a farkon makon rashin lafiya.
A wani lokaci, cutar za ta iya ɓacewa daga cikin makogwaro, amma za ta iya ƙara yawan a cikin huhu.
A cikin mutane masu kamuwa da cutar da aka gwada a mako na biyu, in ba haka ba za a iya ɗaukar samfurori daga zurfin numfashi ta hanyar catheter mai tsotsewa, ko kuma a yi amfani da kayan da aka fitar da su tare da tari.
An shirya daya daga cikin gwajin PCR na farko a Charité, Berlin, a watan Janairun 2020, ta amfani da Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR), kuma ya kafa tushen kayan aikin 250,000 don rarrabawa ta Hukumar Lafiya ta Duniya (WHO).
A ranar 28 ga watan Janairu, 2020, kamfanin Kogenebiotech na Koriya ta Kudu ya kirkiro wani kit din gano SARS-CoV-2 (PowerChek Coronavirus) wanda ya danganci PCR a matakin asibiti.
"Yana gano asalin ""E"" gene da ke cikin dukkan beta coronavirus da kuma RdRp gene wanda ke nuna SARS-CoV-2. BGI Group a China na ɗaya daga cikin kamfanoni na farko da suka sami izini don gaggawa don amfani da kayan gano SARS-CoV-2 na PCR daga Hukumar Kula da Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan
Sakamakon da ba a warware ba ya haifar da sakamakon da ba a warware ba saboda ƙarancin reagents a ɗayan gwajin kwayoyin halitta guda uku na tsofaffin sigar kayan gwajin, da kuma hana gwaji a CDC a Atlanta; wanda ya haifar da nasarar aiwatar da samfurori sama da 100 a kowace rana a kan matsakaici a cikin Fabrairu 2020.
Ba a tabbatar da cewa gwaje-gwaje da aka yi ta amfani da abubuwa biyu sun kasance masu inganci ba har zuwa 28 ga Fabrairu, 2020, kuma har zuwa wannan lokacin ba a ba da izinin fara gwajin ga dakunan gwaje-gwaje na jihar da na gida ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin gaggawa.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da samun gwajin COVID-19 bisa RT-PCR a duk faɗin ƙasar.
Quest Diagnostics ta kuma samar da gwajin COVID-19 a duk fadin kasar a ranar 9 ga Maris, 2020.
Babu iyakancewar adadi da aka sanar; dole ne a tattara samfurori da sarrafa su kamar yadda CDC ta buƙata.
A Rasha, gwajin COVID-19 ya kasance wanda Cibiyar Nazarin Virology da Biotechnology ta Jihar ta VECTOR ta shirya da kuma samar.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin ta Hukumar Kula da Lafiya ta Tarayya. A ranar 12 ga Maris, 2020, an samu rahotanni cewa Mayo Clinic ta shirya gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awoyi 3.5 da yawa, don haka ta ba da izinin yin gwaji na na'urar kusan 4,128 a cikin awanni 24 na lokaci.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa ga Abbott Laboratories (Eura) don gwaji a cikin tsarin Abbott na m2000; FDA ta ba da irin wannan izinin ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta samu EUA daga FDA don gwaji, wanda ya ɗauki kusan minti 45.
FDA ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Tun da ba a buƙatar sake zagayowar zafin jiki na lokaci-lokaci, wannan hanyar na iya samar da sakamako mai kyau a cikin ƙasa da minti biyar kuma zai iya haifar da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai na'urori kusan 18,000 a Amurka, kuma Abbott na fatan kara samarwa don samar da gwaje-gwaje 50,000 a rana. Wani gwaji yana amfani da maganin rigakafi na monoclonal, wanda ke da alaƙa da ƙwayoyin nucleocapside (N) na sabon coronavirus, kuma ana shirya wannan gwajin a Taiwan da fatan zai iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin sauri na mura.
"A cikin wata bita ta wallafe-wallafe a watan Maris na shekarar 2020 an kammala cewa ""radio-radiography na ƙirjin yana da matukar muhimmanci a cikin bincike na asali, amma yana iya kasancewa a cikin bayanan CT [computed tomography] tun kafin bayyanar cututtuka ta fara".
Abubuwan da ke cikin CT sun haɗa da bin-daya, multi-lober ground-glass optical efficiency tare da rarraba gefen gefe, rashin daidaituwa da baya.
A cikin yanayin da cutar ta taso, ana samun rinjaye na subplural, hauka da kuma karfafawa.
Wani binciken da ya kwatanta PCR da CT a Wuhan, inda cutar ta samo asali a yanzu, ya nuna cewa CT tana da matukar damuwa fiye da PCR, amma ba ta da ma'ana, kuma yawancin hotunan ta suna dacewa da sauran cututtukan cutar huhu da cututtuka.
"A watan Maris na shekarar 2020 ne Kwalejin Radiology ta Amirka ta ba da shawarar cewa ""ba za a yi amfani da CT a matsayin gwajin farko ba don tantance COVID-19 ko kuma don ganewar asali". Kamar yadda a watan Maris na shekarar 2020, CDC ta ba da shawarar PCR don tantancewar farko".
Wani ɓangare na maganin rigakafi ga kamuwa da cuta shine samar da rigakafi tare da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta a cikin mutane, don tantance rigakafi, da kuma lura da mutane daga kwanaki 7 bayan bayyanar cututtuka. Ana iya yin kimantawa ta hanyar gwaji a cikin manyan dakunan gwaje-gwaje (Central Laboratories, CLT) da kuma gwajin kulawa a wurin sabis (PoCT).
A cikin dakunan gwaje-gwaje masu yawa masu mahimmanci, tsarin sarrafa kai na aiki mai kyau zai iya yin wannan aikin, amma kasancewa da su zai dogara ne akan yawan samarwa ga kowane tsarin.
Ana amfani da samfurin jini guda ɗaya don CLT, ko da yake ana iya amfani da samfurin jini don bin tsarin rigakafi.
A cikin jiki, ana yin kwayar cutar ta jini ta hanyar yin kwayar cutar ta jiki.
A ranar 26 ga Maris, 2020, FDA ta sanar da sunayen hukumomin 29 da suka ba da sanarwar da ta dace ga hukumar kuma yanzu suna iya ba da gwajin rigakafin su.
A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, waɗanda zasu iya gano IgG da IgA antibodies a cikin samfurin jini da ke adawa da cutar.
Wannan gwajin yana da iko na yin samfurori ɗari a cikin 'yan sa'o'i, kuma saboda haka yana da sauri fiye da kimantawar PCR na gargajiya na RNA na kwayar cuta.
A farkon watan Afrilu, Burtaniya ta gano cewa ba a sayi kayan gwajin rigakafi da suka dace don amfani da su ba.
"Hong Kong ta kirkiro wani shiri inda marasa lafiya masu cutar za su iya zama a gida, ""sashen gaggawa zai ba da samfurin tube ga mai haƙuri"", zai yi fesa a ciki, ya mayar da shi, kuma ya sami sakamakon gwajin nan da nan. NHS ta Burtaniya ta sanar da cewa suna ƙaddamar da shirin a kan gwaji don bincika abubuwan da ake zargi a gida, wanda ke kawar da haɗarin kamuwa da cutar ga sauran mutane ta hanyar mai haƙuri idan mai haƙuri ya shiga asibiti, ko kuma ya kawar da buƙatar yin maganin rigakafi idan an yi amfani da motar asibiti. A gwajin motsa jiki na COVID-19 a cikin gwajin da ake zargi da shi, ƙwararren likita na kiwon lafiya ya ɗauki samfurori ta amfani da matakan da suka dace".
Cibiyoyin motsa jiki sun taimaka wa Koriya ta Kudu ta yi gwaje-gwaje mafi sauri, mafi girma a kowace ƙasa. A Jamus, Ƙungiyar Likitocin Kiwon Lafiya ta Kasa ta ce a ranar 2 ga Maris cewa suna da damar yin gwaje-gwaje kusan 12,000 a kowace rana a cikin yanayin da ke gudana, kuma an gwada mutane 10,700 a makon da ya gabata.
Idan likita ya umurce ku da ku yi gwajin, asusun kiwon lafiya zai biya kuɗin.
A cewar shugaban cibiyar Robert Koch, Jamus na da damar gudanar da gwaje-gwaje 160,000 a mako.
A ranar 19 ga watan Maris, an gudanar da gwajin tuki a manyan birane da dama.
A ranar 26 ga Maris, 2020, adadin gwaje-gwajen da aka yi a Jamus ba a san su ba, saboda an ba da rahoton kawai abubuwan da suka dace.
"Binciken farko na dakin gwaje-gwaje ya nuna cewa an gwada aƙalla samfura 483,295 a cikin makon kalandar 12/2020 har zuwa 12/2020 da kuma har zuwa, kuma an gano cewa gwaje-gwaje 33,491 (6.9%) sun kasance masu kyau ga SARS-CoV-2". Masu bincike a Technion da Rambam Hospital a Isra'ila sun haɓaka da kuma gwada wata hanya ta tattara samfurori don gwada samfurori daga marasa lafiya 64 tare, kuma an ƙara gwadawa idan an sami samfurin da aka haɗa a matsayin mai kyau. A ranar 5 ga Fabrairu, 2020, BGI ya gano ""Huo-Yan"" (Cina: 火眼, ko "mai ido" a Bengali) a cikin wani gaggawa na gaggawa na gaggawa na 2000 m2 na samfurin, wanda zai iya aiwatar da fiye da 10,000 a rana.
Wanda ya kafa BGI, Wang Jian, ya duba aikin, kuma ya yi amfani da shi wajen yin aikin a cikin kwanaki biyar, wanda ya nuna cewa idan ba a ƙara ƙarfin gwajin a kan lokaci ba, a cikin Huawei, adadin abubuwan da suka faru zai ninka da kashi 47% kuma ƙarin kuɗin da ake kashewa don magance keɓewa zai ninka.
A cikin birane 12 a kasar Sin kamar birnin Shenzhen, Tianjin, Beijing da Shanghai, dakin gwaje-gwaje na Huo-Yan sun biyo bayan Wuhan Laboratory.
A ranar 4 ga Maris, 2020, ana iya gwadawa a cikin 50,000 a kowace rana. An bayyana tushen budewa, masu yawa (multiplexed) kayayyaki da aka buga ta Origami Assays wanda zai iya gwada samfurori na marasa lafiya 1122 don COVID19 ta amfani da gwaji 93 kawai. Wadannan ƙirar masu daidaitawa za a iya gudanar da su a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar sarrafa kayan aikin robotic ba.
Rashin isasshen reagent da rashin isasshen su a cikin watan Maris sun zama ƙuntatawa ga gwaji a cikin taro a cikin Tarayyar Turai da Burtaniya da Amurka.
Wannan ya sa wasu masu bincike suka binciki tsarin shirye-shiryen samfurori inda aka dumama samfurori na minti 5 a 98 °C (208 °F) don sakin kwayoyin halitta na RNA don gwaji na gaba. A ranar 31 ga Maris, an sanar da cewa UAE yanzu tana gwada mutane da yawa don cutar coronavirus fiye da sauran ƙasashe kuma tana kan hanyar ƙara yawan gwajin don isa ga yawancin jama'a.
"Wannan ya faru ne ta hanyar sayen kayan aiki na gida da kuma yawan yawan yawan jama'a daga Group 42 da BGI (bisa ga dakin gwaje-gwaje na gano gaggawa na "Huo-Yan" a China)".
Wannan dakin gwaje-gwaje da aka gina a cikin kwanaki 14 yana iya yin gwajin RT-PCR sau 10,000 a kowace rana kuma shi ne dakin gwaje-gwaje na farko a duniya da ke aiki a wajen China.
An kirkiro tsarin gwaji daban-daban don magance sassa daban-daban na bayanan kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya ta amince da tsarin Jamus na samar da kayan aiki ga ƙasashen da ba su da albarkatun samar da su.
An bayyana tsarin na Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka shirya ba ta kasance ba har zuwa 28 ga Janairu, wanda ya jinkirta gwajin da ke cikin Amurka. A farkon barkewar cutar, matsaloli sun taso tsakanin China da Amurka game da dogaro da kayan gwajin, kuma waɗannan ƙasashe da Ostiraliya sun kasa samar da isasshen kayan aiki don biyan buƙatun da kuma shawarwarin da masana kiwon lafiya ke bayarwa don gwadawa.
Akasin haka, masana sun ce gwajin da aka yi a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar.
A cikin shekaru da yawa, gwamnatin Koriya ta Kudu ta gina ikon yin gwaji a cikin dakunan gwaje-gwaje na musamman.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira ga karuwa a cikin shirin gwaji a matsayin hanya mafi kyau don rage ci gaban cutar COVID-19. Ƙarin buƙatar gwaji saboda yaduwar kamuwa da cutar ya haifar da ayyukan gwaji na miliyoyin miliyoyin a cikin dakunan gwaje-gwaje na Amurka masu zaman kansu, da kuma matsin lamba akan samar da sinadarai da sinadarai masu lalata sinadarai.
A watan Maris na shekarar 2020, kasar Sin ta yi rahoton cewa tana fama da matsalar daidaito a cikin kayan gwajin ta.
"Kit ɗin gwajin da CDC ta shirya a Amurka sun kasance da ""rashin kuskure""; sai gwamnati ta kawar da matsalolin da suka hana gwajin sirri. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma ta ga cewa sakamakon ba daidai ba ne".
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya haifar da rashin samun samfurori ko rashin amfani da kayan aikin yadda ya kamata.
Ma'aikatar ta Spain ta ce za ta janye kayan gwajin da aka yi musu kuskure, kuma ta maye gurbin su da wani kayan gwajin da Shenzhen Bioeasy ta bayar.
"Prime Minister Matovič ya ba da shawarar jefa su cikin kogin Danube. Ates Kara, Ministan Lafiya na Turkiyya, ya ce kayan gwajin da Turkiyya ta saya daga China suna da "babban lahani" kuma ba su "yi amfani da su ba".
An gano sakamako mai kyau sakamakon tantancewa da kuma killace waɗanda suka sami sakamako mai kyau, da kuma gano waɗanda suka yi hulɗa da mutanen da suka kamu da cutar SARS-CoV-2.
Masu binciken da ke aiki a garin Vo, Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje na kwanaki biyu a kan jimlar mutane 3,400 a kusan kwanaki goma.
Kusan rabin mutanen da suka samu sakamako mai kyau ba su da wata alama kuma an killace duk waɗanda aka gano.
A sakamakon haka, an kawar da sabon kamuwa da cuta.
Ta hanyar gano mutane da suka zo a cikin haɗari, ta hanyar sarrafawa ta hanyar tafiya, gwaji da keɓewa, amma ba tare da wani matsanancin iko ba kamar tilasta rufe gidajen abinci da shagunan sayar da kayayyaki, annobar coronavirus ta duniya ta 2020 a Singapore ta ci gaba da tafiya a hankali fiye da sauran ƙasashe masu tasowa.
An soke wasu bukukuwa, kuma Singapore ta fara ba da shawara ga mazauna gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutu a ranar 23 ga Maris.
Wasu kasashe da dama sun yi amfani da hanyoyin da za su iya hana cutar ta yaduwa ta hanyar gano mutane da suka yi hulɗa da su, ta hanyar sarrafa tafiye-tafiye, gwaji da keɓewa, amma tare da dokar hana fita mai tsanani, kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya nuna cewa kasashen da suka yi gwaji da yawa sun fi yawan wadanda suka mutu, saboda wataƙila sun iya gano marasa lafiya masu sauƙi ko marasa alamun cutar.
WHO ta ba da shawarar cewa kasashen da ba su da damar yin gwaji kuma labaran ƙasa suna da ƙarancin gogewa game da COVID-19 su aika da farkon biyar masu kyau da farkon goma masu cutarwa zuwa ɗayan dakunan gwaje-gwaje na WHO 16 don tabbatar da samfurin COVID-19.
Daga cikin dakunan gwaje-gwaje 16 da aka yi amfani da su, akwai 7 a Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka, da 1 a Ostiraliya.
"A cikin jadawalin da ke ƙasa, shafi na ""Mene ne yawan gwajin da aka yi na tabbatacce"" ya shafi manufofin gwajin na wannan ƙasar".
Kasashen da ake gwada asibiti ne kawai za su sami kashi fiye da na mutanen da ke cikin asibiti, idan duk abin da ya kasance daidai, ko da kuwa akwai alamun cutar ko a'a, duk 'yan kasar suna da gwajin.
Wanke hannu (ko wanke hannu), wanda aka fi sani da tsabtace hannu, yana nufin aikin wanke hannu don kawar da ƙasa, grease, kwayoyin halitta, ko wasu abubuwa marasa kyau.
"Tsabtace hannu a kai a kai a "lokaci mai muhimmanci" a rana yana hana yaduwar cututtuka da yawa, kamar cututtukan da ke tattare da cutar ta tsokoki da kuma cutar ƙwanƙwasa".
Mutane kuma suna iya kamuwa da cututtukan numfashi kamar mura ko sanyi na yau da kullum, misali, idan ba su wanke hannuwansu kafin su taɓa idanu, hanci ko fuska ba (watau, ƙwayar cuta).
Abubuwa biyar da suka fi muhimmanci a rana da ake bukatar a yi wa hannuwanmu wanka da sabulu su ne: kafin da bayan wanke shara, bayan an wanke ko kuma an canja tufafin jariri, kafin a ciyar da jariri, kafin a ci abinci, da kuma bayan an dafa abinci ko kuma a yi wa naman alade, kifi, ko kaza hannu.
Idan babu ruwa da sabulu, za a iya wanke hannayenka da tawada.
Kafin da kuma bayan da ake dafa abinci.
Kafin ka kula da wani marar lafiya da kuma bayan ka kula da shi.
Bayan an canja yadudduka ko kuma an tsabtace gidan wanka da yaron ya yi amfani da shi.
Idan ka yi ciwon hanci ko kuma ka yi tari ko kuma ka yi tari.
Bayan ka taɓa dabba, abincin dabba, ko kuma sharar dabba.
Hanyar da ake amfani da ita wajen kula da hannu tana nufin yin amfani da hanyoyin da ake amfani da su wajen kula da hannu.
Yin wanka kafin a ba da magani ko kuma a kula da shi zai iya hana ko rage yaduwar cutar.
Babban manufar maganin wanke hannu shine kiyaye hannu daga ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cutar) da kuma sunadarai masu cutarwa ko cutarwa.
Wannan yana da mahimmanci ga mutanen da ke kula da abinci ko kuma aiki a fannin likita, amma yana da mahimmanci ga talakawa.
Yin wanka hannu yana da fa'idodi masu yawa ga lafiyar jiki, gami da rage kamuwa da cutar mura, coronavirus da sauran cututtukan cuta; hana cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttingtingtingtingtingtingtingting.
Kuma rage yawan mutuwar jarirai a lokacin haihuwa a gida.
Wani bincike a shekarar 2013 ya nuna cewa ingantaccen aikin wanke hannu na iya haifar da karuwar tsayi ga yara 'yan kasa da shekara biyar zuwa ga karamin ci gaba.
A kasashe masu tasowa, sauye-sauye masu sauki kamar wanke hannu da sabulu na iya rage yawan mutuwar yara daga cututtukan numfashi da na cutar sankarar cuta.
Wannan tsari mai sauki zai iya rage yawan mutuwar daga cutar da kusan kashi 50%.
Ana iya rage yawan yawan shan taba da ake yi a cikin gidajen da ke da ƙananan gidaje da kashi ɗaya bisa uku, kuma ana iya kwatanta wannan da samar da ruwa mai tsabta a yankunan da ba su da isasshen kuɗi.
Yin wanka da hannu da sabulu yana da alaƙa da rage yawan cututtukan cutar sankarar cuta da kashi 48%. Hanya ɗaya da ta fi dacewa da kuma araha wajen hana cutar sankarar cuta da kuma cututtukan numfashi (ARI) shine yin wanka da hannu da sabulu a gidaje, makarantu da al'ummomi a duk faɗin duniya a matsayin aikin sarrafa kansa.
Nyon, wanda shine babban ARI, shine babban dalilin mutuwar yara a ƙarƙashin shekaru biyar. Yana kashe kimanin yara miliyan 1.8 a kowace shekara.
A shekara, kusan yara miliyan 3.5 ne ke mutuwa sakamakon cutar sankara da cutar huhu.
A cewar UNICEF, sauya yawan wanke hannu da sabulu kafin cin abinci da bayan bayan amfani da gidan wanka zai iya ceton rayuka fiye da allurar rigakafi ko maganin magani, rage mutuwar da ke tattare da cutar sankarar cuta da kuma rage mutuwar da ke tattare da kamuwa da cuta ta hanyar numfashi da kashi ɗaya cikin huɗu.
Ana haɗa wanke hannu da sauran tsarin tsabtace jiki a matsayin ɓangare na shirye-shiryen ruwa, tsaftacewa da tsaftacewa (WASH).
Yin wanka da hannu yana kare mutum daga cutar fata (impetigo) da ke kamuwa da cutar ta hanyar kai tsaye.
Wani sakamako mai illa na wanke hannu shine wanke hannu sau da yawa wanda zai iya haifar da lalacewar fata daga bushewar fata.
Wani bincike na Danish a shekara ta 2012 ya nuna cewa yawan wanke hannu zai iya haifar da ciwon gashi, da kuma yanayin da ake kira eczema na hannu, wanda ya zama sananne musamman a cikin ma'aikatan kiwon lafiya.
Yin wanka sau da yawa yana nuna rashin tausayi da kuma rashin tausayi.
Abubuwa biyar da suka fi muhimmanci a rana da ake bukatar a yi wa hannuwanka wanka da sabulu don rage kamuwa da cutar ta tsokoki sune: bayan yin amfani da wanka (fitar da fata, wanka), bayan wanke ko canja tufafi, kafin a ciyar da jariri, kafin cin abinci, da kuma kafin/bayan yin abinci ko kuma bayan ka taɓa hannunka a kan naman kaza, kifi, ko kuma kaji.
Sauran lokutan da ya kamata a yi amfani da dabarun wanke hannu don hana kamuwa da cutar sun haɗa da kafin da bayan an yi wa cututtuka ko raunuka magani; bayan yin tari, tari, ko wanke hanci; bayan taɓa shara ko motsa dabba; da kuma bayan taɓa shara.
A ƙasashe da yawa, yawan wanke hannu da sabulu ba shi da yawa.
Wani bincike a shekarar 2015 ya nuna cewa a cikin kasashe 54 a duniya, yawanci 38.7% na iyalai suna wanke hannu da sabulu. Wani bincike a shekarar 2014 ya nuna cewa kashi 97 cikin dari na Saudiyya ne ya fi girma; kusan kashi 77 cikin dari na Amurka ne ya fi girma; kuma kashi 23 cikin dari na kasar Sin ne ya fi ƙasa da yawa. Akwai tsarin sauya-sauya da yawa a yanzu don inganta yawan wanke hannu da sabulu a lokutan rikici.
"Shirye-shiryen Kula da Lafiya na Muhimmanci da Ma'aikatar Ilimi ta Philippines ta aiwatar da shi misali ne na daukar matakan da suka dace don inganta lafiyar yara da kuma ilimi".
Manufofin wannan shirin sune yin wanka sau biyu a shekara, tare da wanke hannu da sabulu a kowace rana, da kuma wanke hakora a kowace rana da fluoride.
An yi nasarar aiwatar da shi a Indonesia.
Ƙara safa ko kuma mai tsabtace ruwa yana taimaka wajen kawar da kwayoyin halitta daga fata.
Babban aikin sabulu da kuma kayan wankewa shine rage hanawar narkewa da kuma kara narkewa.
Ruwan kawai ba shi da tasiri a tsabtace fata (farfado da fata) saboda kitse da furotin, wanda shine kayan ƙasa na halitta, ba su narke cikin ruwa.
Ana yin tsabtace ta ta hanyar ruwa mai kyau.
Sabulu mai tsabta, saboda yanayin sake amfani da shi, zai iya riƙe ƙwayoyin cuta daga amfani da shi a baya.
Kadan daga cikin nazarin da suka yi game da canja wurin kwayoyin daga sabulu mai ƙazanta ya nuna cewa ba za a iya canja wurin ba saboda ana wanke kwayoyin da toka.
"CCDC ta ci gaba da cewa ""ana bada shawarar yin amfani da sabulu mai ruwa wanda ba a iya sarrafa shi ba tare da amfani da hannu ba""".
An yi ta ba da shawarar sosai ga jama'a game da sabulu na antibacterial.
Har zuwa yau, babu wata hujja da ta nuna cewa ana amfani da maganin hana kamuwa da cutar ko kuma maganin kashe kwayoyin halitta don kwayoyin halitta masu tsayayya da kwayoyin halitta.
Amma sabulu na antibacterial yana dauke da kayan aikin antibacterial na yau da kullun kamar trichlosan, wanda ke da karfin juriya ga kwayoyin.
Saboda haka, ko da yake ba a zaɓa wa kwayoyin rigakafi na maganin rigakafi don sabulu na antibacterial ba, ba za su iya zama masu tasiri kamar yadda ake tallata su ba.
Bugu da ƙari, abubuwan da ke cikin fata da kayan kariya na fata, a cikin kayan aiki na zamani ana iya samun acid (acetic acid, ascorbic acid, lactic acid), antimicrobially active benzoic acid, da ƙarin kayan haɗi na fata (alovera, bitamin, methyl, tsire-tsire na shuka). Wani cikakken bincike daga Jami'ar Oregon School of Public Health ya nuna cewa triclonaine yana da amfani sosai ga masu amfani da sabulu na antibacterial kamar su sabulu na yau da kullun don hana cututtuka da kuma cire ƙwayoyin cuta daga hannu.
Ruwan da ke da zafi sosai don wanke hannuwanmu ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin suna girma da sauri a zafin jiki (37 °C).
Amma, ruwan sabulu mai zafi ya fi ruwan sabulu mai sanyi tasiri wajen kawar da man fetur da ke riƙe da ƙasa da ƙwayoyin cuta.
Amma, a kan abin da ake tsammani a cikin Lai'atu, binciken kimiyya ya nuna cewa amfani da ruwan zafi ba ya da tasiri a kan rage nauyin kwayoyin halitta a hannayenmu.
Wani kayan tsabtace hannu wanda ba ruwa bane ko maganin hana hana shan magani wanda ba ruwa bane.
A ƙarshen 1990s da kuma farkon karni na 21, kayan tsabtace hannu (wanda aka fi sani da rub na barasa, rub na antiseptic, ko kuma tsabtace hannu) na ruwa-ba-ruwa rub ya fara samun karbuwa.
Ana yin isopropyls da yawa daga barasa ko ethanol, wanda aka shirya tare da gel carbomer (polymer na acrylic acid) ko humidifiers kamar su glycerin a cikin ruwa ko foam, don rage sauƙin amfani da tasirin bushewa na barasa.
Ƙara haɗuwa da hydrogen peroxide yana ƙara haɓaka aikin antimicrobial. A hannu sanitizer yana ƙunshe da aƙalla 60 zuwa 95% barasa wanda ke da ikon kashe ƙwayoyin cuta.
Alcohol rub sanitizers kashe kwayoyin cuta, kwayoyin cuta masu yawa (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, influenza, da hepatitis) da kuma fungi.
Abincin roba mai tsabta yana dauke da kashi 70% na giya wanda zai kashe kashi 99.97% (3.5 log reduction, daidai da 35 decibel reduction) bayan 30 seconds na amfani da hannayensu, kuma kashi 99.99% zuwa 99.999% (4 zuwa 5 log reduction) na kwayoyin cuta bayan minti 1 na amfani da hannayensu.
Mafi yawan kayan aikin hana shan giya na hannayen hannu suna da tasiri sosai a kan ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
Ana shafawa a gaban da baya da tsakiyar yatsunsu da kuma ƙarshen su na kusan dakika 30 har sai ruwa, kumfa ko gel sun bushe.
Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amurka ta ba da shawarar yin amfani da rub na tsabtace hannu don wanke hannayenku sosai, musamman idan kun sami gurɓataccen hannu.
Yawan amfani da waɗannan abubuwan ya dogara da sauƙin amfani da su da kuma saurin lalata kwayoyin halitta; kodayake kada a yi amfani da su a matsayin maye gurbin wanke hannu mai kyau idan sabulu da ruwa ba su da wadata.
Idan ba a haɗa emollient da / ko moisturizer na fata a cikin tsari ba, yawan amfani da kayan aikin hannu na tushen barasa na iya haifar da fata mai bushewa.
Ana iya rage ko kawar da tasirin bushewar giya ta hanyar ƙara glycerin da / ko wasu lotions a cikin formula.
A cikin gwaji na asibiti, kayan aikin tsabtace hannu na barasa da ke dauke da kayan taushi sun haifar da rashin damuwa da bushewa a fata fiye da sabulu ko kuma disinfectant.
Rashin jin daɗin fata da ke da alaƙa da rashin lafiyan, rashin lafiyar da ke da alaƙa da rashin lafiyan, ko kuma rashin jin daɗin abubuwa masu ƙanshi da ke cikin giya ko giya ba sa faruwa a cikin ruwan tabarau na giya.
Ya bambanta da wanke hannu da sabulu da ruwa, ƙananan yanayin fara cututtukan cututtukan cututtukan da ke tattare da taɓawa ya zama abin sha'awa.
Duk da yadda suke aiki, kayan da ba su da ruwa ba ba suna tsabtace hannayen mutum ba, suna kashe hannayensu kawai.
Saboda haka, sabulu da ruwa ba su da tasiri sosai wajen hana kamuwa da cutar.
Ingancin kayan aikin hana shan giya ya dogara da kayan aiki da kuma kayan aiki, kuma a lokuta da suka gabata, giya da giya sun yi aiki da yawa fiye da roba.
Kwanan nan, an lura da benzalkonium chloride yana da ingantaccen aiki na antimicrobial ba kamar barasa ba, wanda ya kasance yana da tasiri bayan amfani da shi sau da yawa saboda yiwuwar mummunan halayen fata.
A cikin al'ummomin da ba su da kuɗi, mutane da yawa ba sa biyan kuɗin sabulu kuma suna amfani da ƙasa ko ƙasa.
Ƙasa ko ƙasa za su iya zama da amfani fiye da ruwa kawai, amma ba su da amfani fiye da sabulu.
Wani abin damuwa shi ne, idan ƙasa ko ƙasa ta lalace ta hanyar ƙwayoyin cuta, zai iya ƙara yaduwar cutar maimakon rage ta.
Kamar sabulu, sha'ir yana da ƙwayoyin cuta saboda yana haifar da maganin narkewa a cikin ruwa.
WHO ta ba da shawarar yin amfani da sanding a matsayin madadin sabulu idan babu sabulu.
Hanyoyin wanke hannu masu kyau da Cibiyoyin Kula da Cututtuka na Amurka ke ba da shawarar don hana kamuwa da cututtuka sun haɗa da:
Ka wanke hannunka a cikin ruwan da ke gudana, ko mai zafi ko mai sanyi.
Ana ba da shawarar ruwa saboda zafin ruwa na iya gurɓataccen ruwa, amma yanayin zafin ruwa ba ya haifar da wani bambanci.
Ka shafa sabulu sosai a baya da yatsanka da kuma ƙarƙashin kusoshi.
Sabulu yana cire kwayoyin cutar daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan sun yi amfani da sabulu maimakon ruwa.
Ka shafe shi na akalla dakika 20.
A lokacin shafawa, ana yin taɓawa wanda ke kawar da ƙwayoyin cuta daga fata kuma yana kawar da ƙarin ƙwayoyin cuta idan an shafe shi na dogon lokaci.
Ka wanke kanka da kyau a cikin ruwa.
Ruwa a cikin tafkin zai iya sake gurɓata hannayensu.
Ka wanke shi da tawul mai tsabta ko kuma ka bar shi ya bushe a cikin iska.
Hannun da ke da ruwa da kuma rigar hannu suna da sauƙin sake gurɓatawa. Wuraren da aka fi watsi da su sune yatsunsu, wuyan hannu, tsakanin yatsunsu, da kuma ƙusa.
Fuskokin ƙusa da ƙusa masu ƙusa za su iya ba da mafaka ga ƙwayoyin cuta.
Ana ba da shawarar amfani da maganin shafawa don hana bushewar hannu; bushewar fata na iya cutar da fata wanda zai iya ƙara haɗarin yaduwar kamuwa da cuta.
"A cikin ƙasashe masu tasowa inda babu ruwa daga famfo da / ko sabulu, za a iya yin zaɓuɓɓukan ƙananan kuɗi don amfani da wanke hannu, misali, zuba ruwa daga sarƙoƙi masu rataye ko kuma amfani da ruwa daga lawns masu kyau da / ko shawo idan ya cancanta. A cikin yanayin da aka iyakance samar da ruwa (kamar a makarantu ko yankunan karkara na ƙasashen da ke tasowa), akwai hanyoyin adana ruwa da sauran zaɓuɓɓukan ƙananan kuɗi kamar ""TP-TAP""".
Tippy-tap fasaha ce mai sauki inda ake amfani da wani abu mai laushi wanda aka rataye ta igiya da kuma hanci don zuba ruwa kadan a hannunka tare da hanci da kuma sabulu guda.
Yin bushewar hannu yana da muhimmanci a cikin tsarin tsabtace hannu, amma akwai wasu muhawara game da mafi ingancin bushewa a cikin wanka.
Ƙara yawan bincike ya nuna cewa, tawul ɗin takarda ya fi tsabta fiye da na'urorin wanka masu yawa da ake amfani da su a cikin wanka.
Wani bincike da aka gudanar ta Jami'ar Westminster, London, da kuma Paper Towel Industry European Tissue Symposium a shekara ta 2008 don kwatanta matakan tsabtace jiki da aka bayar ta hanyar takarda, mai sanyaya iska mai sanyaya iska, da kuma mafi zamani jet-air hand dryer.
Bayan wanke hannu da kuma bushewa da na'urar busar da iska mai zafi, adadin kwayoyin ya karu da kashi 194% a yatsunsu da kuma 254% a hannayensu.
Drying tare da jet-air dryer yana haifar da ƙaruwa mai yawa na kwayoyin cuta a yatsunsu da kashi 42% da kuma 15% a cikin hannayen hannu.
Bayan wanke hannu da wanke hannu da tawul, an rage adadin kwayoyin a yatsunsu da kuma yatsunsu da kashi 77% a matsakaita. Masana kimiyya sun kuma gudanar da gwaje-gwaje don tabbatar da ko akwai yiwuwar gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓata.
Jirgin sama mai bushewa, wanda ke fitar da iska a cikin saurin kiyayewa na 180m/s (650 km/h; 400 mph), ya iya fitar da ƙwayoyin cuta daga hannayensu da na'urorin kuma ya kawar da yiwuwar gurɓatawar masu amfani da wanka da kuma yanayin wanka har zuwa mita 2.
Yin amfani da na'urar bushewa ta hannu mai iska mai zafi yana iya yaduwar kwayoyin halitta zuwa mita 0.25 daga na'urar bushewa.
A shekara ta 2005, wani bincike da aka gudanar da TÜV Produkt und Umwelt ya kimanta yadda ake bushe hannaye daban-daban.
Bayan an bushe hannu, an lura da canje-canje a cikin adadin kwayoyin:
Akwai masana'antun bushewa na hannu da yawa daban-daban kuma an kwatanta bushewa da takarda tare da tawul.
Amfani da wanke hannu a lokacin tafiya yana da kyau saboda rashin sabulu da ruwa.
Aikin tsabtace hannayen hannu mai gina barasa yana dauke da akalla kashi 60 cikin dari na giya.
Yin amfani da wanke hannu a cikin asibiti na asibiti ya zama dole bayan da likitan Hungary Ignaz Semmelweis (1846), ya gano tasirin wanke hannu a cikin yanayin asibiti.
Akwai wasu na'urorin lantarki da ma'aikatan asibiti ke ba da feedback don tunatar da su cewa sun manta su wanke hannayensu.
Wani bincike ya nuna cewa yin amfani da su ya rage yawan kamuwa da cuta.
Aikin wanke hannu na likita yana daukan aƙalla 15 seconds kuma yana amfani da isasshen sabulu da ruwa ko gel don shafa kowane ɓangaren hannu.
Dole ne a haɗa yatsunsu tare kuma a shafa hannayensu tare.
Ana iya amfani da goga na bristles don kawar da datti a ƙarƙashin ƙusa.
Tun da yake ƙwayoyin cuta suna iya kasancewa a cikin ruwan hannu, yana da muhimmanci a wanke kumfa sosai kuma a bushe ta da tawul mai tsabta.
Bayan an bushe, ya kamata a yi amfani da tawul ɗin takarda don rufe bututun ruwa (kuma a buɗe wani ƙofar don fita idan ya cancanta).
Wannan zai hana sake gurɓata hannu daga waɗannan farfajiyar.
"A cikin yanayin kiwon lafiya, wanke hannu yana nufin kawar da kwayoyin cuta masu cutarwa da kuma hana su kamuwa da cutar".
Jaridar New England Journal of Medicine ta ruwaito cewa a yawancin yanayin kiwon lafiya, rashin wanke hannu ya kasance ba a yarda da shi ba, da yawa daga cikin likitoci da ma'aikatan aikin jinya suna manta da wanke hannu a kai a kai kafin su taɓa marasa lafiya, don haka ana samun kamuwa da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da wasu hanyoyi masu sauki na iya rage yawan kamuwa da cutar jini ta hanyar catheter da kashi 66 cikin dari. Hukumar lafiya ta duniya ta fitar da takardun da ke nuna wanke hannu da kuma shafa hannu a cikin sashen kula da lafiya.
Za a iya samun jagorar da aka tsara ta ƙungiyar don samun ra'ayoyin jama'a a shafin yanar gizon ta.
Wani bita mai dacewa da Whitby da sauransu suka gudanar.
Kayan aiki na kasuwanci na iya auna da tabbatar da tsabtace hannu idan ana buƙatar tabbatar da bin ƙa'idodin ƙa'idodin ƙa'ida.
Hukumar lafiya ta duniya ta ce akwai "lokaci biyar" na wanke hannu:
Bayan an yi magana da jini / jiki
Kafin a yi aikin kawar da kwayoyin cutar, kuma
"Bayan kula da marasa lafiya. Anadarin sinadarai masu hana kamuwa da cutar a cikin sabulu (" " maganin " ko " sabulu na antimicrobial ") yana ba da ikon lalata kayan wanke hannu".
Ana iya yin wannan aikin kafin tiyata ko a wuraren da akwai cutar da ke hana maganin rigakafi. Don yin tiyata, yana da muhimmanci a yi amfani da na'urar 'sarrafa' hannayenku wanda za a iya kunnawa da rufewa ba tare da taɓa shi ba, da wasu hanyoyin wankewa da chlorhexidin ko iodine, da kuma amfani da tawul don wanke hannu bayan wankewa da kuma wankewa da kuma wasu kayan tsabtace ƙusa.
Dole ne a buɗe dukan kayan ado.
Wannan hanya tana buƙatar wanke hannu da gwiwoyi na mintina 2 zuwa 6.
Ba lallai ba ne a yi masa hannuwansa na dogon lokaci (minti 10).
A lokacin wanka, dole ne a hana ruwa daga hannun zuwa gwiwoyi ya sake shiga cikin hannu.
Bayan an gama wanke hannu, ana wanke hannu da tufafin da ba a kashe rigakafi ba kuma ana sa rigar tiyata.
Don rage yaduwar kwayoyin cutar, yana da kyau a wanke hannu kafin kuma bayan kula da mai rashin lafiya ko kuma a yi amfani da maganin hana kamuwa da cutar hannu.
Don sarrafa kamuwa da cutar Staphylococcus aure a asibiti, an gano cewa mafi yawan amfanin wanke hannu ya kasance daga farkon 20% na wanke hannu, kuma an sami ƙananan ƙarin amfanin lokacin da aka ƙara maimaita tsabtace hannu zuwa 35% na gaba.
Yin wanka da sabulu na yau da kullum ya sa mutum ya kamu da cututtukan cuta sau uku a cikin abinci fiye da wanka da sabulu na yau da kullum. Idan aka kwatanta wanka da hannu da sabulu na zamani da wanka da giya, a cikin matsakaiciyar tsawon dakika 30, kowannensu ya nuna cewa wanke hannu da giya ya rage gurɓataccen kwayoyin cuta da kashi 26 cikin dari fiye da wankewar maganin antibacterial.
Amma sabulu da ruwa / ruwa sun fi tasiri wajen rage cutar H1N1 ta hannun hannu da kuma ƙwayar cuta ta clutteridium a hannun hannu fiye da sabulu da ruwa na tushen hannu.
Akwai bukatar ci gaba da bincike kan wane irin ingantaccen aiki ne ya fi tasiri a cikin yanayin kiwon lafiya daban-daban.
A cikin kasashe masu tasowa, wanke hannu da sabulu an gane shi a matsayin hanya mai tsada, mai mahimmanci don samun lafiya, har ma da abinci mai gina jiki.
Amma, rashin wadatar wadatar ruwa mai inganci a gidaje, makarantu da wuraren aiki, sabulu ko kuma wanke hannu yana haifar da ƙalubale ga samun al'adar wanke hannu a duniya.
Alal misali, a yawancin yankunan karkara na Afirka, akwai zaɓuɓɓukan da ba su da tsada don yin wanka a hannu, amma akwai ƙananan wanka a kusa da kowane gidan wanka na sirri ko na jama'a.
Amma, rashin yawan wanke hannu zai iya zama sakamakon yin amfani da ruwa mai zurfi maimakon rashin sabulu ko ruwa.
Tallafawa da kuma ba da shawara game da wanke hannu da sabulu na iya tasiri kan yanke shawara, ya kara wayar da kan jama'a game da amfanin wanke hannu, kuma ya haifar da sauyin halaye na dogon lokaci.
Don yin aiki yadda ya kamata, dole ne a lura da kuma kimanta shi.
"Binciken da aka yi na bincike 70 ya nuna cewa hanyoyin da aka kafa a cikin al'umma a LMIC suna da tasiri wajen wanke hannu, yayin da kamfen ɗin talla na zamantakewa ba su da tasiri. Misali na tallata wanke hannu a makarantu shine "hanyar tauraro uku" ta UNICEF wanda ke ƙarfafa makarantu su ɗauki matakan da suka dace, masu araha don tabbatar da cewa ɗalibai suna wanke hannu da sabulu a cikin sauran bukatun lafiya".
Idan aka samu mafi ƙarancin ƙimar, makarantu za su iya samun taurari uku daga ɗaya zuwa ƙarshe.
Kafa tashoshin wanke hannu na iya zama wani ɓangare na tallafi ga kamfen ɗin wanke hannu don rage cututtukan cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya misali ne na wani yunkuri na wayar da kan jama'a wanda ke kokarin kawo sauyi a dabi'u. A sakamakon annobar coronavirus ta 2019-20, UNICEF ta inganta amincewa da yin wanke hannu.
DALYs sun yi la'akari da wasu karatu game da rage yawan kudin wanke hannu a kasashe masu tasowa kan rigakafi.
Amma, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin ruwa da ruwa da kuma tsabtace jiki rahusa.
"Ahimcin wanke hannu ga lafiyar mutum  musamman ga mutanen da ke cikin yanayi mara kyau, kamar uwayen da suka haifi jarirai a asibiti ko kuma sojojin da suka ji rauni - biyu daga cikin masu tsaron gida na tsabtace hannu sun gane shi a farkon tsakiyar karni na 19: Ignaz Semmelweis, likitan Hungary wanda ya yi aiki a Vienna, Austria, da Florence Nightingale, "mahimmanciyar aikin jinya na zamani".
Har zuwa wannan lokacin, mutane da yawa sun yi imanin cewa cutar ta samo asali ne daga ƙanshin ƙanshi mai suna Miyasmas.
A cikin shekarun 1980, barkewar cututtukan abinci da cututtukan kiwon lafiya sun jagoranci Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka don inganta tsabtace hannu a matsayin babbar hanyar hana yaduwar cututtuka.
Cutar da aka samu ta cutar Swine Flu a shekarar 2009 da kuma annobar COVID-19 a shekarar 2020, sun kara wayar da kan mutane game da muhimmancin wanke hannu da sabulu don kare kansu daga irin wannan cuta mai yaduwa a kasashen da dama.
"A Jamus, alal misali, an saka wasu hotuna da ke dauke da "daidaitaccen dabarun wanke hannu" a bayan gidajen wanka na jama'a da kuma wajen wanke hannu a gine-ginen ofis da kuma wuraren wanke hannu a filin jirgin sama".
"Wannan furucin "karɓar hannun mutum" yana nufin nuna rashin son kai ga alhakin ko kuma kasancewa cikin laifi".
An samo asali ne daga littafin Matta inda Pontius Pilate ya yi watsi da shawarar da ya yanke na gicciye Yesu Kristi, amma ta zama alama ce ta harshe ta hanyar amfani da shi sosai a cikin wasu al'ummomin Turanci.
A cikin Macbeth na Shakespeare, Lady Macbeth ta fara wanke hannayenta a ƙoƙarin tsabtace takalma na tunani ta hanyar bayyana jin ta da laifi game da laifin da ta aikata kuma ta sa mijinta ya aikata laifi.
An kuma gano cewa mutane, idan suka yi tunanin yin wani abu marar kyau, suna da mafi yawan yin wanka fiye da wasu, kuma suna da mafi yawan darajar kayan wanka.
"Bugu da kari, wadanda aka ba da damar wanke hannu bayan wannan niyyar ba su da damar yin wasu ayyukan "tsabtace" kamar aikin sa kai".
Addinai suna ba da umarni game da wanke hannu don dalilai masu kyau da na alama. Yin wanke hannu na alama, yin amfani da ruwa / ruwa don wanke hannu amma ba amfani da sabulu ba, yana da alama a cikin addinai da yawa, wanda ya haɗa da Bahayism, Hinduism, Tewilah da Nethillat Ya'adiim a cikin Yahudanci, Lawabbo a cikin Kiristanci, da Ozu a cikin Musulunci. Addinai suna ba da umarni game da wanke hannu mai kyau musamman bayan yin wasu ayyuka.
A Hindu, Yahudawa da Musulunci, wanke hannu bayan yin amfani da gidan wanka wajibi ne.
Kuma, a cikin addinin Hindu, addinin Buddha, addinin Sikh, addinin Yahudanci da addinin Musulunci, wanke hannu kafin da kuma bayan cin abinci wajibi ne.
Gudanar da hadarin aiki don COVID-19
Gudanar da haɗarin aiki don COVID-19 shine aiwatar da matakan aminci da lafiya na aiki don hana cutar coronavirus 2019 (COVID-19) don sarrafa haɗarin.
Yin amfani da matakan tsaro na aiki na musamman a wurin aiki ya dogara da yanayin aiki da aikin da ake yi, a kan kimanta haɗarin tushen haɗari, yanayin rashin lafiya a cikin jama'a, da kuma abubuwan haɗarin ma'aikata na musamman waɗanda ke da haɗarin kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da haɗarin haɗari da haɗari suna da ƙarancin haɗari da jama'a da sauran abokan aiki, wanda ke ba da shawarar matakan hana kamuwa da cuta na yau da kullun, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, halayen numfashi, da tsabtace da kuma tsabtace yanayin aiki a kai a kai.
Ayyukan da ke da haɗarin haɗari na haɗari sun haɗa da waɗanda ba a san ko ake zargin suna da COVID-19 ba, amma suna buƙatar haɗuwa da mutane a wuraren kasuwanci waɗanda zasu iya zama masu haɗari ko kuma masu haɗari da cutar ta yau da kullun ko kuma tafiya ta duniya.
Wannan ya hada da ma'aikatan da ke da hulɗa da jama'a, kamar makarantu, wuraren aiki masu yawan jama'a, da kuma wasu wuraren sayar da kayayyaki masu yawa.
Baya ga matakan rigakafin cutar na farko, tsarin kula da haɗari ga wannan rukunin ya haɗa da samar da iska mai iska, masu tsaro masu tsaro da kuma kayan kariya na mutum yayin fuskantar mutum wanda ya kamu da COVID-19 ta amfani da matattarar iska mai ƙarfi.
OSHA ta ce ma'aikatan kiwon lafiya da masu aiki a cikin hanya suna da haɗarin haɗuwa da mutanen da ke da tabbaci ko shakku na COVID-19 wanda zai iya zama mafi haɗari idan waɗannan ma'aikatan suka aiwatar da tsarin samar da Aerosol ko kuma suka tattara samfurori ko tattara samfurori na mutanen da ke da tabbacin ko shakku na COVID-19 ta hanyar wannan aikin.
Waɗannan matakan da suka dace da ma'aikata sun haɗa da matakan injiniya kamar na gidan iska mai matsin lamba mara kyau, da kuma kayan kariya na mutum waɗanda suka dace da aikin aiki.
Cutar COVID-19 a wurin aiki na iya haifar da tasiri mai yawa.
Ma'aikata na iya yin aiki ba tare da aiki ba saboda rashin lafiya, kula da wasu, ko kuma tsoron haɗuwa.
Abubuwan da ake buƙata da kuma yadda ake sayen waɗannan kayayyakin (kamar sayen a lokacin da babu aiki ko ta hanyar isarwa ko sabis na tuki (ba sayen mota ba) na iya canza yanayin kasuwanci a duka fannonin.
A ƙarshe, ana iya hana jigilar kaya daga yankunan da COVID-19 ke da tasiri sosai. Shirye-shiryen shiri da amsa cutar mai yaduwa na iya amfani da shi don jagorantar matakan kariya.
Shirye-shiryen suna magance matakan haɗari da ke tattare da wuraren aiki da ayyukan da ake yi, gami da tushen haɗari, abubuwan haɗari daga gida da zamantakewar jama'a, da abubuwan haɗari na ma'aikata kamar tsufa ko rashin lafiya na dogon lokaci.
Sun kuma bayyana matakan da ake bukata don magance wadannan kasada da kuma shirye-shiryen da za a yi don fuskantar yanayin da zai haifar da barkewar cutar.
Shirye-shiryen shiri da kuma amsa cututtuka masu yaduwa na iya zama batun shawarwari na kasa ko na kasa.
Manufofin mayar da martani ga barkewar cutar sun haɗa da rage kamuwa da cuta tsakanin ma'aikata, kare mutanen da ke cikin haɗarin rikitarwa na kiwon lafiya, kula da ayyukan kasuwanci, da rage tasirin da ke shafar sauran kamfanonin da ke cikin sarkar wadatar su.
Matsayin da ake fama da cutar a cikin al'umma inda kasuwancin yake yana shafar yadda ake amsawa.
Tsarin kula da haɗari mai yawa shine tsarin da aka yi amfani dashi sosai don sarrafa aikin lafiya da lafiya.
Inda ba za a iya kawar da haɗarin COVID-19 ba, mafi ingantattun ƙa'idodi sune sarrafa injiniya, sannan na gudanarwa, kuma ƙarshe kayan tsaro na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayyar ma'aikata ba, kuma wannan zai iya zama mafi kyawun mafita don aiwatarwa.
Gudanar da gudanarwa shine sauya manufofi ko hanyoyin aiki wanda ke buƙatar aiki ta hanyar ma'aikaci ko mai aiki.
Kayan aikin kariya na mutum (PPE) ana ganin sun fi inganci fiye da aikin injiniya da na gudanarwa, amma suna iya taimakawa wajen hana wasu abubuwan da ke faruwa.
Dole ne a zaɓi kowane nau'in PPE bisa ga haɗarin ma'aikaci, kamar yadda ya dace (kamar masu numfashi), dole ne a sanya shi daidai, dole ne a bincika shi, a kula da shi, a maye gurbin shi a kai a kai, kuma dole ne a buɗe shi, a tsabtace shi, kuma a adana shi ko a soke shi yadda ya kamata don kauce wa gurɓata.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ba su da haɗari da haɗari da haɗari suna da ƙarancin haɗari da jama'a da sauran abokan aiki.
Abubuwan da ake ba da shawarar a duk wuraren aiki don hana kamuwa da cuta sun haɗa da wanke hannu akai-akai da kyau, ƙarfafa ma'aikata su kasance a gida idan suna rashin lafiya, samar da halayen numfashi tare da rufe fuska yayin hawaye da tari, samar da kayan shafa da kayan shara, kasancewa a shirye don sadarwa ko sauye-sauye a rana idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aiki na wasu, da kuma kiyaye tsabtace da kuma tsabtace yanayin aiki.
Wani muhimmin mataki na kiyaye ma'aikata, abokan ciniki, masu neman ganawa da sauransu a wuraren aiki shine ganowa da kuma ware masu iya kamuwa da cutar da sauri.
Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amurka ta ba da shawarar cewa ma'aikatan da ke da alamun rashin lafiyar numfashi na yau da kullun su zauna a gida har sai sun kasance ba tare da zazzabi ba ko wasu magungunan da ke canza alamun ba, aƙalla awanni 24 ba, ba tare da yin amfani da maganin rage zazzabi ko wasu alamun bayyanar cututtuka ba, kuma dole ne a sauƙaƙe manufofin hutu na rashin lafiya, wanda zai ba ma'aikata damar zama a gida don kula da dangin da ke rashin lafiya, kuma ma'aikatan su san waɗannan manufofin.
A cewar OSHA, ayyukan da ke da haɗarin haɗari na haɗari sun haɗa da ayyukan da ba a san ko ake zargin COVID-19 a cikinsu ba, amma suna buƙatar samun sauƙin haɗuwa ko kusanci da mutane a cikin mita shida (1.8m) na mutane waɗanda zasu iya kamuwa da SARS-CoV-2 saboda cutar da ke yaduwa a cikin jama'a a wuraren kasuwanci ko kuma mutumin da ya yi tafiya na kwanan nan a cikin ƙasa don ya sami yaduwar COVID-19.
Ayyukan injiniya na musamman ga waɗanda ke da haɗari da yawa sun haɗa da sanya matattarar iska mai ƙarfi, ƙara yawan iska, ƙara yawan iska, kafa shinge na zahiri kamar masu tsabtace filastik masu tsabta, da kuma sanya windows na sabis na abokin ciniki don samun damar aiki. Ayyukan injiniya na musamman ga waɗanda ke da haɗari da yawa sun haɗa da ƙarfafa marasa lafiya su zauna a gida, ƙarfafa ma'aikatan su kasance cikin haɗari na haɗari, ba da horo ga jama'a da kuma haɗarin haɗari na haɗari, ba da izini ga masu amfani da COVID-19 don yin amfani da kayan aiki na yau da kullun, ba da izini ga masu amfani da su ba, ba da izini ga yadda za a iya yin amfani da kayan aiki na COVID-19 don samun damar yin amfani da su, ba da izini ga masu amfani da kayan aiki na yau da kullun, ba da izini ga yadda za a iya yin amfani da su ba, ba da izini ga yadda za a iya yin amfani da kayan aiki na yau da kullun don yin amfani da su, ba da izini ga yadda za a iya yin amfani da su a wuraren aiki na COVID-19 don yin amfani da su, ba da izini ga yadda za a iya yin amfani da su ba da izini don yin amfani da su, ba da izini don yin amfani da izini don yin amfani da izini don yin amfani da izini don yin amfani da izini don yin amfani da izini don yin amfani da izini don yin amfani da izini don yin amfani da izini don yin amfani da izini don yin amfani da izini don yin amfani da izini don yin amfani da izini don amfani da izini don amfani da izini don yin amfani da izini don amfani da izini don amfani da izini don amfani da izini don amfani da izini don amfani da izini don amfani da izini don amfani da izini don amfani da izini don amfani da izini don izini don amfani da izini don amfani da izini don izini don izini don izini don amfani da izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don izini don
Ma'aikatan da ke cikin wannan rukunin haɗari ba sa bukatar yin amfani da na'urar numfashi a lokuta da yawa.
Idan wani mutum ya kamu da rashin lafiya a cikin jirgin sama, dole ne a yi amfani da matakan da suka dace don kare ma'aikatan da sauran fasinjoji, kamar ware mai rashin lafiya daga wasu a tsawon ƙafa 6, sanya wani ma'aikaci don yin hidima ga mai rashin lafiya, da kuma ba da abin rufe fuska ga mai rashin lafiya, ko kuma gaya wa mai rashin lafiya ya rufe fuskarsa da hanci da hanci da ƙusa yayin da yake tari ko tari.
Dole ne ma'aikatan jirgin su sa sa safofin hannu na likita lokacin da suke amsa kiran mai tafiya mara lafiya ko kuma lokacin da suke taɓa ruwa ko yanayin da zai iya cutar da su, kuma idan mai tafiya mara lafiya yana da zazzabi, ciwon tari ko wahalar numfashi, to, ya kamata a yi amfani da ƙarin kayan kariya na mutum.
Ya kamata a yi watsi da safar hannu da sauran abubuwa masu iya cirewa a cikin jaka mai haɗari, sannan a tsabtace da kuma lalata rufin da ke ƙazantawa. Ga jiragen ruwa na kasuwanci, gami da jiragen ruwa masu jigilar kaya da sauran jiragen ruwa masu jigilar kaya, ka'idodin haɗari sun haɗa da jinkirta tafiya idan suna rashin lafiya, keɓe kansu, da kuma sanar da cibiyar likitancin jirgin nan da nan idan wani ya sami zazzabi ko wasu alamun cutar yayin da yake cikin jirgin.
A mafi kyawun yanayin, dole ne a bi diddigin likita a cikin ɗakin da aka keɓe. A cikin makaranta da kuma wuraren kula da yara, idan wani mai kamuwa da cutar ya shiga makarantar, CDC ta ba da shawarar rufewa na ɗan lokaci don tsaftacewa ko ƙonawa.
Lokacin da cutar ta yadu zuwa matsakaici a cikin jama'a, ana iya aiwatar da dabarun kiyaye nesa ta zamantakewa, kamar soke tafiye-tafiye na filin, tarurruka da sauran manyan tarurruka, kamar cin abinci a cikin aji na jiki ko ajiyar kiɗa ko cafeteria; ƙara nesa tsakanin tebur, ware lokacin zuwa ofis da hutu, iyakance lokacin ganawa da ba dole ba, da amfani da sararin samaniya na kiwon lafiya don yara masu alamun mura.
Yayin da cutar ke yaduwa a cikin al'ummomin gida, ana iya la'akari da ƙara yawan rashin aikin makaranta don dabarun kiyaye nesa ta zamantakewa. CDC ta yi la'akari da cewa haɗarin lafiyar ma'aikatan da ke bin doka da ke gudanar da ayyukan yau da kullun yana da ƙananan.
Jami'an da ke da ikon yin aiki da mutane da ke da tabbaci ko kuma ake zargin suna da COVID-19 an shawarce su da su bi ka'idodin da ke daidai da na likitocin gaggawa, tare da kayan kariya na sirri.
Idan ma'aikata suka zo cikin kusanci a lokacin damuwa, dole ne a tsabtace su da kuma kashe su ta amfani da fesa na gida ko wanke kafin sake amfani da belun aikinsu da kayan aikin su, kuma dole ne a bi hanyoyin gudanar da shaidar don sarrafawa da soke PPE da aka yi amfani da su.
OSHA tana ɗaukar ma'aikatan wasu ayyukan kiwon lafiya da sabis na mutuwa a cikin babban ko babban haɗarin haɗari.
Ayyukan da ke da haɗarin haɗari da haɗari sun haɗa da ma'aikatan kula da lafiya, taimako, dakin gwaje-gwaje da sufuri na asibiti, waɗanda ke hulɗa da marasa lafiya waɗanda suka san ko suna da cutar COVID-19.
Idan ma'aikata suka gudanar da hanyoyin da ke haifar da aerosol, ko kuma suka tattara samfurori ko kuma suka yi yawo daga marasa lafiya da aka sani ko ake zargin suna da COVID-19, suna da haɗarin haɗuwa da su.
Hanyoyin da ake amfani da su wajen samar da aerosol sun hada da shigar da bututu, hanyoyin da za a fara zubar da hanji, yin bronchoscopy, wasu hanyoyin hakori da kuma yin gwaji ko kuma tattara samfurori ta hanyar shigar da kayan.
Ayyukan da ke da haɗarin haɗari, waɗanda ke da alaƙa da mutuwa sun haɗa da ma'aikatan da ke aiki don shirya gawarwakin waɗanda aka sani ko ake zargin suna da COVID-19 a lokacin mutuwar; wannan yana haifar da haɗarin haɗari sosai idan sun yi maniyyi. Ƙarin aikin injiniya don mutanen wannan rukunin haɗari ya haɗa da dakin ajiye marasa lafiya waɗanda aka sani ko ake zargin suna da COVID-19, gami da lokacin da ake aiwatar da hanyoyin samar da aerosol.
Kayan iska na musamman na iska mai cutarwa na iya dacewa da wasu wuraren kiwon lafiya da wuraren shan magani.
Dole ne a gudanar da samfurori bisa ga matakan tsaro na 3 na rayuwa.
Hukumar lafiya ta duniya (WHO) ta ba da shawarar cewa a ware masu zuwa zuwa zuwa wuraren jiran kansu bisa ga ko ana zargin suna da COVID-19. OSHA ta ba da shawarar cewa a cikin mutane da suka san ko ake zargin suna da SARS-CoV-2 a cikin mita 6 da kuma mutanen da ke aiwatar da hanyoyin da ke haifar da cutar aerosol, OSHA ta ba da shawarar masu numfashi, ban da sauran PPE.
Dole ne a yi amfani da N95 ko kuma ingantaccen mai tace fuska mai numfashi a cikin tsarin kula da numfashi mai zurfi, wanda ya ƙunshi gwajin lafiya, horo, da gwaji na likita a Amurka.
Sauran nau'ikan masu numfashi na iya ba da ƙarin kariya da inganta lafiyar ma'aikata. WHO ba ta ba da shawarar ɗaukar hoto, saboda COVID-19 ba ta yaduwa ta hanyar abubuwan da ke cikin jiki ba, amma cutar huhu ce.
WHO ta ba da shawarar yin amfani da abin rufe fuska na tiyata don ma'aikatan binciken a ƙofar kawai.
WHO ta ba da shawarar yin amfani da masks, goggles, ko fuska guns, da safofin hannu ga waɗanda ke tattara samfurori na numfashi daga marasa lafiya na COVID-19 ba tare da wani tsari ba.
Idan an aiwatar da aikin samar da aerosol, ana maye gurbin masks na tiyata da N95 ko FFP2 respirator.
Ganin rashin wadatar samar da PPE a duniya, WHO ta ba da shawarar yin amfani da sassan jiki kamar telemedicine, windows masu tsabta don rage buƙatar PPE, kuma ba da izinin shigar da marasa lafiya guda ɗaya na COVID-19 zuwa gidajen da ke da kulawa kai tsaye, amfani da PPE kawai don takamaiman ayyuka, ci gaba da amfani da respirator ba tare da cirewa ba yayin kula da marasa lafiya da yawa na cutar ɗaya, ba da izinin saka idanu da daidaita tsarin samar da PPE, da kuma ƙarfafa masu rashin alamun su sa abin rufe fuska.
Wanda ya aiko: Katherine Maher, Shugaba na Gidauniyar Wikimedia
Kowane ma'aikaci na Wikimedia Foundation
Labari: [Covid-19] Rage nauyi da kuma shirya don nan gaba
Ranar aikawa: 14 ga Maris, 2020, 00:24 UTC
An ba da lasisi: CC0: Babu haƙƙin mallaka
A wannan watan, mun sami kanmu a cikin yanayi mai ban mamaki.
Cutar COVID-19 ta zama abin da ya sa ya zama mafi haske game da haɗin kai na ɗan adam da kuma wajibai da muke da su ga juna.
Ba mu da irin wannan ƙalubale a yau, amma mun san cewa abin da za mu iya yi ya dogara ne da tausayi, haɗin kai da kuma samar da al'umma a duniya.
Abokan hulda da kuma amincewa da muka samu a cikin abokan aikinmu ta hanyar imel, kira da tattaunawa, sun nuna cewa muna da mutane masu ban mamaki da muke da sa'a sosai don aiki tare.
Ina matukar godiya da alfahari da samun ku duka a matsayin abokan aiki.
A makon da ya gabata, wani mutum ya yi mini magana game da aikinmu.
Sun tunatar da ni game da yadda ake ganin Wikipedia a wannan lokacin, kuma yadda wannan muhimmin albarkatun yake nuna cewa yana da iko sosai a yanar gizo kuma yana samuwa ga kowa.
Aikinku zai sa hakan ya yiwu, ko kuna gudanar da shafukan yanar gizo ko ku biya abokan aikinmu ko kuma ku kiyaye jama'armu lafiya, duk abin da kuke yi.
Duniya tana bukatar bayanai da Wikipedia ta bayar, a yanzu fiye da dā.
Wannan lokaci ne da ba kawai abin da muke yi ba, amma yadda muke yi zai yi tasiri sosai a duniya.
Saboda muhimmancin wannan manufa da kuma rawar da kuke takawa a ciki, za mu yi wasu canje-canje masu muhimmanci a hanyar da muke aiki tare daga wannan makon mai zuwa.
Muna da tsarin aiki da kuma tsarin aiki da za mu yi.
Kamar yadda Robin ya ambata a baya, ƙungiyar C-ta haɗu a daren jiya don tattauna tsarinmu da kuma tsara jadawalin kwanaki da watanni masu zuwa.
Mun yi tunani game da yadda za mu iya magance yanayin da muke fuskanta, kuma a cikin tattaunawar mun tattauna yadda za mu iya ci gaba da kasancewa da kamfanin a wannan lokacin.
Yawancinmu muna so mu kawar da matsin lamba kuma mu tallafa wa burinmu na dogon lokaci.
Idan kana bukatar ka mayar da sakonnin, babu matsala.
Ga dukan ma'aikata, masu kwangila, da ma'aikatan da aka yi wa kwangila:
Har zuwa lokacin da za a sanar da mu, muna sa ran za mu yi aiki na tsawon sa'o'i hudu a rana, ko kuma sa'o'i 20 a mako.
Ba mu sanar da hutu ba - idan ka iya yin aiki a lokutan da suka dace, aikin zai iya amfani da kai.
Amma a wannan lokacin duniya ba ta da tabbas, kuma ko kana bukatar ka kula da ƙaunataccenka ko ka kawo kayan abinci ko ka je wurin likita, lafiyarka ita ce abin da muke fifitawa.
Ba mu kula da lokacinku ba.
Kada ka yi aiki idan kana rashin lafiya.
Ba za mu iya cewa ba, amma muna magana ne.
Babu buƙatar hutu na rashin lafiya ko PTO - kawai gaya wa manajanka kuma ka taimaki ƙungiyarka ta gyara kalandar da jadawalin don tabbatar da cewa an rufe manyan wuraren aikin.
(Idan kun kasance masu cutar COVID-19, don Allah ku sanar da Brian na T&C Ops don T&C ta iya taimakawa kuma tabbatar da cewa yanayinku yana samun kulawa ta hukuma).
Za a biya ma'aikatan da ke aiki a kowane awa cikakken albashin su.
Mun riga mun faɗi haka, kuma mun sake yin alkawarin cika alkawarinmu ga masu ba mu aiki da abokan aiki da ke aiki a kai a kai.
Za a biya kowa bisa ga sa'o'in da ya yi aiki a yanayi na yau da kullum.
Hakan ya haɗa da rashin lafiya da rashin iya aiki.
Idan kana son yin aiki, za mu taimake ka.
Mutane da yawa suna amfani da aiki a matsayin hanyar da za su iya fitar da damuwarsu daga duniyar da ke kewaye da su.
Abin da muke yi yana iya zama da amfani sosai, musamman a irin wannan lokacin.
Bugu da ƙari, yana da game da kula da kanka.
Muna so ku tuntuɓi manajan ku don mu san abin da za mu yi tsammani kuma mu daidaita shi.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da dole ne mu yi.
SRE, HR Ops, Trust & Safety, da kuma Fundraising teams (a tsakanin wasu) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin taimako.
Za mu fara aiki tare da dukkan sassanmu don tantance manufofinmu na yanzu kuma mu canza mayar da hankalinmu don yin aiki tare da abin da ake buƙata don aikinmu.
Muna da ayyuka da yawa da za mu yi, amma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan ka yi aiki a hankali yanzu, ba za ka ji rauni ba.
Ba mu da niyyar yin aiki sau biyu don ciyar da kanmu bayan an kawar da cutar.
Ba za a sa ran ka yi aiki na tsawon sa'o'i ba don ka gama aikin a cikin lokaci, wanda ba shi da kyau a yanzu.
Mun amince cewa yanayin ya canza, kuma za mu yi aiki don kafa sababbin manufofi da kuma lokacin da ya dace.
Mene ne ke faruwa da APP?
Don daidaitawa da sabon gaskiyarmu da tsammanin sa'o'in aiki na yau da kullun, muna son daidaitawa da lokacin isar da shirinmu na shekara ta 2020-2021.
Manufarmu ita ce mu ba da shawarar faɗaɗa shirinmu na 2019-2020 wanda zai ba ma'aikata damar yin aiki da farko, ba da ƙarin lokaci a cikin shirya kasafin kuɗi don ba da damar kula da kansu da ƙaunatattun su, yayin da muke biyan bukatun waɗanda suke son ko kuma bukatar yin aiki a cikin ragewa na tsawon makonni masu zuwa.
Wannan tsawaita lokacin ya rage matsin lamba a kan ma'aikatan da ke cikin shirin yanzu da kuma a kan dukan kamfanoni.
Za mu gabatar da shawarwarinmu a gaban hukumar a mako mai zuwa kuma za mu sanar da wakilan da kungiyoyin game da matakai na gaba da wuri-wuri da zarar mun sami tabbaci.
Ina godiya ga tawagar APP saboda jagorancin da kuka bayar a wannan batun.
Yadda ake yin aiki a ofishin, yadda ake tuntuɓar da kuma tsabtace shi
A makon da ya gabata, mun san cewa wani daga cikin abokan aikinmu na SF na iya kamuwa da COVID-19.
Amma saboda mun yi hankali sosai, mun sanya tawagar masu tsabtace cutar a ofishinmu na San Francisco don kawar da dukkan farfajiyar.
Sun yi amfani da maganin rigakafi na kwayar cuta mai inganci don kashe kowace farfajiyar da kuma lobby da kuma bangarorin lif da ke shiga cikin bene.
Ginin yana amfani da kayayyakin da ke amfani da ladabi na sabis na kansa wanda ke taimakawa wajen kiyaye lafiyar masu haya.
Mun ji daɗin cewa ofishin zai kasance a shirye lokacin da muka yanke shawarar komawa.
Ofishinmu na DC yana cikin WeWork, wanda ya musanya yarjejeniyar COVID-19 tare da mu da duk ma'aikatan DC.
A makon da ya gabata, ofishinmu na DC ya koma cikin cikakken tsarin nesa, daidai da umarnin da aka bayar ga San Francisco.
Wasu daga cikin abokan aikinmu a birnin New York sun san cewa muna tattaunawa game da yin hayar wani wuri a Brooklyn.
Wannan tattaunawar na ci gaba amma za a iya jinkirta.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu na dogon lokaci sun san cewa wannan zai iya zama daidaitawa, kuma suna so su ba ku shawara:
Idan taron ya yi tsawo sosai, ka rage tsawonsa zuwa awa ɗaya ko biyu.
Idan kana bukatar ƙarin zaman, ka yi la'akari da yadda za ka raba su cikin ƙananan sassan na kwanaki.
Ka bayyana taron a fili, ka shirya jadawalin taro, kuma ka aika da abubuwan da za a koya a gaba.
Ka sa bidiyon ta zama tsohuwa, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙa haɗin kai da haɗin kai.
Ka sa wani ya jagoranci kowane taro don sauƙaƙe shi, ka tambayi wani ya lura da tambayoyin da ake yi a hira da kuma duba jerin masu magana, kuma ka tambayi wani ya rubuta bayanin kula (ko kuma ya rubuta bayanin kula a cikin haɗin kai).
Idan kana bukatar wani na'urar kai mai sauƙi, ka aika wa goyon bayan fasaha imel.
Ka yi amfani da kayan jin daɗi don yin abincin dare.
Ka shiga tashar #remoties ta Slack don yin magana da abokan aikinka game da rarraba.
HR Task Force tana neman jagororin yanar gizo na tushen aikin aiki don taimakawa haɓaka aikin rarraba a duk faɗin Gidauniyar.
A makon da ya gabata, mun nemi duk masu ba da gudummawa na al'umma su soke taron jama'a kamar editathon da Wikimedia ke tallafawa, har sai WHO ta bayyana cewa annobar ta ƙare.
Mun sanar da su cewa mun fahimci cewa buƙatarmu don sokewa da sauran takunkumi na iya sa ya zama ba zai yiwu su kammala ayyukan ba da gudummawa da suka amince da su ba, kuma ba za a hukunta kowa ba saboda jinkirta ko gyara waɗannan manufofin.
A cikin makon da ke zuwa za mu ba da ƙarin jagora ga Wikimedia da sauran taron yanki da na al'umma.
A cikin dukan al'ummomin duniya, akwai damuwa game da rikicewar tunani na kowa, amma a lokaci guda Wikimedia da sauran wurare, suna da ikon mayar da hankali ga al'ummomin su da kuma kawar da bayyanarsu, dukansu suna da alama.
A cikin kwanaki masu zuwa, CRT na aiki don ƙirƙirar shafi a cikin Meta-Wiki, don samar da sarari ga jama'a don lura da tasirin da kuma bin hanyoyinmu na sadarwa tare da su.
Kasancewa cikin sadarwa tare da abubuwan da suka shafi COVID-19
Za mu aika da gayyatar zuwa kalandarku don taron ma'aikata na musamman a ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa da amsa tambayoyinku da kuma ciyar da lokaci don haɗuwa da juna.
A wannan yanayin, dukkanmu muna da haɗin kai kuma za mu taimaka da duk abin da za mu iya.
A lokacin, za ka iya ci gaba da neman bayanai daga wannan imel, kuma ka sami wasu muhimman bayanai game da COVID-19 a kan Office Wiki.
CRT za ta ci gaba da sabunta waɗannan shafuka kuma za ta ci gaba da samun bayanai.
Muna kuma aiki don ci gaba da tuntuɓar ma'aikatan da ke zaune a ƙasashen da ake fama da cutar.
Idan kana da tambayoyi game da tafiya, abubuwan da suka faru, babban aiki ko ƙalubalen ɗaukar hoto, ko kuma kana buƙatar taimako game da wani abu, don Allah ka sanar da kuma aiki tare da CRT.
Muna nan don taimakawa da kuma daidaitawa a lokacin da ake buƙata.
Idan kana da wasu batutuwa masu mahimmanci ko kuma masu mahimmanci, don Allah ka aika da imel zuwa Brian Judan, Daraktan Ayyukan Duniya na HR International.
Babu wani daga cikin wadannan canje-canje da ya kamata a yi la'akari da shi a matsayin watsi da aikinmu da kuma alhakinmu.
Maimakon haka, ya nuna cewa a yanzu, muna bukatar mu daidaita ayyukanmu da kuma alhakinmu a hanyar da ba mu taɓa yi ba.
Mun yi imanin cewa waɗannan matakan suna da mahimmanci don taimakawa juna, don mu ci gaba da aiki, don samar da tallafin da muke buƙata don motsinmu, da kuma samar da sabis ɗin da duniya ke dogara da shi.
Lokacin da lokaci ya zo, aikin da muka tsara zai kasance a gabanmu.
Yanzu ne lokacin taimaka wa juna da kuma samar da sarari don muhimman abubuwan da za su faru a makonni masu zuwa, wataƙila ma a watanni masu zuwa.
Muna bukatar ku yi aiki tare don yin hakan, don haka muna so ku kula da kanku da kuma iyalanku don ku kasance cikin koshin lafiya a duk lokacin da ake bukata.
Yanzu, don Allah ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Catherine, ƙungiyar CRT (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Hyme V, Joel L, Lynette L, Ryan M, da Tony S) da sauran ƙungiyar jagoranci (Grant I, Heather W, Hyme V, Janine U, Lisa S, Robin A, Ryan M, da Toby N).
BAnjiotensin-transforming enzyme 2 (ACE2) wani abu ne mai saurin haɗuwa da huhu, jijiyoyi, zuciya, koda, da kuma ƙwayoyin hanji.
ACE2 yana hana aikin da ake amfani da shi na angiotensin-transforming enzyme (ACE) ta hanyar rage adadin angiotensin-II da kuma ƙara Ang1-7 wanda ya sa ya zama kyakkyawan magani mai mahimmanci don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin hanyar shiga cikin kwayoyin halitta don wasu cututtukan coronaviruses.
An fi kiran sigar ɗan adam na enzyme hACE2.
Angiotensin-transforming catalyst 2 shine zinc-binding metallolzyme wanda ke kan farfajiya na endothelial da sauran kwayoyin halitta.
Protein ACE2 yana da yankin N-terminal peptide M2 da kuma yankin C-terminal colectrain renal amino acid transporter.
ACE2 shine mai wucewa guda ɗaya na nau'in I membrane protein, wanda wurin da ke aiki a cikin saurin aiki ba a rufe shi a saman ƙwayoyin huhu da sauran ƙwayoyin halitta ba.
Ƙasar waje ta ACE2 ta rabu da yankin transmembrane ta wani enzyme da ake kira shades, kuma sakamakon haka an saki furotin mai narkewa a cikin jini kuma a ƙarshe an fitar da shi ta hanyar fitsari.
ACE2 yana cikin mafi yawan gabobin: ACE2 yana da alaƙa da membrane na ƙwayoyin cuta na huhu na nau'in II, wanda ya danganci ƙwayoyin cuta na ƙananan hanji, ƙwayoyin cuta na ƙaramin hanji, ƙwayoyin cuta na sassan jiki da na jijiyoyin jiki, da ƙwayoyin cuta na jijiyoyin jini.
Hakanan an sami maganganun ACE2 mRNA a cikin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa, stratum, hypothylamus, da brainstorm.
Ayyukan farko na ACE2 shine aiki a matsayin mai daidaitawa na ACE.
ACE angiotensin I yana raba hormone zuwa vasokonstrikting angiotensin II.
ACE2 ya bambanta carboxylic-terminal amino acid phenylalanine (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) daga angiotensin II kuma ya hydrolyz shi zuwa vasodilator angiotensin (1-7) (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya ware wasu wasu wasu peptides, ciki har da [des-Arg9]-bradykinin, apelin, neurotensin, dinorphine A, da ghrelin.
ACE2 yana sarrafa musayar ƙwayar cuta na SLC6A19, wanda yake da alaƙa da amino acid mai ɗauke da shi, kuma yana da alaƙa da cututtukan zuciya.
A matsayin furotin na transmembrane, ACE2 yana aiki a matsayin babban maɓallin shigarwa a cikin ƙwayoyin cuta na wasu coronavirus, wanda ya haɗa da HCoV-NL63; SARS-CoV (wanda ke da alhakin SARS); da kuma SARS-CoV-2 (wanda ke da alhakin COVID-19).
A takaice dai, an bayyana cewa an haɗa SARS-CoV da SARS-CoV2 na spike S1 a cikin ƙwayoyin halitta na ACE2 zuwa farfajiyar ƙwayoyin halitta wanda ke haifar da endocytosis da kuma motsawar ƙwayoyin cuta da enzymes a cikin ƙwayoyin halitta.
Wannan shigarwa na buƙatar kuma priming na S protein ta hanyar TMPRSS2 mai masaukin sarin protease, wanda ke da kariya a matsayin mai yiwuwa warkarwa a halin yanzu. Wannan ya taimaka wa wasu su yi tunanin cewa rage matakan ACE2 a cikin sel na iya taimakawa wajen yaki da kamuwa da cuta.
Duk da haka, kungiyoyi masu yawa da kuma kungiyoyi masu kulawa sun bada shawarar ci gaba da maganin ACE inhibitors da ARB.
"A cikin nazarin tsarin da aka buga a ranar 11 ga Yuli, 2012, da kuma meta-analysis ya gano cewa ""idan aka kwatanta da masu kulawa, amfani da ACE inhibitors yana da alaƙa da raguwar haɗarin cutar huhu da 34% a cikin ƙasa".
Bugu da ƙari, "masu da ke shan maganin ACE sun rage haɗarin kamuwa da cutar, musamman ma waɗanda ke da haɗarin kamuwa da cutar huhu da cututtukan zuciya".
"Amfani da masu hana ACEs na da alaƙa da raguwar mutuwar da ke tattare da cutar huhu, duk da cewa sakamakon ya kasance ƙasa da yadda ya dace a cikin haɗarin cutar pneumonia gaba ɗaya".
Ana ɗaukar ACE2 (rhACE2) na mutum mai sake haɗuwa a matsayin sabon magani don lalacewar huhu mai tsanani, kuma ya bayyana don inganta haemodynamics na huhu da kuma oxygenation na jarirai, tare da alamun cutar huhu mai tsanani da lipopolysaccharide ke haifar.
RHACE2 yana da rabin rai na kimanin sa'o'i 10 a cikin mutane kuma yana farawa a cikin minti 30, kuma tsawon lokacin tasiri (tsayawa) yana da awanni 24.
Wasu bincike sun nuna cewa mutanen da ba su iya jurewa da masu hana tsarin RAS na farko ba ko kuma suna da cututtuka inda ake samun karuwar iskar angiotensin II za su iya nuna bege ga rhACE2.
"B'COVID-19 apps sune aikace-aikacen software na wayar hannu waɗanda aka tsara don gano lamba a cikin martani ga annobar coronavirus ta 2019-20, wato, tsarin gano mutumin da ya kamu da cutar (""lambar"") ".
An ci gaba da samar da aikace-aikace da yawa tare da taimakon gwamnati a wasu yankuna da yankuna.
An gina wasu kayayyakin more rayuwa don ƙirƙirar aikace-aikacen gano lamba.
An bayyana damuwa game da sirrin sirri, musamman game da tsarin da ke aiki akan gano yanayin masu amfani da app.
Zaɓuɓɓukan shiga ba tare da izini ba sun haɗa da amfani da siginar Bluetooth don yin rajistar mai amfani a wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyukan tallafawa irin waɗannan aikace-aikacen da ke da tushen Bluetooth kai tsaye a cikin tsarin aikin su na Android da iOS.
A kasar Sin, gwamnatin kasar ta kaddamar da wani aikace-aikace tare da Alipay wanda ke ba 'yan kasar damar duba idan sun yi hulɗa da mutanen da suka kamu da COVID-19.
Ana amfani da shi a birane fiye da 200 na kasar Sin. Akwai wani app da ake kira TraceTogether a Singapore.
Kungiyar fasahar bayanai ta kasar ta kirkiro wannan app din, an bayyana shi a matsayin bude tushen kuma za a mika shi ga gwamnati. North Macedonia ta kaddamar da App din Dakatar da Coronavirus!, wani app na Bluetooth wanda ke da nufin gano bayyanar cututtuka na wadanda ke da cutar da kuma samar da gaggawa ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da kuma Ma'aikatar Lafiya sun kirkiro wannan app.
Tun daga 14 ga Afrilu 2020, app din yana jiran izinin Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnati ta sanar da cewa ana ci gaba da bunkasa app din neman hanyoyin sadarwa kuma zai kasance a cikin makonni kadan. An shirya irin wannan app din ("StopCovid") a Ireland da Faransa".
Kasashen Australia da New Zealand suna la'akari da aikace-aikacen bisa ga TraceTogether app da BlueTrace Protocol a Singapore. Rasha na shirin ƙaddamar da aikace-aikacen geofencing don marasa lafiya masu COVID-19 da ke zaune a Moscow, don tabbatar da cewa ba sa barin gida.
Ross Anderson, Farfesa a fannin tsaro na jami'ar Cambridge, ya lissafa wasu matsaloli masu yuwuwa tare da tsarin da ke dogara da aikace-aikace, ciki har da rashin amfani idan an iyakance karɓar aikace-aikacen ga ƙananan ɓangaren jama'a.
"Da yake magance damuwar game da yaduwar aikace-aikacen "Coronavirus" masu rikitarwa ko cutarwa, Apple ya ƙayyade iyakancewar irin kamfanoni da za su iya ƙara aikace-aikacen da suka shafi coronavirus a cikin App Store, tare da iyakance su kawai ga "masu mulki" ko kuma wasu kamfanoni masu suna".
Google da Amazon sun yi irin wannan takunkumin.
Masu ba da shawara kan tsare sirri sun nuna damuwa game da amfani da aikace-aikacen coronavirus don saka idanu kan jama'a, musamman, ko za a kammala kayan aikin saka idanu da aka gina don magance cutar coronavirus a duniya bayan barazanar ta tafi.
Amnesty International da wasu kungiyoyi 100 sun fitar da wata sanarwa inda suka yi kira ga a takaita irin wannan sa ido.
Kamfanin ya sanar da sharuɗɗa guda takwas game da shirin gwamnati:
"Dole ne mai kula ya zama "doka, da bukata, da kuma dacewa".
Dole ne a sami hasken rana don haɓaka saka idanu da saka idanu;
Dole ne a iyakance amfani da bayanai don dalilai na COVID-19;
Dole ne a kare kare kare bayanai da kuma ganowa da kuma tabbatar da tsaro bisa hujja;
Dole ne a yi amfani da sa ido na dijital don hana cutar rashin daidaito da rarrabuwa;
Dole ne doka ta bayyana cewa ana raba wani bayanai tare da wasu kamfanoni;
Dole ne a ba da 'yan ƙasa' yancin yin zanga-zanga da kuma kare su daga cin zarafi.
"Dukkanin masu ruwa da tsaki masu dacewa, gami da kwararrun masanan lafiya da kungiyoyin da ke kan iyaka, za su buƙaci muhimmiyar shiga. Kungiyar Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan
Manufar shirin Google/Apple da aka gabatar shine cire su daga tsarin aiki na na'urorin su ta hanyar magance matsalolin sa ido na dindindin idan ba a buƙatar aiwatar da su ba.
Wasu ƙasashe sun yi amfani da saka idanu kan wuraren da ke kan hanyar sadarwa maimakon aikace-aikace, wanda ya kawar da buƙatar saukar da aikace-aikacen da kuma yiwuwar kauce wa saka idanu.
A Isra'ila, an amince da ganowa ta hanyar sadarwa.
Akwai manyan matsalolin sirri ga hanyoyin sadarwa na cibiyar sadarwa waɗanda ke da damar shiga bayanan wuri mara inganci.
Duk da haka, ba a buƙatar samun damar bayanan wuri na sirri na duk tsarin uwar garken na tsakiya; an gina tsarin adana bayanan sirri da yawa waɗanda ke amfani da uwar garken na tsakiya don haɗin kai kawai (duba sashin da ke ƙasa).
An yi amfani da tsarin da ba a da app ba a Koriya ta Kudu don saka idanu kan hulɗa.
Maimakon amfani da aikace-aikacen da aka sanya, tsarin ya tattara bayanan bin sawu daga tushe daban-daban, gami da bayanan bin sawu na na na'urar hannu da bayanan ma'amala akan katunan, kuma ya haɗa su tare don aika sanarwar saƙon rubutu ga mutanen da ke da yiwuwar kamuwa.
Bugu da ƙari, gwamnati ta yi amfani da wannan bayanin don faɗakar da yiwuwar haɗari, ta kuma ba da damar yin amfani da bayanan wuri ga jama'a, saboda wasu abubuwa da aka amince da su saboda canje-canje masu yawa a cikin Dokar Sirrin Bayanai bayan barkewar cutar MERS.
Wasu ƙasashe, ciki har da Jamus, sun yi la'akari da amfani da tsarin da ke da ci gaba da ci gaba da tsare sirri da kuma tsare sirri.
A ranar 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba.
Tun daga aƙalla 2013 bincike ya fara ne don gano sadarwa mai kiyaye sirri tare da wani ɓangare na ilimin da ya dace. Kamar yadda aka fara a ranar 7 ga Afrilu, 2020, fiye da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar
Duk da haka, PEPP-PT wani aiki ne na haɗin gwiwa wanda ke da tsarin da aka tsara da kuma rarraba kuma ba wata hanya guda ba. Dokokin rarraba sun haɗa da tsarin da ke da alaƙa da tsare sirri na ɓoye-keɓewa (DP-PPT/DP-3T), lambobin tuntuɓar wucin gadi (TCN, fka lamba, CEN), da kuma hanyoyin da ke da alaƙa da sirri don gano sadarwa ta hannu (PACT), da sauransu.
A cikin waɗannan yarjejeniyoyi, bayanan sirri da za a iya ganowa ba sa barin na'urar kuma duk abin da ya faru yana faruwa a cikin na'urar.
A cikin MIT Media Lab, ƙungiyar masu zaman kansu na SafePaths tana haɓaka, wani dandamali don amfani da dabarun kare sirrin yayin tattarawa da amfani da bayanan wuri ko hanyar shiga don saka idanu kan yaduwar COVID-19.
Wannan ya dogara ne akan takarda mai suna Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic, wanda aka buga a watan Maris na 2020. Wani irin wannan ƙoƙari shine Enigma MPC ta kafa SafeTrace Platform, kamfanin da ke samar da fasahar sirri wanda a zahiri an kafa shi a MIT Media Lab.
SafeTrace yana amfani da fasahar tsaro ta kayan aiki don ba masu amfani damar musayar bayanan wuri da lafiyar su tare da sauran masu amfani da jami'ai ba tare da yin jayayya da sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Alliance ta duniya ta wasu kungiyoyi da ke da niyyar rage rarrabuwa da kuma ba da damar hulɗa ta duniya don ganowa da faɗakar da aikace-aikace, wanda babban mahimmin abu ne don karɓar su a cikin babban tsari da kuma manyan ka'idojin halayyar da ake buƙata.
A ranar 9 ga Afrilu, 2020, Gwamnatin Singapore ta sanar da cewa tana da yarjejeniyar BlueTrace mai tushe wanda ke amfani da ita ta hanyar aikace-aikacen ta.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa Android da iOS na hannu, sun sanar da wani shiri na gano mutanen da suka yi hulɗa da su, wanda zai kare sirrin su kamar yadda suke so, wanda ke aiki ne a kan cakuda fasahar Bluetooth low energy da kuma sirrin sirrin sirrin sirrin.
Sun kuma bayyana ainihin fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, tsarin yana shirin samuwa a matakai uku:
Don ba da damar gwamnatoci su kirkiro ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'u da ƙa'idodin ƙa'u da ƙa'idodin ƙa'idodin ƙa'idodin ƙa'u da ƙa'idodin ƙa'u da ƙa'u da ƙa'idodin ƙa'u da ƙa'idodin ƙa'u da ƙa ƙa ƙa ƙa ƙa ƙa ƙa'idodin ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa
Haɗa wannan aikin kai tsaye zuwa iOS da Android: Google da Apple suna shirin warware matsalolin ɗaukar hoto da ci gaba da saka idanu ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki da kuma cire shi a cikin irin wannan hanyar a lokacin bala'i.
Magungunan magani (wanda aka fi sani da magani mai amfani da dalilai daban-daban, sake yin amfani da shi, sabon magani ko magani mai sauyawa) magani ne da aka amince da shi don magance wata cuta ko cuta daban da wadda aka fara kirkireshi.
Wannan hanya ce ta bincike na kimiyya da ake bi a halin yanzu don bunkasa ingantacciyar hanyar magance COVID-19.
Sauran hanyoyin bincike sun hada da samar da rigakafin COVID-19 da kuma kamuwa da cutar ta plasma. SARS-CoV-2 yana dauke da wasu kwayoyi 66 da ke da takamaiman sunadarai, kowannensu yana da wuraren da ke ɗaure da ligand da yawa.
Waɗannan shafukan da ke ɗaurewa suna ba da ingantaccen shiri don ƙirƙirar magungunan rigakafin cutar da ke da tasiri akan furotin COVID-19.
Mafi mahimmancin sunadarai masu amfani da SARS-CoV-2 sune papine protease, RNA-dependent RNA polymerase, Helix, S protein, da ADP ribophosphatase.
Hussain A.A., da sauransu sun gudanar da nazarin mahaɗan 'yan takara daban-daban wanda aka inganta kuma aka bincika a cikin binciken da ya gabata don kama da ƙashin ƙwayoyin takarar da aka yarda da su ta hanyar magani mai ƙarfi na SARS-CoV-2 don haɓaka haɓaka don ba da shawarar ƙirar binciken asibiti.
Chlorokine magani ne mai hana cutar malaria wanda ake amfani dashi don yaki da wasu cututtukan autoimmune.
A ranar 18 ga watan Maris, WHO ta sanar da cewa, chlorokine da kuma wasu kwayoyi masu alaka da shi, hydroxychloroquine, suna cikin kwayoyi hudu da za a yi nazari a kansu a matsayin wani ɓangare na gwajin gwaji na Solidarity.
Gwamnan New York, Andrew Cuomo, ya sanar da cewa gwajin chlorokine da hydroxychloroquine a jihar New York zai fara ne daga ranar 24 ga Maris.
Ba a amince da maganin ba ta hanyar tsarin gwajin gwaji na FDA kuma an yarda da shi a matsayin magani na gwaji don gaggawa don amfani da marasa lafiya waɗanda ke asibiti amma ba su iya shiga gwajin gwaji ba a ƙarƙashin Tarayyar Turai.
"CDC ta ce ba a tabbatar da amfani da Hydroxychloroquine ba, sashi ko kuma dorewa don hanawa da kuma magance kamuwa da cutar SARS-CoV-2".
Likitoci sun ce "ba su da wani zaɓi" kuma suna amfani da maganin.
Wani rukuni na bincike na Turkiyya a Istanbul na gudanar da karamin bincike kan amfani da chlorokoine tare da zinc, bitamin A, bitamin C da bitamin D.
A jami'ar Duke da kuma Oxford suna gudanar da bincike mai zurfi.
Makarantar likitancin NYU Langon tana gudanar da gwaji game da aminci da ingancin amfani da hydroxychloroquine na rigakafi.
"Tun da aka yi a Wuhan da Shenzhen, a kasar Sin, an yi bincike a kan yadda za a iya amfani da Faviprabir don "bayyana yadda yake da tasiri".
A cikin kwanaki hudu, mutane 35 a Shenzhen sun samu sakamako mai kyau, yayin da mutane 45 da ba su samu ba sun yi kwanaki 11 suna rashin lafiya.
A wani binciken da aka gudanar a Wuhan, an yi wa mutane 240 da ke fama da cutar huhu, rabin sun karɓi Favipiravir kuma rabin sun karɓi Umfenovir.
Hukumar kula da magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke goyon bayan maganin ba ta da kyau kuma ba ta da kyau.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don tarawa da kuma amfani da su don samar da magunguna ga sojojin don asibitocin jami'a, inda za a yi amfani da magungunan don magance marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya ba da shawarar ga gwamnatin Trump game da sayen magunguna. Magungunan na iya zama marasa tasiri a yanayin rashin lafiyar inda cutar ta riga ta ninka.
Yana iya zama ba shi da lafiya ga mata masu ciki ko waɗanda suke ƙoƙarin yin ciki.
"Bincike na Lopinavir/Ritonavir (Kaletra) a hade da maganin rigakafin cutar na Lopinavir da Ritonovir ya kawo cewa ""ba a lura da wani amfani ba".
An tsara magunguna don hana cutar HIV kwafa ta hanyar ɗaure shi zuwa protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin canza magunguna don gano wani fili wanda zai yi alaƙa da prothease na SARS-CoV-2. Akwai jayayya a cikin masana kimiyya game da amfani da albarkatu don canza manufar magunguna da aka haɓaka musamman don HIV/AIDS.
WHO ta haɗa Lopinavir/Ritonavir a cikin gwajin tallafi na duniya.
An kirkiro Remdesivir kuma an ci gaba da shi a matsayin magani ga cutar Ebola da kuma kamuwa da cutar Marburg ta Gilead Sciences. Gilead Sciences ta gano cewa Remdesivir yana da aikin anti-virus a cikin vitro a kan yawancin philo-, pneumonia-, paramixone- da coronavirus-virus.
Wata matsala da ke tattare da maganin rigakafi ita ce, ta hanyar mutation, ana samun rigakafi wanda zai iya haifar da cututtuka da cututtuka masu tsanani.
Wasu karatun farko na farko sun nuna cewa akwai yiwuwar samun babban hanawar jini na Remdesivir don hanawa. Yawancin gwaje-gwaje masu bincike suna aiki, gami da gwaje-gwaje biyu da asibitin Jami'ar Cleveland suka gudanar; daya ga mutanen da ke da rashin lafiya mai matsakaici, ɗayan kuma ga mutanen da ke da rashin lafiya mai tsanani.
Akwai gwaje-gwaje guda uku na asibiti na Vitamin C a halin yanzu don asibiti da kuma bayar da magani ga mutanen da ke fama da COVID-19; biyu suna da placebo-controlled (China, Kanada) da kuma daya mara kyau (Italiya).
Jihar New York ta fara gwaji don maganin rigakafi azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) na shirin gudanar da gwaji na alvesco (cycliconide) a Taizhin don maganin cututtukan coronavirus na farko, wanda aka ɗauka ta hanyar numfashi don numfashi.
Ana gudanar da wani gwaji na wani nau'in enzyme 2 mai canza angiotensin a cikin marasa lafiya 200 masu tsanani da ke asibiti a Denmark, Jamus da Austria don tantance tasirin maganin.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar da Colchicine ke takawa wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya masu saukin kamuwa da COVID-19.
Wannan binciken da ake kira COLCORONA yana daukar manya 6000 masu shekaru 40 da sama da haka wadanda suka kamu da COVID-19 kuma suka sami alamun bayyanar cututtuka marasa lahani wanda ba su buƙatar shiga asibiti.
Matan da suke da ciki ko kuma suna shayarwa, ko kuma ba su da wata hanyar hana haihuwa mai inganci, ba su cancanci ba.
Ana gwada wasu maganin rigakafi a Italiya.
Ana amfani da ƙananan haparin mai nauyi don magance marasa lafiya sosai kuma ya ƙarfafa Hukumar Kula da Magunguna ta Italiya ta fitar da jagororin amfani da shi.
An sanar da wata binciken da aka gudanar a Italiya a ranar 14 ga Afrilu, kan amfani da maganin maganin maganin rigakafi da maganin warkarwa na anoxaparin sodium a kan marasa lafiya 300.
Tun da SARS-CoV-2 cutar ce, a yau da kullum, hankalin kimiyya ya mayar da hankali kan sake samar da magungunan kashe-guda da aka amince da su waɗanda aka ƙirƙira don cututtukan da suka gabata kamar su MERS, SARS da West Nile.
Raibhavirin: An bada shawarar Raibhavirin don maganin COVID-19 bisa ga jagororin fitowar 7 na kasar Sin.
Umfenovir: An bada shawarar Umfenovir don maganin COVID-19 bisa ga jagorar fitowar 7 na kasar Sin
Wasu maganin rigakafi da aka gano suna iya amfani da su don sababbin dalilai don magance COVID-19 sune:
Tassilyzumab (Anti-IL-6 receptor): An amince da shi a kasar Sin.
Ana gudanar da gwaje-gwaje a Italiya da China. Ka duba Tocilizumab#COVID-19.
B'A COVID-19 rigakafi ne wanda aka tsara don rigakafin cutar coronavirus 2019 (COVID-19).
Ko da yake babu wani rigakafin da ya kammala gwajin, ana ci gaba da yin ƙoƙari don samar da irin wannan rigakafin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin samun allurar rigakafi don cutar mai tasiri, SARS-CoV-2 a cikin ƙasa da watanni 18.
A watan Afrilu, an samu takardun neman rigakafi guda biyar a binciken tsaro na farko.
An gano COVID-19 a watan Disambar 2019.
A shekarar 2020, an samu babban barkewar cutar a duniya, wanda ya haifar da zuba jari mai yawa da kuma gudanar da bincike don samar da allurar rigakafi.
Yawancin kamfanoni suna amfani da bayanan da aka bayyana don haɓaka alluran rigakafin SARS-CoV-2.
A watan Afrilu, an ce, yanayin da CEPI ke shirin samar da allurar shine saurin, samar da iyawa, aikace-aikace masu yawa da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun bayyana cewa a farkon shekarar 2020 akwai bincike da ci gaban dandamali daban-daban na fasaha 10 da ke aiki don samar da allurar rigakafi mai tasiri akan COVID-19.
Babban burin dandamali da aka ci gaba da su a cikin binciken tsaro na Phase I sun haɗa da:
Nucleic acid (DNA da RNA) (Fase I mai haɓaka da kuma takarar allurar rigakafi: Moderna, mRNA-1273)
Masu ɗaukar kwayar cutar (mai haɓaka mataki na 1 da mai neman allurar rigakafi: Cancino Biology, Adenovirus Type 5 vector)
A watan Afrilu, masana kimiyya na CEPI sun bayyana cewa, mutane 115 da aka yi wa allurar rigakafi suna cikin matakai na farko na ingantawa, 78 daga cikinsu an tabbatar da su a matsayin ayyukan aiki (Active Project) (ya zuwa 79 a cewar Cibiyar Milken) da kuma 37 daga cikin wasu, amma duk wannan ya fito ne daga bayanan da aka bayyana a fili (ana tsammanin ana shirin).
Mataki na I-II na gwajin yana gudanar da gwajin farko na aminci da rigakafi, kuma ana yin su ne a kan layi, placebo-controlled, da kuma wurare da yawa yayin da ake tsara ƙarin takamaiman, ingantattun sashi.
Gwaje-gwaje na III, wanda ya haɗa da gwajin allurar rigakafi da ƙungiyoyin kulawa don hana cututtuka, yawanci suna da ƙarin mahalarta, yayin da a cikin adadi mai kyau ana lura da tasirin sakamako mara kyau.
"Daga cikin masu neman allurar rigakafi 79 a ci gaba (kamar yadda aka tabbatar a farkon watan Afrilu na 2020), 74 har yanzu ba a tantance su a kan mutane ba (duk da haka suna ƙarƙashin "bincike na farko").
A ranar 24 ga Janairu, 2020, Jami'ar Queensland a Ostiraliya ta sanar da cewa tana bincike kan yiwuwar allurar rigakafi mai ɗaure kwayoyin halitta da za ta iya gyara kwayoyin cutar ta hanyar kwayoyin halitta don haifar da amsa ga rigakafi.
A kusa da ranar 24 ga Janairu, 2020, a Kanada, Cibiyar Hoto ta Duniya (VIDO-Intervac) ta Jami'ar Saskatchewan ta sanar da fara aiki kan allurar rigakafi don fara gwaji a jikin mutum a 2021.
A ranar 26 ga Janairu, 2020, an sanar da ayyukan samar da allurar rigakafi a Cibiyar Kula da Cututtuka ta kasar Sin da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanonin Magunguna na Janssen karkashin Hanneke Schuitemaker sun sanar da cewa sun fara aikin samar da allurar rigakafi.
Janssen na ci gaba da samar da allurar riga-kafi ta Sabia tare da abokin aikinta na biotechnology, Vaxart.
A ranar 18 ga Maris, 2020, ta sanar da haɗin gwiwa tare da Emergent Bio Solutions Vacart don samar da allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, Cibiyar Kula da Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwa
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala hada-hadar rigakafin kuma sun fara gwaji.
A ranar 27 ga Fabrairu, 2020, kamfanin NewGenerex Immuno-Oncology, wanda ke da alaka da Generex, ya sanar da cewa suna fara aikin yin allurar rigakafi don samar da maganin AI-K peptide na COVID-19.
Sun so su kirkiro takaddar rigakafin da za a iya gwadawa a cikin mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryen samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Hukumar Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da
A ranar 10 ga watan Maris, 2020, Emergent Biosolutions ta sanar da cewa ta shiga cikin Novavax Inc.
A cikin ci gaba da samar da rigakafi.
Abokan hulɗa sun sanar da shirin yin gwaji na farko da na farko a cikin Yuli 2020.
A ranar 12 ga watan Maris na shekarar 2020, ma'aikatar lafiya ta Indiya ta sanar da cewa tana aiki a kan kwayoyin 11 kuma za a dauki akalla shekaru biyu da rabi kafin a samar da rigakafi, duk da cewa a cikin sauri.
A ranar 12 ga Maris, 2020, wani kamfanin kere kere a birnin Quebec, Quebec, ya ba da rahoton ci gaban kwayoyin cutar coronavirus, wanda aka samu daga Cibiyoyin Kula da Lafiya na Kanada, wanda aka ba da kudi ta hanyar bayarwa.
A cikin watan Yuli ko Agusta 2020, ana shirin yin gwajin gwaji a jikin mutum.
A farkon makon nan, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba da 'ma'ana mai yawa' ga Kurvac don samun kwangilar rigakafin Covid-19, wanda gwamnatin Jamus ta yi ta nuna rashin amincewa da shi.
A ranar 17 ga Maris, 2020, kamfanin kera magunguna na Amurka, Fiza, ya sanar da haɗin gwiwa tare da kamfanin Biotech na Jamus don samar da allurar rigakafin mRNA.
BNT162 mai neman rigakafin mRNA ne, wanda a halin yanzu yana cikin gwaji na farko, kuma ana sa ran gwajin gwaji zai fara a watan Afrilu 2020.
A ranar 17 ga Maris, 2020, a Italiya, wani kamfanin nazarin halittu na Italiya mai suna TAKIS Biotech ya sanar da cewa za su samu sakamakon gwajin gwaji a watan Afrilu na shekarar 2020 kuma za a iya gwada takararsu ta karshe a jikin mutum a kaka.
A ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) a Faransa ta sanar da saka hannun jari na dala miliyan 4.9 a wata kungiya ta bincike don allurar rigakafin COVID-19, wanda ya hada da Institut Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh, wanda ya kawo kudaden shigar da CEPI ke yi a samar da allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI don samar da allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin takaddun rigakafi daban-daban guda shida a kan dabbobi.
Masu binciken daga Kwalejin Imperial na London sun sanar a ranar 20 ga Maris, 2020 cewa suna shirya rigakafin RNA mai haɓaka kansa don COVID-19.
An kirkiro takarar rigakafin a cikin kwanaki 14 bayan karbar umarni daga China.
A karshen watan Maris, Gwamnatin Kanada ta sanar da bayar da dala miliyan 275 don samar da kudi don ayyukan bincike 96 kan rigakafin likita daga COVID-19, gami da masu neman allurar rigakafi da yawa a kungiyoyi da jami'o'i na Kanada, kamar su Medicago da Jami'ar Saskatchewan.
"A lokaci guda, gwamnatin Kanada ta ba da sanarwar dala miliyan 192 don samar da allurar COVID-19 musamman, kuma tana da shirin kafa wani "banki na alluran rigakafi" na kasa don amfani da su idan akwai wani sabon barkewar cutar coronavirus".
"A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Likita ta Jami'ar Pittsburgh sun sanar da gwajin gwajin yiwuwar rigakafin COVID-19 mai suna PittCoVacc a kan beraye, inda suka ce ""MNA ta fitar da alluran SARS-CoV-2 S1 na karamin kashi na SARS-CoV-2 wanda ya yi tasiri mai karfi a kan maganin antigen-specific antibody response [a cikin beraye] wanda ya bayyana a farkon mako na 2 bayan yin allurar"".
A ranar 16 ga Afrilu, 2020, a Kanada, Makarantar Kwalejin Magunguna ta Jami'ar Waterloo ta sanar da shirin neman takarar allurar rigakafin DNA a matsayin mai yiwuwa mai cutarwa.
Za a yi amfani da bacteriophage don tsara DNA a cikin kwayoyin halitta na mutum don samar da kwayoyin cutar marasa lahani, wanda zai iya motsa tsarin garkuwar jiki don samar da rigakafi ga SARS-CoV-2 virus.
A watan Maris na 2020, Hewlett Packard Enterprise, tare da haɗin gwiwar kamfanin Cloud Computing na Amazon, Microsoft da Google, sun kirkiro albarkatun haɗin gwiwa na gwamnatin Amurka, masana'antu da jami'o'i uku don samun damar shiga manyan kwamfutoci daga IBM.
Wasu alluran rigakafi suna da tasirin heterologous, wanda ake kira sakamako na rashin daidaito.
Wannan yana nufin cewa suna da amfani fiye da cututtukan da suke hanawa.
Ana kokarin shigar da ma'aikatan kiwon lafiya 4,170 a Australia don ƙarin gwaji na yau da kullun.
Akwai yiwuwar cewa alluran da ake ci gaba da ci gaba ba za su kasance masu aminci ko tasiri ba.
Nazarin farko na kimanta tasirin rigakafi a cikin samfuran dabbobi na COVID-19 kamar ACE2-transgenic mice, sauran dabbobi na gwaji, da dabbobi masu shayarwa waɗanda ba mutane ba ya nuna buƙatar matakan kula da lafiya ta 3-biosafety da daidaitawa na duniya don gudanar da kwayar cutar mai rai don tabbatar da ingantattun hanyoyin kariya.
An gwada alluran rigakafin SARS da MERS a kan samfurin dabbobi ba na mutum ba.
A shekarar 2020, babu wani magani ko rigakafin rigakafi ga SARS wanda aka tabbatar da cewa yana da lafiya da tasiri ga mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma ci gaba da sababbin alluran rigakafi da magunguna don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya na duniya. Babu wata takardar rigakafin da aka tabbatar da cutar MERS.
Lokacin da cutar ta barke, an yi imanin cewa binciken SARS na yanzu zai iya samar da samfurin da zai taimaka wajen samar da allurar rigakafi da rigakafi don kamuwa da cutar MERS-CoV.
A watan Maris na shekarar 2020, akwai allurar rigakafin MERS (wanda ta dogara da DNA) da ta fara gwaji na farko a cikin mutane, kuma akwai wasu uku a yanzu, dukansu alluran rigakafin cutar-vector, biyu adenoviral-vector (ChAdOx1-MERS, BVRS-GamVac) da kuma MVA-vectored (MVA-MERS-S).
Sakonnin kafofin sada zumunta sun yada ka'idar da ta ce an san cutar da ke bayan COVID-19 kuma riga an samu rigakafin.
Patents da aka ambata a cikin wasu shafukan sada zumunta na sada zumunta suna da alaƙa da patents na yanzu don jerin kwayoyin halitta da kuma alluran rigakafi don wasu nau'ikan coronavirus kamar SARS coronavirus.
Cutar B'Coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa da ke haifar da cutar SARS-CoV-2 (Civir Acute Respiratory Syndrome).
Alamomin da aka fi sani da su sun haɗa da zazzabi, tari da kuma rashin numfashi.
Sauran alamun na iya haɗa da gajiya, ciwon tsoka, fitsari, ciwon wuya, rashin ƙanshi, da ciwon ciki.
Lokacin bayyanar cututtuka daga kamuwa da cutar zuwa bayyanar cututtuka yana da kwanaki biyar, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin cututtuka suna da sauƙi, a wasu lokuta ci gaba na iya haifar da cutar huhu ta hanyar cututtuka da kuma rashin aiki na gabobin jiki.
A ranar 17 ga Afrilu, 2020, an samu karin kamuwa da cutar miliyan 2.24 a kasashe da yankuna 210 da suka yi sanadiyar mutuwar mutane sama da 153,000.
Fiye da mutane 568,000 sun warke. Kwayar cutar tana yadawa ga mutane a farkon lokacin da suka yi hulɗa da su, sau da yawa ta hanyar ƙananan ƙwayoyin da suke fitowa daga bakuna, wanda ya haifar da tari, cizon safa ko magana.
Sa'ad da aka samar da ƙwayoyin cuta a lokacin numfashi, sukan fada a ƙasa ko saman ƙasa maimakon su yada ta nesa.
Idan mutum ya taɓa fuskarsa ko hanci ko fuskarsa bayan ya taɓa wani abu mai gurɓataccen yanayi, zai iya kamuwa da cutar.
Kwayar cutar na iya rayuwa har zuwa awanni 72 a saman.
Yana da matukar cutarwa a cikin kwanaki uku na farko da bayyanar cututtuka ta fara, kodayake yana iya yaduwa kafin bayyanar cututtuka da kuma a cikin matakan da suka biyo baya na cutar.
Ana ba da shawarar masu tsabtace gida da waɗanda ake zargin suna da cutar su yi amfani da abin rufe fuska.
Shawarwarin amfani da abin rufe fuska ga jama'a na yau da kullun sun bambanta, wasu hukumomi suna ba da shawarar yin amfani da su, wasu suna ba da shawarar yin amfani da su, wasu kuma suna buƙatar yin amfani da su.
A halin yanzu babu allurar rigakafi ko maganin rigakafin cutar COVID-19.
A cikin dukkanin yankuna shida na WHO, an sami yawancin cututtukan cututtukan gida a yawancin ƙasashe.
Waɗanda suka kamu da cutar za su iya zama marasa bayyanar cututtuka ko kuma su nuna alamun mura kamar zazzabi, tari, gajiya, da kuma rashin numfashi.
Alamun gaggawa sun haɗa da numfashi, ciwon kirji ko damuwa, rikicewa, wahalar tashi, da kuma fuska ko lebe mai launin shuɗi; ana ba da shawarar samun sabis na likita nan da nan idan waɗannan alamun sun kasance.
Alamu na numfashi na sama da ba su da yawa, kamar su na numfashi, ruwa a cikin hanci ko ciwon wuya, suna iya faruwa.
Alamun gastrointestinal kamar kumburi, kumburi, da kuma fitsari sun kasance cikin bambancin kashi.
Wasu daga cikin wadanda suka kamu da cutar a kasar Sin sun fara da bugun kirji da kuma ciwon kirji.
A wasu mutane, cutar tana iya haifar da cutar huhu, rashin lafiyar jiki da kuma mutuwa.
Wannan shi ne lokacin da kwayoyin cuta suka fara aiki.
Lokacin da kwayar cutar COVID-19 ta fara farawa yana da kwanaki biyar zuwa shida amma zai iya zama daga kwana biyu zuwa 14.
Rahotanni sun nuna cewa ba a nuna alamun cutar a cikin mutane 97.5% da ke da alamun cutar ba a cikin kwanaki 11.5 na kamuwa da cutar.
Ba a san cikakken matsayin waɗannan masu ɗaukar hoto ba a cikin kamuwa da cuta; amma akwai hujjoji na farko da suka nuna cewa suna iya yin aiki don yada cutar.
Ba a san adadin mutanen da suka kamu da cutar ba kuma ana nazarin su a yanzu, rahoton Cibiyoyin Kula da Cututtuka da Rigakafin Koriya (KCDC) ya ce, kashi 20% na duk waɗanda aka tabbatar da cutar sun kasance marasa alamun cutar yayin da suke asibiti.
A ranar 1 ga watan Afrilu, Hukumar Lafiya ta kasar Sin ta fara hada marasa lafiya marasa alamun cutar a cikin yawan wadanda ke fama da cutar a kullum; a wannan rana, 130 (78%) daga cikin mutane 166 da suka kamu da cutar sun kasance marasa alamun cutar a lokacin gwajin.
A cikin 'yan jarirai, ana iya samun ƙwayoyin cuta da yawa.
Idan ka yi magana da ƙarfi fiye da yadda ake magana a yau, za ka iya samun ƙwayoyin leɓunan da yawa.
Wani bincike a Singapore ya nuna cewa shan tari ba tare da rufe fuska ba zai iya sa ƙananan saukad da su yada har zuwa mita 4.5 (15 feet).
Ko da yake cutar ba ta da iska, amma National Academy of Sciences ta nuna cewa za a iya samun yaduwar kwayoyin halitta kuma an ba da tabbataccen samfurin RNA na kwayar cutar ta iska wanda aka sanya a cikin hanyar hawa a waje da gidajen mutane.
Wasu hanyoyin magani kamar intubation da cardiopulmonary resuscitation (CPR) na iya haifar da numfashi don fitar da ƙwayoyin iska, wanda ke haifar da yaduwar iska.
Ana ganin cewa cutar tana da ƙananan haɗari, duk da cewa akwai damuwa cewa za ta iya yaduwa ta hanyar saliva. Idan akwai alamun a cikin mutane, cutar tana da matukar damuwa; ana iya yaduwa kafin bayyanar alamun bayyanar, amma haɗarin ya rage.
Cibiyoyin Turai don Rigakafin Cututtuka da Kulawa (ECDC) sun ce ba a san yadda cutar ke yaduwa ba, amma mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar cutar tana rayuwa a saman ƙasa na tsawon sa'o'i zuwa kwanaki.
Musamman, an gano cutar a cikin allon kwali har kwana ɗaya, a cikin filastik (polypropylene) da bakin karfe (AISI 304) har kwana uku, da kuma a cikin tagulla har tsawon awanni huɗu a kashi 99%.
Wannan ya bambanta dangane da zafi da zafin jiki.
Sabulu da kuma masu tsabtace ruwa suna iya zama masu amfani idan aka yi amfani da su yadda ya kamata; samfurori na sabulu suna karya matakan kariya daga kitse na cutar, suna kashe shi, kuma suna cire su daga fata da sauran farfajiyar.
Sauran hanyoyin, kamar su benzalkonium chloride da chlorhexidine gluconate (abin kashe kwayoyin cutar tiyata) ba su da tasiri sosai. A cikin wani binciken da aka gudanar a Hong Kong, an dauki samfurin lalat a tsakiyar kwanaki biyu bayan an fara asibiti.
A ranar biyu na gwajin, mutum biyar daga cikin marasa lafiya biyar sun nuna cewa sun fi kamuwa da cutar.
Ciwon huhu na acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shine sabon cututtukan cututtukan numfashi mai tsanani, wanda aka fara gano daga cikin mutane uku da ke fama da cutar huhu da ke da alaƙa da ƙungiyar cututtukan numfashi a Wuhan.
Dukkanin halaye na cutar SARS-CoV-2 suna faruwa a cikin yanayin da ake danganta da coronavirus.
A waje da jikin mutum, kwayar cutar ta mutu a cikin sabulu na gida, wanda ya lalata kumfa mai kariya.
Fuskar ta fi fama da cutar COVID-19 saboda yawan adadin kwayoyin cutar da ake samu a cikin ƙwayoyin huhu na nau'in II na alviollar shine enzyme angiotensin-transforming enzyme 2 (ACE2) wanda ke shiga cikin ƙwayoyin mai gina jiki.
"Yana amfani da wani nau'in glycoprotein na musamman da ake kira "spike" (pepoplumer) don yin hulɗa da ACE2 don shiga cikin ƙwayoyin cuta".
Kashi 12 cikin 100 na mutanen da suka kamu da cutar da cutar da aka yi musu asibiti a birnin Wuhan, China, sun kamu da mummunan bugun zuciya, kuma suna da yawa a cikin cututtuka masu tsanani.
A yayin ci gaban cutar, yawan cututtukan zuciya da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktukan cututtuktuktuktuktukan cututtuktukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
Masu karɓar ACE2 suna shiga zuciya da sauri kuma suna da hannu a aikin zuciya.
A cikin ICU marasa lafiya da suka kamu da COVID-19, an gano thrombosis (31%) da kuma venous thromboembolism (25%) kuma yana iya kasancewa yana da alaƙa da mummunan hangen nesa.
Duk da yake SARS-COV-2 yana da yanayin zuwa epithelial cell -ACE2, wanda ke haɗawa da hanyar numfashi, marasa lafiya masu tsanani na COVID-19 suna da alamun tsarin hyperinflammation.
Musamman, an gano cewa kwayoyin cutar GM-CSF-secreting T-cells a cikin marasa lafiya na COVID-19 suna da alaƙa da sake dawo da cutar huhu mai tsanani (re-recruitment) da kuma ƙwayar IL-6 mai ƙonewa.
Binciken ya nuna cewa an samu cutar lymphocytic inflorated.
WHO ta fitar da wasu hanyoyin gwaji don cutar.
Hanyar gwajin ta dace ta amfani da maɓallin sarrafawa na polymerase chain reaction (rRT-PCR) a ainihin lokacin.
Ana yin gwajin ne a kan samfurori na numfashi da aka samu ta hanyar swab na nasopharenjia; duk da haka, ana iya amfani da samfurin swab na nasal ko na lebe.
A cikin 'yan sa'o'i da kwanaki biyu ne sakamakon ya bayyana.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki samfurori biyu na jini a cikin mako biyu kuma sakamakon yana da ƙarancin ƙimar nan take.
Masana kimiyya na kasar Sin sun sami damar gano nau'in coronavirus da kuma bayyana tsarin kwayoyin halitta don haka dakunan gwaje-gwaje a duk faɗin duniya zasu iya haɓaka gwajin polymerase chain reaction (PCR) da kansa don gano kamuwa da cutar.
A ranar 4 ga Afrilu, 2020, an shirya don ci gaba da gwajin rigakafi (wanda zai iya gano kamuwa da cuta mai aiki da kuma gano ko mutum ya kamu da cutar a baya), amma har yanzu ba a yi amfani da shi sosai ba.
A gwajin, gwajin da aka yi a kasar Sin ya nuna cewa ya yi daidai ne daga kashi 60 zuwa 70 cikin 100.
A ranar 21 ga Maris, 2020, FDA ta amince da gwajin farko na gida don amfani a ƙarshen wannan watan a Amurka. Jagorancin bincike da asibitin Zhongnan na Jami'ar Wuhan ya fitar ya ba da shawarar hanyoyin gano kamuwa da cuta dangane da halaye na ganewa da haɗarin cutar.
Bi-lateral, multi-lobar ƙasa-glass opticity tare da rarraba mai nisa, mara kyau da baya na yau da kullun yana da mahimmanci a farkon kamuwa da cuta.
Ana iya ganin subplural predominance, rashin daidaituwa na paving (cikawa na lobular septal ta hanyar cika alveolar mai canzawa) da kuma haɗuwa, dangane da ci gaban cutar.
Akwai bayanai kadan game da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cututtukan cuttukan cututtukan cututtukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttuk
Babban bayanan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
Macroscopy: Fluorescence, pericarditis, lung consolidation (kama ruwa a cikin huhu) da kuma bugun jini
Akwai nau'i hudu na cutar huhu:
Rashin ƙwayar cuta: ƙwayar cuta ta cikin huhu, ƙwayar cuta mai yawa, ƙwayar cuta mai yawa, ƙwayar cuta mai yawa, ƙwayar cuta mai yawa, ƙwayar cuta mai yawa, ƙwayar cuta mai yawa, da kuma ƙwayar cuta mai yawa.
Rashin ƙwayar cuta mai tsanani: Rashin ƙwayar cuta mai lalacewa (DAD) tare da ƙwayar cuta mai lalacewa.
DAD yana haifar da cututtukan cututtukan numfashi mai tsanani (ARDS) da kuma mummunan hypoxia.
Nune-nune Sarano: Tsarin kwayoyin halitta a cikin rami na alviola da kuma cututtukan huhu na interstitial fibrosis
Jini: Yadawar jini mai narkewa (DIC); amsa ta leukoearithroblastic
Abubuwan da za a iya hana kamuwa da cutar sun hada da kasancewa a gida, guje wa wuraren da mutane suke, wanke hannuwanmu da ruwa da sabulu da numfashi a kai a kai na akalla 20 seconds, da kuma guje wa taɓa idanu, hanci ko fuska da hannayenmu.
CDC ta ba da shawarar yin amfani da ƙusa a cikin baki da hanci yayin tari ko ƙwanƙwasa, kuma idan babu ƙusa, amfani da ɓangaren ciki na kugu.
Bayan tari ko kuma numfashi, ana ƙarfafa tsabtace hannu.
CDC ta ba da shawarar yin amfani da suturar rufe fuska a cikin jama'a don iyakance kamuwa da cutar ta hanyar marasa bayyanar cututtuka. An tsara dabarun nesa da zamantakewa don rage haɗuwa da mutanen da suka kamu da cutar tare da manyan kungiyoyi ta hanyar rufe makarantu da wuraren aiki, ta hanyar hana tafiya, da kuma soke manyan taron jama'a.
Umarnin kiyaye nesa ya hada da cewa mutane su kasance aƙalla 6 feet (1.8m) nesa.
"Babu wani magani da aka sani da zai iya hana COVID-19". Tun da ba a tsammanin samun allurar rigakafi ba har zuwa 2021, babban ɓangaren sarrafa COVID-19 shine ƙoƙarin rage ƙarancin annobar, wanda ake kira ""taƙaita layin"".
CDC ta kuma shawarci mutane su wanke hannayensu a kai a kai da sabulu da ruwa na akalla dakika 20, musamman bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan
WHO ta kuma ba da shawarar yin amfani da aƙalla 60% na barasa-based sanitizers idan babu sabulu da ruwa kawai. WHO ta ba da takardun biyu don samar da gida a wuraren da ba a samun kayan aikin hannu na kasuwanci.
Ana amfani da maganin rigakafi a cikin waɗannan shirye-shiryen daga ethanol ko isopropanol.
"Ana amfani da hydrogen peroxide don kawar da ƙwayoyin cuta a cikin giya; ba shi da ""abu mai aiki don maganin maganin hanci""".
Ana ƙara glycerol a matsayin humidifier.
Mutane suna samun taimako ta hanyar sabis na taimako, wanda zai iya haɗa da maganin ruwa, taimakon oxygen, da kuma taimakon sauran gabobin da suka kamu da cutar.
Hukumar ta CDC ta bada shawarar cewa duk wanda ake zargin yana dauke da cutar ya sa abin rufe fuska.
Ana amfani da Oxygenation na Extrakorporeal Membrane (ECMO) don magance matsalolin rashin numfashi, amma har yanzu ana la'akari da fa'idodi.
Ana ba da shawarar yin tsabtace mutum da kuma ingantaccen salon rayuwa da abinci don inganta rigakafin.
WHO da Hukumar Lafiya ta Kasa ta kasar Sin sun fitar da shawarwari kan kula da mutanen da ke cikin asibiti da ke fama da cutar COVID-19.
Masu binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Har zuwa watan Afrilu 2020, babu takamaiman magani ga COVID-19.
Don bayyanar cututtuka, wasu masu ilimin likitanci suna ba da shawarar paracetamol (acetaminophen) maimakon ibuprofen don amfani na farko.
Ya kamata a yi hankali don rage haɗarin kamuwa da cutar, musamman a cikin yanayin kiwon lafiya lokacin aiwatar da hanyoyin kamar intubation ko iska ta hannu wanda zai iya haifar da ƙwayoyin iska.
Ga masu aikin kiwon lafiya da ke kula da mutanen da ke fama da COVID-19, CDC ta ba da shawarar cewa a ajiye mutum a cikin dakin keɓewa na cutar ta iska (AIIR), ban da amfani da gargadi na hujja, alamun taɓawa da kuma gargadi na iska. CDC ta bayyana umarnin amfani da kayan kariya na mutum (PPE) a lokacin annobar duniya.
Abubuwan da aka ba da shawarar sune: PPE gaunt, respirator ko fuska, kariya ga idanu da safofin hannu na likita. Idan akwai, ana ba da shawarar mai numfashi (maimakon fuska).
An ba da izinin N95 respirator don yanayin masana'antu amma FDA ta amince da masks don amfani a ƙarƙashin Dokar Amfani da Gaggawa (EUA).
An tsara su don kare su daga ƙura kamar ƙwayoyin iska, amma ba a ba da tabbacin inganci ga takamaiman kayan aiki na kwayoyin halitta don amfani da takamaiman lakabi ba.
Idan ba a samu masks ba, CDC ta bada shawarar yin amfani da masks na gida a matsayin rufe fuska ko kuma ƙarshen.
Yawancin masu kamuwa da cutar ba su da COVID-19 mai tsanani don buƙatar iska ta inji ko zaɓuɓɓuka, amma wasu sun sami kashi mai tsanani.
Ana nazarin nau'ikan taimakon numfashi a cikin mutanen da ke fama da rashin lafiyar numfashi na COVID-19 ga mutanen da ke asibiti tare da wasu shaidu na hana intubation ta hanyar amfani da high-flow na canus na numfashi ko kuma matsin lamba na iska mai kyau.
Ba a san ko kowanne daga cikin waɗannan abubuwa biyu zai kawo sakamako iri ɗaya ga waɗanda suke da ciwo mai tsanani ba.
Wasu likitoci sun zaɓi yin amfani da iska ta iska idan ana samun iska ta iska saboda wannan fasaha ta iyakance yaduwar ƙwayoyin iska fiye da na ƙananan ƙwayoyin cuta.
Yawancin ƙasashe masu tasowa ba su da isasshen asibiti a kowace mutum, wanda ke iyakance ikon gudanar da kiwon lafiya don magance ƙaruwar yawan COVID-19 da ke buƙatar shiga asibiti.
Wani bincike a kasar Sin ya nuna cewa kashi 5% na masu karbar kulawa ta gaggawa sun shiga cikin gidajen kulawa, kashi 2.3% na masu bukatar taimakon inji don samun iska, kuma kashi 1.4% sun mutu.
A kasar Sin, kusan kashi 30 cikin dari na mutanen da suka kamu da COVID-19 a asibitoci sun shiga ICU.
COVID-19 yana haifar da ciwon rashin lafiyar numfashi mai tsanani (ARDS) da kuma ƙara rikitarwa ga iska yayin da oxygenation ke zama da wahala.
Don kara yawan iskar oxygen ana bukatar matsin lamba da kuma manyan masu iska masu karfin PEEP, yayin da ake bukatar rage hadarin cutar huhu da kuma cutar huhu.
Ba za a iya samun PEEP mai girma a cikin tsofaffin iska ba.
A cikin Janairu 2020, an fara binciken yiwuwar magani, kuma ana gudanar da gwaje-gwaje na gano wasu magungunan rigakafi.
A cikin wannan labarin, mun ga cewa Red DeCivir ya kasance mafi kyau.
Ko da yake sabon magunguna na iya ɗaukar har zuwa 2021, yawancin magunguna da ake gwaji da su a yanzu sun riga an yarda da su don wasu amfani ko kuma suna cikin gwaji na gaba.
Ana iya gwada maganin rigakafi a cikin mutane masu fama da mummunan cuta.
WHO ta ba da izinin ɗan sa kai don shiga cikin gwajin tasirin magani da aminci. FDA ta ba da izinin wucin gadi ga kwandishan plasma a matsayin magani na gwaji a inda rayuwar mutum ke cikin haɗari ko kuma cikin gaggawa.
Ba a gudanar da binciken bincike na farko da ya dace don tabbatar da cewa yana da lafiya da tasiri ga cututtuka ba.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da wani app na wayar hannu don magance cutar.
Ana tambayar masu amfani su rubuta sunayensu da lambar ID.
Aikace-aikacen yana iya amfani da bayanan sa ido don gano 'ƙarin haɗari' da kuma yiwuwar haɗarin kamuwa da cuta.
Kowane mai amfani zai iya bincika matsayin wasu masu amfani uku.
Ba wai kawai app din yana ba da shawarar yin toshe kai ba, amma kuma yana gargadi da jami'an lafiya na gida idan aka gano wani hadari. Ana amfani da manyan bayanan bayanai na wayar hannu, fasahar gano fuska, bin diddigin wayar hannu da kuma ilimin kere-kere don saka idanu kan mutane da suka kamu da cutar a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izinin hukumomin tsaro su saka idanu kan bayanan wayar salula na mutanen da ake zargin sun kamu da cutar korona.
An yi wannan ne don kare mutanen da suka iya yin hulɗa da mutanen da suka kamu da cutar da kuma tilasta yin rigakafin.
A watan Maris na shekarar 2020, kamfanin sadarwa na Deutsche Telekom ya ba da bayanan da ke kan tarho na wayar tarho ga Cibiyar Robert Kah, wata hukumar gwamnatin tarayya ta Jamus, don hana yaduwar cutar.
Rasha ta yi amfani da fasahar gano fuska don gano masu karya dokar killace.
"Julio Galera, kwamishinan lafiya na yankin Italiya, ya ce masu amfani da wayoyin hannu sun gaya masa cewa, "kashi 40 cikin dari na mutane suna tafiya a ko'ina".
Gwamnatin Jamus ta shirya taron da ya dauki tsawon sa'o'i 48 a karshen mako, inda aka kai mutane sama da 42.000.
Shugaban kasar ta Estonia, Kersti Kaljulaid, ya kuma yi kira ga duniya da ta yi amfani da hanyoyin kirkire-kirkire wajen magance yaduwar cutar korona.
Mutane na iya yin rashin lafiya saboda yin keɓewa, ƙuntatawa a kan tafiya, sakamakon rashin lafiyar magani ko tsoron kamuwa da cutar.
"BBC ta yi magana da Rory O'Connor, cewa, ""kara karambanin zamantakewa, kadaici, damuwa game da lafiya, damuwa da tattalin arziki na tattalin arziki bala'i ne mai tsanani ga lafiyar mutum da kuma lafiyar mutum".
Kamar sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cuttukan cuttukan cututtukan cuttukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
A cikin ƙananan cututtuka, sau da yawa ana samun warkarwa cikin makonni biyu, amma a cikin waɗanda ke da mummunan ko mummunan cuta, yana iya ɗaukar makonni uku zuwa shida don warkewa.
Bayanai daga wasu irin cututtukan cutar kamar SARS da MERS sun nuna cewa mata masu juna biyu na iya kamuwa da COVID-19 a cikin haɗari, amma akwai karancin bayanai game da COVID-19. COVID-19 na iya haifar da cutar pneumonia a cikin wasu mutane, yana lalata huhu.
A cikin mafi yawan mutanen da suka kamu da cutar, COVID-19 na iya haifar da ci gaban cututtukan cututtukan numfashi mai tsanani (ARDS) wanda zai iya haifar da rashin lafiyar numfashi, sautin zuciya, ko rashin lafiyar jiki.
Abubuwan rikitarwa da COVID-19 ke tattare da su sun haɗa da sepsis, rashin daidaituwa na jini, da kuma lalacewar zuciya, koda da hanta.
A cikin kashi 6 cikin dari na wadanda aka kwantar da su asibiti da COVID-19, an gano rashin daidaituwa a cikin jini, musamman ma a cikin prothrombin, yayin da a cikin kashi 4 cikin dari na waɗanda aka kwantar da su asibiti, an lura da rashin daidaituwa a cikin koda.
An samu karuwar cututtukan hanta a cikin kimanin kashi 20-30 cikin dari na mutanen da ke da COVID-19.
Rahoton ya nuna cewa, tsawon lokacin da aka yi tsakanin bayyanar cututtuka da mutuwa, ciki har da shan asibiti, ya kai kwanaki goma.
Duk da haka, akwai kwanaki bakwai tsakanin shigar da marasa lafiya zuwa ICU da mutuwa.
A cikin binciken da aka yi na farkon kamuwa da cutar, tsawon lokacin da aka samu bayyanar cututtuka na farko zuwa mutuwa, tare da tsawon kwanaki shida zuwa 41, ya kasance kwanaki 14.
Wani bincike da hukumar lafiya ta kasar Sin ta gudanar ya nuna cewa mace-macen maza sun kai kashi 2.8 cikin dari, mata kuma kashi 1.7 cikin dari.
Gwaje-gwajen gyaran gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin g
An lura da canje-canje na cytopathic na cutar a cikin ƙwayar cuta.
Hotunan huhu suna kama da na acute respiratory distress syndrome (ARDS).
A cikin mutuwar da aka sanar da Hukumar Lafiya ta Kasa ta kasar Sin, an gano ciwon zuciya da karuwar ciwon zuciya ko matakan troponin a cikin kashi 11.8 cikin dari na mutuwar.
A cewar wani rahoto na watan Maris a Amurka, kashi 89 cikin dari na wadanda aka kwantar da su asibiti sun riga sun kamu da cutar.
Yawan mutuwar da aka samu daga wannan cuta ya bambanta ba kawai saboda bambancin yanki ba amma kuma saboda rashin daidaito na tsarin.
Idan aka rage yawan masu cutar da suka kamu da cutar, za a iya yin karin lissafi.
Amma, gaskiyar ita ce, mutuwar ta kasance sakamakon kamuwa da cutar a baya, wanda ke nufin cewa an rage yawan mutuwar a yanzu.
Masu shan sigari suna da damar samun alamun COVID-19 masu tsanani sau 1.4 fiye da wadanda ba sa shan sigari, kuma suna da damar samun buƙatar kulawa mai tsanani ko mutuwa kusan sau 2.4.
Jami'an asibitocin Hong Kong sun lura da raguwar ƙarfin huhu na 20% zuwa 30% a cikin wasu mutanen da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar sashi.
Wannan zai iya haifar da ciwon bayan-ciwon hankali bayan warkewa.
Har zuwa watan Maris na 2020, ba a san ko kamuwa da cutar ta baya ta samar da inganci da rigakafi na dogon lokaci tsakanin mutanen da suka warke daga cutar ba.
Ana iya samun rashin lafiyar da yawa dangane da halayyar sauran cututtukan corona, amma a cikin waɗannan lokuta an ba da rahoton warkewa daga COVID-19 bayan sakamakon gwajin COVID-19 mai kyau.
Ana zargin cewa wadannan abubuwan sun haifar da raguwar kamuwa da cuta fiye da sake kamuwa da cuta.
An yi imanin cewa cutar ta samo asali ne daga dabbobi, ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar.
Ba a san ainihin asalin ba, amma a watan Disamba na 2019, an yi amfani da kamuwa da cutar ta hanyar kamuwa da cutar daga mutum zuwa mutum.
Wani binciken da aka yi na farko na 41 da aka tabbatar da cutar COVID-19 ya bayyana a cikin The Lancet a watan Janairun 2020, inda aka fara sanar da ranar fara bayyanar cututtuka a ranar 1 ga Disamba, 2019.
WHO ta bayyana cewa farkon bayyanar cututtuka ya fara ne a ranar 8 ga Disamba, 2019.
Ana amfani da wasu matakan da aka saba amfani da su wajen tantance yawan mutuwar.
Wadannan lambobi sun bambanta ta yankuna, kuma suna shafar halaye na yawan jama'a kamar yawan gwaji, ingancin tsarin kiwon lafiya, zaɓin magani, tsawon lokacin da aka yanke tun farkon barkewar cutar, da shekaru, jinsi, da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta ƙayyade mutuwar daga cutar ta SARS-CoV-2 da aka tabbatar a cikin lab tare da lambar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan
Bisa ga kididdigar daga Jami'ar Johns Hopkins, yawan mutuwar da kamuwa da cutar a duniya ya kai 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Sauran tsarin sun haɗa da yawan mutuwar kamuwa da cuta (Case Fatallity Rate, CFR) wanda ke nuna yawan mutanen da aka gano sun mutu saboda cutar, da kuma yawan mutuwar kamuwa da cuta (Infection Fatallity Rate, IFR), wanda ke nuna yawan mutanen da suka kamu (masu kamuwa da cuta da marasa kamuwa da cuta) waɗanda suka mutu saboda cutar.
Wadannan kididdigar ba su da wani lokaci na ƙarshe kuma suna bin wasu ƙididdigar yawan jama'a daga kamuwa da cuta zuwa ganowa.
Ko da yake ba a samar da rigakafi a cikin dukan mutanen da suka kamu da cutar ba, kasancewar rigakafi na iya ba da bayanai game da yawan mutanen da suka kamu da cutar.
Cibiyar barkewar cutar a Italiya, Castiglione Diadda, karamar kauye ce mai yawan mutane 4600, inda mutane 80 (1.7%) suka riga sun mutu.
A Gangelet, cutar ta bazu ne ta hanyar bikin Carnival kuma ta yadu tsakanin matasa, wanda ke haifar da ƙananan mutuwar, kuma duk mutuwar COVID-19 ba za a iya rarraba su ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai lalace ba.
A Netherlands, ana iya tantance masu ba da jini da ke da maganin rigakafi na kusan kashi 3 cikin 100.
An tabbatar da mutuwar mutane 69 (kashi 0.004%) daga COVID-19.
A sakamakon haka, cutar ta shafi maza da mata daban-daban.
A cikin binciken da aka gudanar a China da Italiya, yawan mutuwar maza sun fi girma.
Maza suna fuskantar haɗari sosai a cikin shekarunsu na 50, kuma a cikin shekarunsu na 90, bambanci tsakanin maza da mata ya ƙare.
A kasar Sin, yawan mutuwar ya kai kashi 2.8 cikin dari na maza da kuma kashi 1.7 cikin dari na mata.
Ba a san ainihin dalilan wannan bambancin tsakanin jinsi ba, amma ana iya ganin cewa akwai abubuwan da suka shafi al'ada da kuma halayyar mutum.
Bambancin rigakafin rigakafi dangane da jinsi, yawan shan sigari a cikin mata yana da ƙarancin yawa, kuma ci gaban cututtukan co-aiki a cikin maza a ƙarami fiye da mata na iya zama abin da ke haifar da mafi girman mutuwar a cikin maza.
A Turai, maza sun kai kashi 57% na wadanda suka kamu da cutar, kuma maza sun kai kashi 72% na wadanda suka mutu a COVID-19.
Tun daga watan Afrilu na 2020, gwamnatin Amurka ba ta saka idanu kan bayanan jinsi na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan cuta irin su Ebola, HIV, influenza da SARS suna shafar maza da mata daban.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne da kuma wadanda suka fi kamuwa da cutar.
A ranar 11 ga watan Fabrairun 2020, Hukumar Lafiya ta Duniya ta sanar da cewa za a kira cutar "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin Corona, VI shine cutar, D shine cuta, kuma 19 shine lokacin da aka fara gano barkewar cutar: 31 ga Disamba, 2019.
An zabi sunan ne don kauce wa ambaton takamaiman wuri (misali, China), jinsunan dabbobi, ko kuma rukunin mutane, daidai da shawarwarin duniya na sanyawa don hana cutar ta lalacewa. An sanya sunan cutar da ke haifar da COVID-19 a matsayin cutar coronavirus ta respiratory acute respiratory syndrome 2 (SARS-CoV-2).
"A cikin hulɗar jama'a WHO ta yi amfani da ƙarin ""COVID-19 virus"" da kuma ""virus da ke da alhakin COVID-19""".
"Masu cutar da kuma cutar ana kiranta "Coronavirus".
"A lokacin farkon barkewar cutar a birnin Wuhan na kasar Sin, an yi amfani da kalmar nan "Coronavirus" da kuma "Wuhan Coronavirus" don bayyana cutar.
A watan Janairun 2020, WHO ta ba da shawarar cutar 2019-nCov da 2019-nCoV na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a cikin madaidaicin sarkar samarwa, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar na'urorin safa da sassan iska.
Alal misali, a asibiti na Italiya, mai bada kayan ya kasa samar da bawul din iska a lokacin da ake bukatarsa sosai, kuma wani sabon kamfanin ya gwada kayan da aka yi da kuma samar da bawul 100 da dare.
Bayan barkewar cutar COVID-19, an samu wasu ka'idoji, rashin gaskiya da jita-jita game da asalin cutar, matakanta, rigakafi, magani da sauran fannoni, kuma hakan ya yi saurin yaduwa a yanar gizo.
An yi imanin cewa mutane suna iya yada cutar ga sauran dabbobi.
Binciken bai samu wata hujja ba game da kwayar cutar a cikin alade, kaza da kaji.
Babu wani magani ko allurar rigakafi da aka amince da ita don magance cutar.
Kungiyar gwamnati, kungiyoyin ilimi da masana'antu suna gudanar da bincike na kasa da kasa kan alluran rigakafi da magunguna don COVID-19.
A watan Maris, Hukumar Lafiya ta Duniya ta fara gwajin "Help for Mutual Support" don tantance tasirin maganin maganin maganin riga-kafi guda hudu da suka fi yin alkawari.
Babu allurar rigakafi, amma kamfanoni suna aiki don samar da takaddun rigakafi.
Ana amfani da aikin da aka yi a kan SARS-CoV saboda duka SARS-CoV da SARS-CoV-2 suna amfani da ACE2 don shiga cikin ƙwayoyin mutum.
Ana binciken dabarun rigakafin guda uku.
Da farko, masu bincike sun yi niyyar samar da cikakken rigakafin cutar.
Ana amfani da cutar ta hanyar kashewa ko mutuwa don kawar da amsawar rigakafin mutum na gaggawa ga sabon kamuwa da cutar ta COVID-19.
Hanyar ta biyu, wato, allurar rigakafi, ita ce samar da allurar da za ta iya sa rigakafin jikin mutum ya zama mai saurin kamuwa da cutar.
A cikin SARS-CoV-2, binciken ya gano wani furotin mai suna S-spike wanda ke taimakawa kwayar cutar ta shiga cikin mai amfani da enzyme ACE2.
Dabarar ta uku ita ce allurar nucleic acid (DNA ko RNA, sabuwar hanyar yin allurar rigakafi).
Don aminci da inganci, ana buƙatar gwada alluran gwaji daga ɗayan waɗannan dabarun. A ranar 16 ga Maris, 2020, an fara gwajin gwaji na farko na allurar tare da masu sa kai huɗu a Seattle.
Ana samun kwayar cutar da ke da lambar kwayoyin halitta da ba ta haifar da cutar ba daga maganin. An nuna cewa karuwar antibody-dependent yana da ƙalubale ga samar da maganin SARS-COV-2, amma yana da ban mamaki.
Tun daga watan Afrilu 2020, an gudanar da gwaji sama da 300 na gudanarwa.
A cikin gwaje-gwaje bakwai, an yi nazarin magunguna da aka riga aka amince da su don magance cutar zazzabin cizon sauro, wanda ya haɗa da nazarin huɗu a kan Hydroxychloroquine ko Chlorokine.
Yawancin bincike a kasar Sin na amfani da magungunan rigakafi don dalilai daban-daban, kuma ana sa ran a bayar da rahoto a ƙarshen watan Afrilu a kan gwaje-gwaje na Phase III tara na Remdesivir a ƙasashe daban-daban.
A cikin watan Afrilu na shekarar 2020, an shirya wani bita mai zurfi game da ci gaban allurar COVID-19 da kuma candidates na miyagun ƙwayoyi. An kimanta wasu magungunan riga-kafi na yanzu don magance COVID-19, ciki har da Remdesivir, Chlorokine da Hydroxychloroquine, Lopinavir / Rithonavir da Interferon Bitter.
A watan Maris na 2020, an tabbatar da gwajin aikin da Remdesivir ya yi.
An samu ci gaba a cikin marasa lafiya da aka yi amfani da magungunan gwaji na Remdesivir.
Ana gudanar da gwaje-gwaje na Phase III a Amurka, China da Italiya. An yi nazarin chloroquine, wanda aka yi amfani da shi don magance malaria, a kasar Sin a watan Fabrairun 2020 tare da sakamakon farko.
Duk da haka, akwai bukatar a sake nazarin ginshiƙan bincike.
Hukumomin kiwon lafiya na kasar Korea da na kasar Sin sun bada shawarar yin amfani da chloroquine.
Amma, Cibiyar Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwaya, ta Wuhan, ta ce, yayin da ake bayar da shawarar cewa, a karbar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar kwayar
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chloroquine a kan shawarar likitoci masu kula da mutanen da ke fama da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban sashi na rabaivirin don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar nitanoxanoid don ƙarin nazarin vivo bayan an nuna rashin ƙarfi na SARS-CoV-2. Nazarin ya nuna cewa samar da furotin mai ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin
Akwai ƙuntatawa mai tsanani a cikin nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba wanda ya hana ƙungiyar likitanci karɓar waɗannan magunguna ba tare da ƙarin nazarin su ba. Oseltamivir ba ya hana SARS-CoV-2 a cikin vitro kuma ba shi da wani sanannen aiki a cikin maganin COVID-19.
A cikin mummunan COVID-19 na gaba, cutar cytokine na iya zama mawuyacin hali.
Akwai hujja cewa hydroxychloroquine na iya samun saurin sakin cytokine. Bayan kammala karamin bincike, Hukumar Lafiya ta Kasa ta kasar Sin ta hada tosillizumab a cikin takardar shaidar likita.
Wannan gwaji na biyu na rashin daidaito a matakin kasa a Italiya bayan samun sakamako mai kyau a cikin mutanen da ke da mummunan cutar.
Yin gwajin jini tare da serum ferritin don gano cutar cytokine yana nufin hana ci gaban cutar, wanda ake ganin yana haifar da mutuwar wasu mutane masu cutar.
A shekara ta 2017, an amince da maganin interleukin-6 mai karɓar maganin FDA don maganin cutar cytokine mai karɓar steroid a cikin binciken da ya gabata don magance cutar cytokine mai karɓar ƙwayar cuta.
Har zuwa yau, babu wata hujja ta bazuwar da ta nuna cewa tosilezumab magani ne mai amfani ga CRS.
Ana neman hanyar yin allurar rigakafi mara allurar rigakafi da aka samar da rigakafi ga waɗanda suka warke daga COVID-19 a matsayin hanyar da ba ta da allurar rigakafi.
An gwada wannan dabarar don SARS tare da sakamakon da ba a tabbatar ba.
Dakatar da kwayar cuta shine tsarin da ake tsammani na musamman wanda ta hanyar maganin antibody mai aiki zai iya taimakawa wajen kare kariya daga SARS-CoV-2.
Duk da haka, wasu matakai kamar antibody dependent cellular cytotoxicity da / ko phagocytosis na iya yiwuwa.
Sauran nau'ikan maganin antibody na kashewa, misali, amfani da maganin antibody na monoclonal da aka samar, suna cikin ci gaba.
Ana iya samar da maganin convalescent, wanda ya ƙunshi ruwa daga cikin jini daga marasa lafiya da suka warke kuma ana iya ƙara yawan antibodies don saurin tsara wannan kwayar cutar.
Cutar coronavirus, wata aji ce ta cututtuka da ke da alaƙa da juna
Likita Lee Wenliang, likitan asibitin Wuhan na tsakiya, ya mutu bayan ya sanar da yaduwar cutar bayan ya kamu da COVID-19.
